Psyllid ID: psy925

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------7
Protein Sequence
MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ
Secondary Structure (PSIPRED)
cccccccccccHHHHHHHHHHcccccccccccHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccccccccccHHHHHHHHHHcccccccccccHHHHHHHHHHccccHHHcccHHHHHHHHHcccccccc
Coil and Loop (DISEMBL)
mnraemssdeplADVVKHVEKgyqmeapegcppeeYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ
Flexible Loop (DISEMBL)
mnraemssdeplaDVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ
Low Complexity Region (SEG)
MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ
Disordered region (IsUnstruct)
***************************************************TFRQLKAKLLTFM*****
Disordered Region (DISOPRED)
MNRAE**SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS**
Disordered Region (DISEMBL)
***********LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ
Disordered Region (DISPRO)
******SSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	69	2.2.26 [Sep-21-2011]
P41241	450	Tyrosine-protein kinase C	yes	N/A	0.724	0.111	0.58	1e-11
P41240	450	Tyrosine-protein kinase C	yes	N/A	0.724	0.111	0.56	1e-11
P32577	450	Tyrosine-protein kinase C	yes	N/A	0.724	0.111	0.56	2e-11
Q0VBZ0	450	Tyrosine-protein kinase C	yes	N/A	0.724	0.111	0.56	2e-11
P41239	450	Tyrosine-protein kinase C	yes	N/A	0.739	0.113	0.529	7e-11
P00522	1620	Tyrosine-protein kinase A	no	N/A	0.710	0.030	0.489	1e-08
P42684	1182	Abelson tyrosine-protein	no	N/A	0.811	0.047	0.446	7e-08
Q4JIM5	1182	Abelson tyrosine-protein	no	N/A	0.811	0.047	0.446	7e-08
P14234	517	Tyrosine-protein kinase F	no	N/A	0.782	0.104	0.462	7e-08
P42683	508	Proto-oncogene tyrosine-p	no	N/A	0.739	0.100	0.470	8e-08

>sp|P41241|CSK_MOUSE Tyrosine-protein kinase CSK OS=Mus musculus GN=Csk PE=1 SV=2

 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 29/50 (58%), Positives = 36/50 (72%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L    RPTF QL+ +L
Sbjct: 391 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAATRPTFLQLREQL 440

Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs) including LCK, SRC, HCK, FYN, LYN or YES1. Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. Suppresses signaling by various surface receptors, including T-cell receptor (TCR) and B-cell receptor (BCR) by phosphorylating and maintaining inactive several positive effectors such as FYN or LCK.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2

>sp|P41240|CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens GN=CSK PE=1 SV=1

 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 28/50 (56%), Positives = 37/50 (74%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L   +RP+F QL+ +L
Sbjct: 391 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 440

Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs) including LCK, SRC, HCK, FYN, LYN or YES1. Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. Suppresses signaling by various surface receptors, including T-cell receptor (TCR) and B-cell receptor (BCR) by phosphorylating and maintaining inactive several positive effectors such as FYN or LCK.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P32577|CSK_RAT Tyrosine-protein kinase CSK OS=Rattus norvegicus GN=Csk PE=1 SV=1

 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/50 (56%), Positives = 36/50 (72%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PL DVV  VEKGY+M+AP+GCPP  Y++M+  W L    RPTF QL+ +L
Sbjct: 391 PLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440

Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs) including LCK, SRC, HCK, FYN, LYN or YES1. Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. Suppresses signaling by various surface receptors, including T-cell receptor (TCR) and B-cell receptor (BCR) by phosphorylating and maintaining inactive several positive effectors such as FYN or LCK.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q0VBZ0|CSK_BOVIN Tyrosine-protein kinase CSK OS=Bos taurus GN=CSK PE=2 SV=1

 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/50 (56%), Positives = 36/50 (72%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L    RP+F QL+ +L
Sbjct: 391 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAATRPSFLQLREQL 440

Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs) including LCK, SRC, HCK, FYN, LYN or YES1. Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. Suppresses signaling by various surface receptors, including T-cell receptor (TCR) and B-cell receptor (BCR) by phosphorylating and maintaining inactive several positive effectors such as FYN or LCK.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P41239|CSK_CHICK Tyrosine-protein kinase CSK OS=Gallus gallus GN=CSK PE=1 SV=1

 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 27/51 (52%), Positives = 38/51 (74%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           PL DVV  VEKGY+M+ P+GCP   YE+M++ W+L P  RP+F QL+ +L+
Sbjct: 391 PLKDVVPRVEKGYKMDPPDGCPAIVYEVMKKCWTLDPGHRPSFHQLREQLV 441

Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs). Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P00522|ABL_DROME Tyrosine-protein kinase Abl OS=Drosophila melanogaster GN=Abl PE=1 SV=3

 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 31/49 (63%)

Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           L DV   ++KGY+ME P GCPPE Y++MRQ W      RPTF+ +   L
Sbjct: 574 LTDVYHKLDKGYRMERPPGCPPEVYDLMRQCWQWDATDRPTFKSIHHAL 622

Arm and Abl proteins function cooperatively at adherens junctions in both the CNS and epidermis; critical for embryonic epithelial morphogenesis regulating cell shape changes and cell migration. Plays a critical role in transducing embryonic midline repulsive cues; may regulate cytoskeletal dynamics underlying a growth cone's response to midline cues. The ability of pCC/MP2 axons to correctly interpret midline repulsive cues and stay on the ipsilateral side is dependent on the strength of both Slit/robo and Abl-dependent signaling pathways.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P42684|ABL2_HUMAN Abelson tyrosine-protein kinase 2 OS=Homo sapiens GN=ABL2 PE=1 SV=1

 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 25/56 (44%), Positives = 33/56 (58%)

Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           L+ V   +EKGY+ME PEGCPP+ YE+MR  W   P  RP+F +      T   +S
Sbjct: 491 LSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETMFHDS 546

Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL, DOK1 or ARHGAP35. Adhesion-dependent phosphorylation of ARHGAP35 promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. ABL2 acts also as a regulator of multiple pathological signaling cascades during infection. Pathogens can highjack ABL2 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q4JIM5|ABL2_MOUSE Abelson tyrosine-protein kinase 2 OS=Mus musculus GN=Abl2 PE=1 SV=1

 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 25/56 (44%), Positives = 33/56 (58%)

Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           L+ V   +EKGY+ME PEGCPP+ YE+MR  W   P  RP+F +      T   +S
Sbjct: 491 LSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETMFHDS 546

Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates acrtin cytoskeletal structure through its F-actin-bundling activity.Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL or DOK1. Required for adhesion-dependent phosphorylation of ARHGAP35 which promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P14234|FGR_MOUSE Tyrosine-protein kinase Fgr OS=Mus musculus GN=Fgr PE=1 SV=2

 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 25/54 (46%), Positives = 34/54 (62%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V++ VE GY M  P GCP   YE+M QAW L PE RPTF  L++ L  +  ++
Sbjct: 454 EVLEQVEHGYHMPCPPGCPASLYEVMEQAWRLDPEERPTFEYLQSFLEDYFTST 507

Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors devoid of kinase activity and contributes to the regulation of immune responses, including neutrophil, monocyte, macrophage and mast cell functions, cytoskeleton remodeling in response to extracellular stimuli, phagocytosis, cell adhesion and migration. Promotes mast cell degranulation, release of inflammatory cytokines and IgE-mediated anaphylaxis. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as MS4A2/FCER1B, FCER1G and FCGR2. Acts downstream of ITGB1 and ITGB2, and regulates actin cytoskeleton reorganization, cell spreading and adhesion. Depending on the context, activates or inhibits cellular responses. Functions as negative regulator of ITGB2 signaling, phagocytosis and SYK activity in monocytes (PubMed:11672534). Required for normal ITGB1 and ITGB2 signaling, normal cell spreading and adhesion in neutrophils and macrophages (PubMed:8666673 and PubMed:9687507). Functions as positive regulator of cell migration and regulates cytoskeleton reorganization via RAC1 activation (PubMed:15561106). Phosphorylates SYK (in vitro) and promotes SYK-dependent activation of AKT1 and MAP kinase signaling (PubMed:21746961). Phosphorylates PLD2 in antigen-stimulated mast cells, leading to PLD2 activation and the production of the signaling molecules lysophosphatidic acid and diacylglycerol. Promotes activation of PIK3R1. Phosphorylates FASLG, and thereby regulates its ubiquitination and subsequent internalization. Phosphorylates ABL1. Promotes phosphorylation of CBL, CTTN, PIK3R1, PTK2/FAK1, PTK2B/PYK2 and VAV2. Phosphorylates HCLS1 that has already been phosphorylated by SYK, but not unphosphorylated HCLS1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P42683|LCK_CHICK Proto-oncogene tyrosine-protein kinase LCK OS=Gallus gallus GN=LCK PE=2 SV=2

 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 24/51 (47%), Positives = 35/51 (68%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E YE+M Q W  QPE RPTF  +K+ L  F 
Sbjct: 447 EVIQNLERGYRMPQPDNCPQELYELMMQCWKEQPEERPTFEYMKSVLEDFF 497

Tyrosine kinase that plays an essential role for the selection and maturation of developing T-cell in the thymus and in mature T-cell function. Is constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors and plays a key role in T-cell antigen receptor(TCR)-linked signal transduction pathways.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	69
270014846	513	hypothetical protein TcasGA2_TC010831 [T	0.724	0.097	0.78	1e-16
91092630	477	PREDICTED: similar to tyrosine-protein k	0.724	0.104	0.78	1e-16
195571699	804	GD20649 [Drosophila simulans] gi|1941997	0.724	0.062	0.8	1e-16
194744371	727	GF16628 [Drosophila ananassae] gi|190627	0.724	0.068	0.8	2e-16
195329792	804	GM26085 [Drosophila sechellia] gi|194120	0.724	0.062	0.8	2e-16
221378832	1052	C-terminal Src kinase, isoform G [Drosop	0.724	0.047	0.8	2e-16
24646022	723	C-terminal Src kinase, isoform I [Drosop	0.724	0.069	0.8	2e-16
45550738	805	C-terminal Src kinase, isoform H [Drosop	0.724	0.062	0.8	2e-16
195501861	724	GE10101 [Drosophila yakuba] gi|194184076	0.724	0.069	0.8	2e-16
390178771	1114	GA30184, isoform A [Drosophila pseudoobs	0.724	0.044	0.8	2e-16

>gi|270014846|gb|EFA11294.1| hypothetical protein TcasGA2_TC010831 [Tribolium castaneum]

 Score = 90.1 bits (222), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 39/50 (78%), Positives = 44/50 (88%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PLADVVKHVEKGY+MEAPEGCP E YE+MRQAW L P+ RPTF+ +KAKL
Sbjct: 456 PLADVVKHVEKGYKMEAPEGCPSEVYEIMRQAWDLNPDKRPTFQDVKAKL 505

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|91092630|ref|XP_968479.1| PREDICTED: similar to tyrosine-protein kinase [Tribolium castaneum]

 Score = 90.1 bits (222), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 39/50 (78%), Positives = 44/50 (88%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PLADVVKHVEKGY+MEAPEGCP E YE+MRQAW L P+ RPTF+ +KAKL
Sbjct: 420 PLADVVKHVEKGYKMEAPEGCPSEVYEIMRQAWDLNPDKRPTFQDVKAKL 469

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195571699|ref|XP_002103840.1| GD20649 [Drosophila simulans] gi|194199767|gb|EDX13343.1| GD20649 [Drosophila simulans]

 Score = 90.1 bits (222), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/50 (80%), Positives = 42/50 (84%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PLADVVKHVE GY+MEAPEGCPPE YEMMRQAW L P  RPTF +LK KL
Sbjct: 747 PLADVVKHVEVGYKMEAPEGCPPEIYEMMRQAWDLNPAKRPTFAELKVKL 796

Source: Drosophila simulans

Species: Drosophila simulans

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|194744371|ref|XP_001954668.1| GF16628 [Drosophila ananassae] gi|190627705|gb|EDV43229.1| GF16628 [Drosophila ananassae]

 Score = 90.1 bits (222), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/50 (80%), Positives = 42/50 (84%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PLADVVKHVE GY+MEAPEGCPPE YEMMRQAW L P  RPTF +LK KL
Sbjct: 670 PLADVVKHVEVGYKMEAPEGCPPEIYEMMRQAWDLNPAKRPTFAELKVKL 719

Source: Drosophila ananassae

Species: Drosophila ananassae

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195329792|ref|XP_002031594.1| GM26085 [Drosophila sechellia] gi|194120537|gb|EDW42580.1| GM26085 [Drosophila sechellia]

 Score = 90.1 bits (222), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/50 (80%), Positives = 42/50 (84%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PLADVVKHVE GY+MEAPEGCPPE YEMMRQAW L P  RPTF +LK KL
Sbjct: 747 PLADVVKHVEVGYKMEAPEGCPPEIYEMMRQAWDLNPAKRPTFAELKVKL 796

Source: Drosophila sechellia

Species: Drosophila sechellia

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|221378832|ref|NP_731611.2| C-terminal Src kinase, isoform G [Drosophila melanogaster] gi|442618589|ref|NP_001262476.1| C-terminal Src kinase, isoform L [Drosophila melanogaster] gi|220903053|gb|AAN13523.2| C-terminal Src kinase, isoform G [Drosophila melanogaster] gi|440217320|gb|AGB95858.1| C-terminal Src kinase, isoform L [Drosophila melanogaster]

 Score = 90.1 bits (222), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/50 (80%), Positives = 42/50 (84%)

Query: 11   PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            PLADVVKHVE GY+MEAPEGCPPE YEMMRQAW L P  RPTF +LK KL
Sbjct: 995  PLADVVKHVEVGYKMEAPEGCPPEIYEMMRQAWDLNPAKRPTFAELKVKL 1044

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|24646022|ref|NP_731607.1| C-terminal Src kinase, isoform I [Drosophila melanogaster] gi|24646024|ref|NP_731608.1| C-terminal Src kinase, isoform J [Drosophila melanogaster] gi|24646026|ref|NP_731609.1| C-terminal Src kinase, isoform K [Drosophila melanogaster] gi|28573084|ref|NP_788638.1| C-terminal Src kinase, isoform F [Drosophila melanogaster] gi|23171028|gb|AAN13519.1| C-terminal Src kinase, isoform I [Drosophila melanogaster] gi|23171029|gb|AAN13520.1| C-terminal Src kinase, isoform J [Drosophila melanogaster] gi|23171030|gb|AAN13521.1| C-terminal Src kinase, isoform K [Drosophila melanogaster] gi|28381250|gb|AAO41544.1| C-terminal Src kinase, isoform F [Drosophila melanogaster]

 Score = 90.1 bits (222), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/50 (80%), Positives = 42/50 (84%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PLADVVKHVE GY+MEAPEGCPPE YEMMRQAW L P  RPTF +LK KL
Sbjct: 666 PLADVVKHVEVGYKMEAPEGCPPEIYEMMRQAWDLNPAKRPTFAELKVKL 715

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|45550738|ref|NP_650097.2| C-terminal Src kinase, isoform H [Drosophila melanogaster] gi|45446455|gb|AAF54668.3| C-terminal Src kinase, isoform H [Drosophila melanogaster]

 Score = 89.7 bits (221), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/50 (80%), Positives = 42/50 (84%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PLADVVKHVE GY+MEAPEGCPPE YEMMRQAW L P  RPTF +LK KL
Sbjct: 748 PLADVVKHVEVGYKMEAPEGCPPEIYEMMRQAWDLNPAKRPTFAELKVKL 797

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195501861|ref|XP_002097975.1| GE10101 [Drosophila yakuba] gi|194184076|gb|EDW97687.1| GE10101 [Drosophila yakuba]

 Score = 89.7 bits (221), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/50 (80%), Positives = 42/50 (84%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PLADVVKHVE GY+MEAPEGCPPE YEMMRQAW L P  RPTF +LK KL
Sbjct: 667 PLADVVKHVEVGYKMEAPEGCPPEIYEMMRQAWDLNPAKRPTFAELKVKL 716

Source: Drosophila yakuba

Species: Drosophila yakuba

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|390178771|ref|XP_003736723.1| GA30184, isoform A [Drosophila pseudoobscura pseudoobscura] gi|388859583|gb|EIM52796.1| GA30184, isoform A [Drosophila pseudoobscura pseudoobscura]

 Score = 89.7 bits (221), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/50 (80%), Positives = 42/50 (84%)

Query: 11   PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            PLADVVKHVE GY+MEAPEGCPPE YEMMRQAW L P  RPTF +LK KL
Sbjct: 1057 PLADVVKHVEVGYKMEAPEGCPPEIYEMMRQAWDLNPAKRPTFAELKVKL 1106

Source: Drosophila pseudoobscura pseudoobscura

Species: Drosophila pseudoobscura

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	69
FB|FBgn0262081	1052	Csk "C-terminal Src kinase" [D	0.724	0.047	0.8	1.7e-16
ZFIN|ZDB-GENE-061103-493	450	csk "c-src tyrosine kinase" [D	0.840	0.128	0.5	4.7e-12
MGI|MGI:88537	450	Csk "c-src tyrosine kinase" [M	0.724	0.111	0.58	2.1e-11
WB|WBGene00000812	539	csk-1 [Caenorhabditis elegans	0.753	0.096	0.519	2.3e-11
UNIPROTKB|P41240	450	CSK "Tyrosine-protein kinase C	0.724	0.111	0.56	2.7e-11
RGD|1308800	450	Csk "c-src tyrosine kinase" [R	0.724	0.111	0.56	4.4e-11
UNIPROTKB|Q0VBZ0	450	CSK "Tyrosine-protein kinase C	0.724	0.111	0.56	5.7e-11
UNIPROTKB|E2RFF7	450	CSK "Uncharacterized protein"	0.724	0.111	0.56	5.7e-11
UNIPROTKB|P41239	450	CSK "Tyrosine-protein kinase C	0.739	0.113	0.529	1.6e-10
UNIPROTKB|F1SJ27	449	CSK "Uncharacterized protein"	0.724	0.111	0.54	4.2e-10

FB|FBgn0262081 Csk "C-terminal Src kinase" [Drosophila melanogaster (taxid:7227)]

 Score = 217 (81.4 bits), Expect = 1.7e-16, P = 1.7e-16
 Identities = 40/50 (80%), Positives = 42/50 (84%)

Query:    11 PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             PLADVVKHVE GY+MEAPEGCPPE YEMMRQAW L P  RPTF +LK KL
Sbjct:   995 PLADVVKHVEVGYKMEAPEGCPPEIYEMMRQAWDLNPAKRPTFAELKVKL 1044

GO:0004713 "protein tyrosine kinase activity" evidence=ISS;IDA;NAS

GO:0007165 "signal transduction" evidence=NAS

GO:0004672 "protein kinase activity" evidence=NAS

GO:0008285 "negative regulation of cell proliferation" evidence=IMP;NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0045926 "negative regulation of growth" evidence=IGI;IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0045197 "establishment or maintenance of epithelial cell apical/basal polarity" evidence=IMP

GO:0034334 "adherens junction maintenance" evidence=IMP

GO:0010669 "epithelial structure maintenance" evidence=IMP

GO:0043068 "positive regulation of programmed cell death" evidence=IMP

GO:0007293 "germarium-derived egg chamber formation" evidence=IMP

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IDA

ZFIN|ZDB-GENE-061103-493 csk "c-src tyrosine kinase" [Danio rerio (taxid:7955)]

 Score = 170 (64.9 bits), Expect = 4.7e-12, P = 4.7e-12
 Identities = 29/58 (50%), Positives = 42/58 (72%)

Query:    11 PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSL 68
             PL +VV  VEKGY+M++P+GCPP  Y++M+Q W+L   +RP+FR L+ KL   + N L
Sbjct:   391 PLKEVVPRVEKGYKMDSPDGCPPVVYDIMKQCWTLDAVVRPSFRDLREKLQDIITNEL 448

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0060027 "convergent extension involved in gastrulation" evidence=IMP

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

MGI|MGI:88537 Csk "c-src tyrosine kinase" [Mus musculus (taxid:10090)]

 Score = 164 (62.8 bits), Expect = 2.1e-11, P = 2.1e-11
 Identities = 29/50 (58%), Positives = 36/50 (72%)

Query:    11 PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L    RPTF QL+ +L
Sbjct:   391 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAATRPTFLQLREQL 440

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=ISO;TAS

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=TAS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005886 "plasma membrane" evidence=ISO;TAS

GO:0005911 "cell-cell junction" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO;TAS

GO:0008285 "negative regulation of cell proliferation" evidence=ISO;IGI;IMP

GO:0010989 "negative regulation of low-density lipoprotein particle clearance" evidence=ISO

GO:0016020 "membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019903 "protein phosphatase binding" evidence=ISO

GO:0032715 "negative regulation of interleukin-6 production" evidence=ISO

GO:0033673 "negative regulation of kinase activity" evidence=ISO

GO:0035556 "intracellular signal transduction" evidence=TAS

GO:0042997 "negative regulation of Golgi to plasma membrane protein transport" evidence=ISO

GO:0043406 "positive regulation of MAP kinase activity" evidence=ISO

GO:0045121 "membrane raft" evidence=ISO

GO:0045779 "negative regulation of bone resorption" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0050765 "negative regulation of phagocytosis" evidence=ISO

GO:0050863 "regulation of T cell activation" evidence=TAS

GO:0060368 "regulation of Fc receptor mediated stimulatory signaling pathway" evidence=ISO

GO:0070064 "proline-rich region binding" evidence=ISO

GO:0070373 "negative regulation of ERK1 and ERK2 cascade" evidence=ISO

GO:0071375 "cellular response to peptide hormone stimulus" evidence=ISO

WB|WBGene00000812 csk-1 [Caenorhabditis elegans (taxid:6239)]

 Score = 165 (63.1 bits), Expect = 2.3e-11, P = 2.3e-11
 Identities = 27/52 (51%), Positives = 41/52 (78%)

Query:    11 PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT 62
             P+ DVV+++EKGY+MEAPEGCPPE +++M + W+L  + RP+F Q+  +L T
Sbjct:   483 PIQDVVRYIEKGYRMEAPEGCPPEIFKVMNETWALSAQDRPSFGQVLQRLTT 534

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005942 "phosphatidylinositol 3-kinase complex" evidence=IEA

GO:0035014 "phosphatidylinositol 3-kinase regulator activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0009792 "embryo development ending in birth or egg hatching" evidence=IMP

GO:0002119 "nematode larval development" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005911 "cell-cell junction" evidence=IDA

GO:0030536 "larval feeding behavior" evidence=IMP

GO:0043050 "pharyngeal pumping" evidence=IMP

GO:0048747 "muscle fiber development" evidence=IMP

UNIPROTKB|P41240 CSK "Tyrosine-protein kinase CSK" [Homo sapiens (taxid:9606)]

 Score = 163 (62.4 bits), Expect = 2.7e-11, P = 2.7e-11
 Identities = 28/50 (56%), Positives = 37/50 (74%)

Query:    11 PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L   +RP+F QL+ +L
Sbjct:   391 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 440

GO:0005524 "ATP binding" evidence=IEA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0007420 "brain development" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0010989 "negative regulation of low-density lipoprotein particle clearance" evidence=IEA

GO:0019903 "protein phosphatase binding" evidence=IEA

GO:0032715 "negative regulation of interleukin-6 production" evidence=IEA

GO:0033673 "negative regulation of kinase activity" evidence=IEA

GO:0034332 "adherens junction organization" evidence=IEA

GO:0043406 "positive regulation of MAP kinase activity" evidence=IEA

GO:0045121 "membrane raft" evidence=IEA

GO:0045779 "negative regulation of bone resorption" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0048709 "oligodendrocyte differentiation" evidence=IEA

GO:0050765 "negative regulation of phagocytosis" evidence=IEA

GO:0060368 "regulation of Fc receptor mediated stimulatory signaling pathway" evidence=IEA

GO:0070064 "proline-rich region binding" evidence=IEA

GO:0070373 "negative regulation of ERK1 and ERK2 cascade" evidence=IEA

GO:0071375 "cellular response to peptide hormone stimulus" evidence=IEA

GO:0005886 "plasma membrane" evidence=TAS;IPI

GO:0005515 "protein binding" evidence=IPI

GO:0042997 "negative regulation of Golgi to plasma membrane protein transport" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=TAS

GO:0008022 "protein C-terminus binding" evidence=TAS

GO:0005737 "cytoplasm" evidence=IDA;TAS

GO:0004713 "protein tyrosine kinase activity" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007596 "blood coagulation" evidence=TAS

GO:0030168 "platelet activation" evidence=TAS

GO:0031295 "T cell costimulation" evidence=TAS

GO:0050852 "T cell receptor signaling pathway" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=IDA

GO:0005813 "centrosome" evidence=IDA

GO:0043231 "intracellular membrane-bounded organelle" evidence=IDA

RGD|1308800 Csk "c-src tyrosine kinase" [Rattus norvegicus (taxid:10116)]

 Score = 161 (61.7 bits), Expect = 4.4e-11, P = 4.4e-11
 Identities = 28/50 (56%), Positives = 36/50 (72%)

Query:    11 PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             PL DVV  VEKGY+M+AP+GCPP  Y++M+  W L    RPTF QL+ +L
Sbjct:   391 PLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO;IDA

GO:0005794 "Golgi apparatus" evidence=IEA;ISO

GO:0005813 "centrosome" evidence=IEA;ISO

GO:0005886 "plasma membrane" evidence=IEA;ISO

GO:0005911 "cell-cell junction" evidence=IEA;ISO

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0007420 "brain development" evidence=IEP

GO:0008285 "negative regulation of cell proliferation" evidence=ISO;IDA

GO:0010989 "negative regulation of low-density lipoprotein particle clearance" evidence=IDA

GO:0019903 "protein phosphatase binding" evidence=IPI

GO:0032715 "negative regulation of interleukin-6 production" evidence=IDA

GO:0033673 "negative regulation of kinase activity" evidence=IDA

GO:0034332 "adherens junction organization" evidence=IEP

GO:0042997 "negative regulation of Golgi to plasma membrane protein transport" evidence=IEA;ISO

GO:0043231 "intracellular membrane-bounded organelle" evidence=ISO

GO:0043406 "positive regulation of MAP kinase activity" evidence=IDA

GO:0045121 "membrane raft" evidence=IDA

GO:0045779 "negative regulation of bone resorption" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0048709 "oligodendrocyte differentiation" evidence=IEP

GO:0050765 "negative regulation of phagocytosis" evidence=IDA

GO:0060368 "regulation of Fc receptor mediated stimulatory signaling pathway" evidence=IDA

GO:0070064 "proline-rich region binding" evidence=IPI

GO:0070373 "negative regulation of ERK1 and ERK2 cascade" evidence=IDA

GO:0071375 "cellular response to peptide hormone stimulus" evidence=IDA

UNIPROTKB|Q0VBZ0 CSK "Tyrosine-protein kinase CSK" [Bos taurus (taxid:9913)]

 Score = 160 (61.4 bits), Expect = 5.7e-11, P = 5.7e-11
 Identities = 28/50 (56%), Positives = 36/50 (72%)

Query:    11 PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L    RP+F QL+ +L
Sbjct:   391 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAATRPSFLQLREQL 440

GO:0005886 "plasma membrane" evidence=IEA

GO:0042997 "negative regulation of Golgi to plasma membrane protein transport" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005794 "Golgi apparatus" evidence=IEA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E2RFF7 CSK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 160 (61.4 bits), Expect = 5.7e-11, P = 5.7e-11
 Identities = 28/50 (56%), Positives = 36/50 (72%)

Query:    11 PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L    RP+F QL+ +L
Sbjct:   391 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAATRPSFLQLREQL 440

GO:0005524 "ATP binding" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

UNIPROTKB|P41239 CSK "Tyrosine-protein kinase CSK" [Gallus gallus (taxid:9031)]

 Score = 156 (60.0 bits), Expect = 1.6e-10, P = 1.6e-10
 Identities = 27/51 (52%), Positives = 38/51 (74%)

Query:    11 PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
             PL DVV  VEKGY+M+ P+GCP   YE+M++ W+L P  RP+F QL+ +L+
Sbjct:   391 PLKDVVPRVEKGYKMDPPDGCPAIVYEVMKKCWTLDPGHRPSFHQLREQLV 441

GO:0005524 "ATP binding" evidence=IEA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

UNIPROTKB|F1SJ27 CSK "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 152 (58.6 bits), Expect = 4.2e-10, P = 4.2e-10
 Identities = 27/50 (54%), Positives = 35/50 (70%)

Query:    11 PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             PL DVV  VEKGY+M+AP+GCP   YE+M+  W L    RP+F QL+ +L
Sbjct:   390 PLKDVVPRVEKGYKMDAPDGCPAAVYEVMKNCWHLDAATRPSFLQLREQL 439

GO:0042997 "negative regulation of Golgi to plasma membrane protein transport" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005794 "Golgi apparatus" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P32577	CSK_RAT	2, ., 7, ., 1, 0, ., 2	0.56	0.7246	0.1111	yes	N/A
P41241	CSK_MOUSE	2, ., 7, ., 1, 0, ., 2	0.58	0.7246	0.1111	yes	N/A
P41240	CSK_HUMAN	2, ., 7, ., 1, 0, ., 2	0.56	0.7246	0.1111	yes	N/A
Q0VBZ0	CSK_BOVIN	2, ., 7, ., 1, 0, ., 2	0.56	0.7246	0.1111	yes	N/A
P41239	CSK_CHICK	2, ., 7, ., 1, 0, ., 2	0.5294	0.7391	0.1133	yes	N/A

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	69
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-18
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-16
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-14
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-13
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-07
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-06
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-06
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-05
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-04
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.001
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.001
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.001
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	0.003

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 88.6 bits (220), Expect = 1e-23
 Identities = 33/54 (61%), Positives = 40/54 (74%)

Query: 10  EPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
            PL DVV HVEKGY+MEAPEGCPPE Y++M+  W L P  RPTF+QL+ +L   
Sbjct: 203 IPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 75.4 bits (185), Expect = 2e-18
 Identities = 28/50 (56%), Positives = 37/50 (74%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PL DVV  VEKGY+M+AP+GCPP  Y++M+Q W L    RP+F QL+ +L
Sbjct: 204 PLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 69.5 bits (171), Expect = 3e-16
 Identities = 22/53 (41%), Positives = 31/53 (58%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
                 +V++ +E GY++  PE CP E YE+M Q W+  PE RPTF +L   L
Sbjct: 206 PGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 65.3 bits (160), Expect = 1e-14
 Identities = 22/50 (44%), Positives = 32/50 (64%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
              +V++++ KGY++  PE CP E YE+M   W L PE RPTF +L  +L
Sbjct: 212 SNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 62.5 bits (153), Expect = 1e-13
 Identities = 20/50 (40%), Positives = 32/50 (64%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
              +V+++++ GY++  P  CPPE Y++M Q W+  PE RPTF +L   L
Sbjct: 208 SNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 61.8 bits (151), Expect = 2e-13
 Identities = 22/50 (44%), Positives = 34/50 (68%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             A+V+++++KGY++  P  CPPE Y++M Q W+  PE RPTF +L   L
Sbjct: 209 SNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 3e-13
 Identities = 22/48 (45%), Positives = 31/48 (64%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            +V++ VE+GY+M  P  CP E Y++M Q W   PE RPTF  L++ L
Sbjct: 211 REVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 61.0 bits (148), Expect = 4e-13
 Identities = 23/45 (51%), Positives = 32/45 (71%)

Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EKGY+ME PEGCPP+ YE+MR  W   P  RP+F ++
Sbjct: 211 LSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.1 bits (148), Expect = 4e-13
 Identities = 24/49 (48%), Positives = 34/49 (69%)

Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           L +V + VEKGY+ME PEGCP + Y +M   W  +P+ RP+F +L+ KL
Sbjct: 203 LKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 3e-12
 Identities = 23/51 (45%), Positives = 33/51 (64%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           A+V++ V++GY+M  P GCP E Y++M   W   P+ RPTF  L+ KL  F
Sbjct: 211 AEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 56.8 bits (137), Expect = 1e-11
 Identities = 23/50 (46%), Positives = 35/50 (70%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           +V++++E+GY+M  P+ CP E YE+MR  W  +PE RPTF  L++ L  F
Sbjct: 211 EVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 55.4 bits (134), Expect = 4e-11
 Identities = 19/44 (43%), Positives = 27/44 (61%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           A+V+  +E G ++  PE CP E Y +M   W  +PE RPTF +L
Sbjct: 205 AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 55.5 bits (134), Expect = 5e-11
 Identities = 19/47 (40%), Positives = 28/47 (59%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L
Sbjct: 216 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 53.6 bits (129), Expect = 2e-10
 Identities = 18/47 (38%), Positives = 30/47 (63%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V   +  GY+M  P  CP E Y++M + W+ +PE RP+F+ L+ +L
Sbjct: 212 EVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 53.1 bits (127), Expect = 4e-10
 Identities = 21/47 (44%), Positives = 31/47 (65%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V++ VE+GY+M  P+ CP   +E+M Q W   PE RPTF  L++ L
Sbjct: 211 EVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 52.4 bits (125), Expect = 6e-10
 Identities = 19/47 (40%), Positives = 32/47 (68%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V++ VE+GY+M  P+GCP   +E+M+  W   P+ RPTF  +++ L
Sbjct: 211 EVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 51.9 bits (124), Expect = 7e-10
 Identities = 20/51 (39%), Positives = 32/51 (62%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           +DV+  +++GY+M   E CP E Y++M+  W  + E RPTF  L++ L  F
Sbjct: 211 SDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 8e-10
 Identities = 19/47 (40%), Positives = 26/47 (55%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           DV+K VE GY++  P  CP   Y++M   W      RPTF Q+ + L
Sbjct: 216 DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.1 bits (122), Expect = 1e-09
 Identities = 17/50 (34%), Positives = 31/50 (62%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           +V + +E G +ME P+ CPPE Y++M+  W+   + RP F  ++ +L  +
Sbjct: 206 EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 51.2 bits (123), Expect = 2e-09
 Identities = 18/50 (36%), Positives = 29/50 (58%), Gaps = 1/50 (2%)

Query: 13  ADVVKHVEKGYQ-MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           + ++K ++K  + +E PE CP + Y +M Q W+  P  RPTF  L+  L 
Sbjct: 207 SQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.4 bits (123), Expect = 2e-09
 Identities = 17/40 (42%), Positives = 27/40 (67%)

Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K +++GY+M +PE  P E Y++M+  W   P  RPTF+Q+
Sbjct: 328 KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 50.8 bits (121), Expect = 2e-09
 Identities = 19/44 (43%), Positives = 31/44 (70%)

Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           + VEKGY+M  P+ CP + Y++M++ W  +PE RP F +L+ +L
Sbjct: 205 EQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 50.5 bits (121), Expect = 3e-09
 Identities = 20/46 (43%), Positives = 30/46 (65%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++GY+ME P+ C  E Y +MR  W   P  RPTF+QL
Sbjct: 239 PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.6 bits (121), Expect = 3e-09
 Identities = 20/40 (50%), Positives = 28/40 (70%)

Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K V++GYQM  P+  PPE Y +M+  W+L+P  RPTF Q+
Sbjct: 326 KMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.0 bits (119), Expect = 5e-09
 Identities = 21/51 (41%), Positives = 33/51 (64%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
            +V++ +E+GY+M  PE CP E Y +M + W  +PE RPTF  +++ L  F
Sbjct: 210 PEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 49.8 bits (119), Expect = 6e-09
 Identities = 17/40 (42%), Positives = 26/40 (65%)

Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K +++GY+M  PE  P E Y++M+  W   P  RPTF+Q+
Sbjct: 255 KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.4 bits (118), Expect = 6e-09
 Identities = 18/63 (28%), Positives = 33/63 (52%), Gaps = 4/63 (6%)

Query: 6   MSSDEPLADVVKHV----EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           M +D+    +V H+    +   ++ AP GCP E Y +M++ W+  P  RP+F +L  ++ 
Sbjct: 222 MGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281

Query: 62  TFM 64
              
Sbjct: 282 AIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 8e-09
 Identities = 18/47 (38%), Positives = 28/47 (59%)

Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           V+K V  G  ++ PE CP +  E+MR  W   P++RPTF ++ + L 
Sbjct: 230 VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 48.6 bits (116), Expect = 1e-08
 Identities = 17/43 (39%), Positives = 26/43 (60%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           +VV+ V  GY++  P+  P E Y +M   W  +PE RP F++L
Sbjct: 209 EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 48.6 bits (116), Expect = 1e-08
 Identities = 19/42 (45%), Positives = 28/42 (66%)

Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +E GY+M AP+ CP E Y +M Q W+  PE RP+F ++  +L
Sbjct: 208 IESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 48.4 bits (115), Expect = 2e-08
 Identities = 19/49 (38%), Positives = 28/49 (57%)

Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           ++ GY+ME PE C  E Y +M   W  +P+ RPTF  +  +L   M+ S
Sbjct: 242 LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 47.7 bits (113), Expect = 3e-08
 Identities = 20/48 (41%), Positives = 30/48 (62%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           A++ + + +GY+ME P  C  E YE+MRQ W  +P  RP F Q+  +L
Sbjct: 225 AELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 47.4 bits (112), Expect = 4e-08
 Identities = 18/48 (37%), Positives = 30/48 (62%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           A++ + + +GY++E P  C  E Y++MRQ W  +P  RP+F Q+   L
Sbjct: 218 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 47.3 bits (112), Expect = 5e-08
 Identities = 18/46 (39%), Positives = 29/46 (63%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K + +G++M+ P  C  E Y +MR+ W   P  RPTF+QL
Sbjct: 241 PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 46.8 bits (111), Expect = 6e-08
 Identities = 17/47 (36%), Positives = 30/47 (63%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V++HV  G +++ PE CP + Y++M   W+  P  RPTF +++  L
Sbjct: 221 EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 46.7 bits (111), Expect = 7e-08
 Identities = 16/40 (40%), Positives = 23/40 (57%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V+ +V  G  +  P+ CP E Y +MR  WS  P  RP+F
Sbjct: 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF 279

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 46.6 bits (110), Expect = 7e-08
 Identities = 21/47 (44%), Positives = 30/47 (63%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L
Sbjct: 211 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 257

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 46.7 bits (111), Expect = 7e-08
 Identities = 17/47 (36%), Positives = 30/47 (63%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M   W  +PE+RPTF +L +++
Sbjct: 210 DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 46.1 bits (109), Expect = 1e-07
 Identities = 16/50 (32%), Positives = 32/50 (64%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           +V+  +E+G +++ P  CPPE Y +M+  W  + E RP F +++ ++ T+
Sbjct: 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 45.9 bits (109), Expect = 1e-07
 Identities = 15/40 (37%), Positives = 23/40 (57%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +++ P+GCP   Y +M   W   PE RP F
Sbjct: 229 EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNF 268

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 45.9 bits (109), Expect = 1e-07
 Identities = 18/50 (36%), Positives = 29/50 (58%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           ++  +++ GY++  P  CP E + +M   W+L PE RP+F QL   L  F
Sbjct: 227 EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 1e-07
 Identities = 18/46 (39%), Positives = 30/46 (65%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y +MR+ W   P  RPTF+QL
Sbjct: 241 PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.8 bits (108), Expect = 2e-07
 Identities = 19/46 (41%), Positives = 29/46 (63%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL
Sbjct: 247 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 3e-07
 Identities = 16/45 (35%), Positives = 25/45 (55%)

Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           +E+G ++  P+ CP E Y +M+  W  + + RPTFR L   L   
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 44.6 bits (105), Expect = 3e-07
 Identities = 19/46 (41%), Positives = 29/46 (63%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL
Sbjct: 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 44.5 bits (105), Expect = 4e-07
 Identities = 16/48 (33%), Positives = 32/48 (66%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +++  ++ KG +++ P  C  + YE+M Q WS +P+ RP+F+ L+ +L
Sbjct: 222 SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 44.2 bits (104), Expect = 6e-07
 Identities = 18/48 (37%), Positives = 30/48 (62%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           A++ + + +GY++E P  C  E Y++MRQ W  +P  RP+F Q+   L
Sbjct: 230 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 43.8 bits (103), Expect = 7e-07
 Identities = 17/47 (36%), Positives = 27/47 (57%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           DV+K VE G+++ AP  CP   +++M   W  +   RP F Q+ + L
Sbjct: 216 DVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 43.7 bits (103), Expect = 8e-07
 Identities = 16/43 (37%), Positives = 25/43 (58%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           DV+K +E+GY++ AP  CP   +++M   W      RP F Q+
Sbjct: 217 DVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQI 259

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.5 bits (102), Expect = 9e-07
 Identities = 14/38 (36%), Positives = 24/38 (63%)

Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           ++ GY+M  P+    E Y++M + W+ +PE RP+F  L
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 43.3 bits (102), Expect = 9e-07
 Identities = 15/48 (31%), Positives = 27/48 (56%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            ++  ++  G +++ PE C  E Y++M   W   P+ RPTF +L+  L
Sbjct: 222 HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 43.2 bits (102), Expect = 1e-06
 Identities = 14/53 (26%), Positives = 27/53 (50%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           P  ++   +EKG ++  P  C  + Y ++ + W +  E RPTF++L  +    
Sbjct: 216 PAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 42.7 bits (101), Expect = 2e-06
 Identities = 13/29 (44%), Positives = 18/29 (62%)

Query: 28  PEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P  CP + YE+M + W    E RPTFR++
Sbjct: 262 PPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 42.7 bits (100), Expect = 2e-06
 Identities = 14/44 (31%), Positives = 24/44 (54%)

Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT 62
           +E+G ++  PE CP   Y +M + W   P  RP+F  +  +L +
Sbjct: 209 IEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 42.0 bits (99), Expect = 3e-06
 Identities = 12/47 (25%), Positives = 25/47 (53%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V++ + +G  ++ P  CP E Y++M   W   P+ R   + +  +L
Sbjct: 232 EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.0 bits (99), Expect = 3e-06
 Identities = 13/45 (28%), Positives = 28/45 (62%)

Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           +  +++ +++G ++  P  CP E Y++M+  W  +P+ RP+F  L
Sbjct: 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 4e-06
 Identities = 17/53 (32%), Positives = 29/53 (54%)

Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +  +V+ +E+G ++  P  CP E Y++MR+ W  QP  R TF+ L       +
Sbjct: 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 41.1 bits (96), Expect = 7e-06
 Identities = 15/42 (35%), Positives = 25/42 (59%)

Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           V+K V  G  ++ P+ CP    ++MR  W   P++RPTF ++
Sbjct: 230 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 40.9 bits (96), Expect = 8e-06
 Identities = 13/49 (26%), Positives = 25/49 (51%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT 62
           +V++ +     +  PE CP   Y +M + W+  P  RP F+ +  +L +
Sbjct: 234 EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 39.6 bits (92), Expect = 2e-05
 Identities = 13/48 (27%), Positives = 28/48 (58%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           + ++ + +G ++E P  CPPE Y +M+  W  +P+ R   + + ++L 
Sbjct: 232 EAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 39.6 bits (92), Expect = 2e-05
 Identities = 17/49 (34%), Positives = 26/49 (53%), Gaps = 4/49 (8%)

Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +MS+ E    V+K +  G+++ AP  CP   Y++M Q W      RP F
Sbjct: 213 DMSNHE----VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRF 257

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 39.5 bits (92), Expect = 2e-05
 Identities = 15/48 (31%), Positives = 27/48 (56%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           ++VV+ +  G+++  P       YE+M+  W  +PE RP+F  L  +L
Sbjct: 208 SEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 39.2 bits (91), Expect = 3e-05
 Identities = 15/47 (31%), Positives = 24/47 (51%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V++ V K   +   E CPP  Y +M + W   P  RP F+ +  +L
Sbjct: 234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 39.2 bits (91), Expect = 3e-05
 Identities = 14/42 (33%), Positives = 27/42 (64%)

Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++
Sbjct: 230 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 38.6 bits (90), Expect = 4e-05
 Identities = 17/57 (29%), Positives = 31/57 (54%), Gaps = 3/57 (5%)

Query: 4   AEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             +S +E L  +        ++  PEGCP   Y++M + W++ P+ RP+F +L + L
Sbjct: 220 YGLSDEEVLNRLQ---AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 38.9 bits (90), Expect = 5e-05
 Identities = 16/44 (36%), Positives = 25/44 (56%)

Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           + +++G +M AP+   PE Y+ M   W  +P  RPTF +L   L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 38.1 bits (88), Expect = 8e-05
 Identities = 16/43 (37%), Positives = 23/43 (53%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           +  + ++ G +M APE   PE Y +M   W   P+ RPTF  L
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSAL 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 37.3 bits (86), Expect = 1e-04
 Identities = 15/52 (28%), Positives = 26/52 (50%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT 62
           P  ++   +EKG ++  P  C  + Y +M + W +  E RP FR+L  +   
Sbjct: 216 PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 37.3 bits (86), Expect = 1e-04
 Identities = 15/38 (39%), Positives = 24/38 (63%)

Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           +++GY+M  P     E YE+M++ W  + E+RP F QL
Sbjct: 355 IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 36.8 bits (85), Expect = 2e-04
 Identities = 17/43 (39%), Positives = 25/43 (58%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           +  + +++G +M APE   PE Y +M   W   PE RPTF +L
Sbjct: 284 EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 36.5 bits (84), Expect = 3e-04
 Identities = 14/50 (28%), Positives = 27/50 (54%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           P +++   +EKG ++  P  C  + Y +M + W +  + RP FR+L  + 
Sbjct: 216 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 265

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 36.0 bits (83), Expect = 5e-04
 Identities = 15/43 (34%), Positives = 26/43 (60%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           +VV+ + +G+++  P+      YE+M   W  +PE RPTF +L
Sbjct: 209 EVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAEL 251

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 35.7 bits (82), Expect = 5e-04
 Identities = 16/53 (30%), Positives = 29/53 (54%)

Query: 4   AEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           AE  +     +V   +EKG ++  P+ C  + Y +M + W +   +RPTF++L
Sbjct: 209 AEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 35.6 bits (82), Expect = 5e-04
 Identities = 14/47 (29%), Positives = 24/47 (51%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           DV+  +E+ Y++  P  CP   +++M   W      RP F Q+ + L
Sbjct: 219 DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 35.3 bits (81), Expect = 8e-04
 Identities = 14/33 (42%), Positives = 17/33 (51%)

Query: 28  PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           P  CP   YE+M Q WS     RP+F  + A L
Sbjct: 270 PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 35.0 bits (80), Expect = 0.001
 Identities = 14/50 (28%), Positives = 27/50 (54%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           DV++ +     +  P+ CP   Y +M + W+  P  RP F+ + ++L T+
Sbjct: 234 DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 34.7 bits (79), Expect = 0.001
 Identities = 12/47 (25%), Positives = 27/47 (57%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V++ + +G  ++ P  CP E Y++M   W  +P +R   +++ + L
Sbjct: 230 EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 34.6 bits (79), Expect = 0.001
 Identities = 13/48 (27%), Positives = 27/48 (56%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +++  ++ +G +++ P  C    Y +M   W L P+ RP+F  L+ +L
Sbjct: 221 SEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 33.7 bits (77), Expect = 0.003
 Identities = 14/44 (31%), Positives = 24/44 (54%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           ++ V+ V +G ++  P     + Y +M   W  + E RPTF+QL
Sbjct: 208 SETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	69
KOG0197|consensus	468		99.85
KOG1026|consensus	774		99.77
KOG4257|consensus	974		99.72
KOG0196|consensus	996		99.72
KOG4278|consensus	1157		99.71
KOG0200|consensus	609		99.67
KOG1095|consensus	1025		99.66
KOG1024|consensus	563		99.65
KOG0192|consensus	362		99.6
KOG0199|consensus	1039		99.54
PHA02988	283	hypothetical protein; Provisional	99.47
KOG1025|consensus	1177		99.45
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.45
KOG0194|consensus	474		99.43
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.43
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.42
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.39
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.35
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.35
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.32
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.32
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.32
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.31
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.3
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.29
KOG0193|consensus	678		99.28
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.27
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.27
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.27
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.26
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.26
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.26
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.25
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.25
KOG4721|consensus	904		99.24
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.24
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.23
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.23
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.23
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.22
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.22
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.22
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.22
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.22
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.22
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.22
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.22
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.21
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.21
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.21
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.2
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.2
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.19
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.19
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.18
KOG1094|consensus	807		99.18
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.18
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.17
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.17
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.17
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.17
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.17
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.17
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.16
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.15
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.15
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.15
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.15
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.14
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.14
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.14
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.14
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.14
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.13
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.13
KOG0195|consensus	448		99.12
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.12
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.12
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.1
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.1
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.09
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.09
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.09
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.08
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.08
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.07
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.06
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.06
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.04
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.02
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.01
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	98.99
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	98.99
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	98.98
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	98.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	98.95
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	98.95
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	98.94
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	98.93
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	98.92
PTZ00283	496	serine/threonine protein kinase; Provisional	98.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	98.9
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	98.9
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	98.89
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	98.89
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	98.88
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	98.87
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	98.86
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	98.84
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	98.84
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	98.84
PTZ00267	478	NIMA-related protein kinase; Provisional	98.84
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	98.83
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	98.83
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	98.83
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	98.82
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	98.82
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	98.81
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	98.8
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	98.8
KOG0581|consensus	364		98.8
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	98.78
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	98.76
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	98.76
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	98.75
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	98.74
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	98.74
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	98.74
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	98.74
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	98.74
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.73
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	98.73
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	98.7
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	98.7
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	98.69
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	98.69
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	98.68
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	98.68
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	98.68
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	98.67
KOG0198|consensus	313		98.66
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	98.66
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	98.65
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	98.65
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	98.64
PHA02882	294	putative serine/threonine kinase; Provisional	98.64
PLN00034	353	mitogen-activated protein kinase kinase; Provision	98.63
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	98.62
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	98.62
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	98.62
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	98.62
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	98.61
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	98.61
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	98.61
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	98.61
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	98.61
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	98.6
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	98.6
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	98.6
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	98.59
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	98.59
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	98.59
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	98.58
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	98.58
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	98.56
KOG0201|consensus	467		98.56
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	98.54
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	98.54
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	98.54
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	98.52
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	98.52
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	98.51
PTZ00263	329	protein kinase A catalytic subunit; Provisional	98.51
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	98.5
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	98.5
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	98.5
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	98.49
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	98.49
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	98.47
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	98.47
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	98.45
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	98.44
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	98.43
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	98.42
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	98.42
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	98.41
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	98.41
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	98.4
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	98.4
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	98.4
KOG4645|consensus	1509		98.39
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	98.39
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	98.39
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	98.39
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	98.38
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	98.36
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	98.35
KOG0588|consensus	786		98.35
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	98.35
KOG0578|consensus	550		98.34
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	98.33
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	98.33
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	98.32
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	98.32
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	98.31
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	98.31
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	98.3
KOG0575|consensus	592		98.29
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	98.28
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	98.27
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	98.27
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	98.27
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	98.26
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	98.26
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	98.25
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	98.25
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	98.23
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	98.23
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	98.23
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	98.23
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	98.22
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	98.22
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	98.21
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	98.21
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	98.2
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	98.2
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	98.19
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	98.19
KOG0983|consensus	391		98.19
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	98.19
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	98.19
KOG0591|consensus	375		98.18
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	98.18
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	98.17
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	98.17
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	98.17
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	98.16
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	98.16
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	98.16
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	98.15
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	98.14
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	98.13
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	98.13
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	98.12
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	98.12
KOG0582|consensus	516		98.11
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	98.11
KOG1023|consensus	484		98.11
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	98.11
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	98.11
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	98.1
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	98.1
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	98.1
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	98.09
PTZ00036	440	glycogen synthase kinase; Provisional	98.09
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	98.09
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	98.09
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	98.08
PTZ00266	1021	NIMA-related protein kinase; Provisional	98.07
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	98.06
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	98.06
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	98.05
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	98.05
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	98.03
PTZ00024	335	cyclin-dependent protein kinase; Provisional	98.03
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	98.03
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	98.03
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	98.02
KOG0583|consensus	370		98.0
KOG0584|consensus	632		98.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	97.99
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	97.98
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	97.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	97.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	97.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	97.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	97.96
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	97.94
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	97.93
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	97.93
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	97.92
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	97.92
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	97.9
KOG4279|consensus	1226		97.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	97.89
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	97.85
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	97.85
PLN00009	294	cyclin-dependent kinase A; Provisional	97.85
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	97.84
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	97.83
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	97.83
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	97.82
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	97.8
KOG0589|consensus	426		97.78
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	97.78
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	97.78
KOG0580|consensus	281		97.78
KOG0615|consensus	475		97.78
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	97.77
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	97.77
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	97.76
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	97.76
KOG1989|consensus	738		97.76
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	97.75
KOG0592|consensus	604		97.73
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	97.73
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	97.7
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	97.7
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	97.7
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	97.69
KOG0033|consensus	355		97.67
KOG0579|consensus	1187		97.62
PTZ00284	467	protein kinase; Provisional	97.61
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	97.6
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	97.56
KOG0596|consensus	677		97.56
KOG1006|consensus	361		97.55
KOG2052|consensus	513		97.53
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	97.45
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	97.43
KOG2345|consensus	302		97.41
KOG0598|consensus	357		97.41
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	97.33
KOG4717|consensus	864		97.31
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	97.28
PHA03209	357	serine/threonine kinase US3; Provisional	97.28
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	97.23
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	97.21
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	97.18
KOG0577|consensus	948		97.17
KOG0603|consensus	612		97.17
KOG0574|consensus	502		97.1
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	97.09
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	96.99
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	96.93
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	96.9
KOG0032|consensus	382		96.9
KOG0694|consensus	694		96.9
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	96.88
PHA03211	461	serine/threonine kinase US3; Provisional	96.86
KOG0593|consensus	396		96.84
KOG0587|consensus	953		96.81
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	96.77
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	96.77
PHA03212	391	serine/threonine kinase US3; Provisional	96.73
KOG0614|consensus	732		96.7
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	96.67
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	96.66
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	96.65
KOG0599|consensus	411		96.61
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	96.6
KOG0616|consensus	355		96.56
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	96.56
PHA03207	392	serine/threonine kinase US3; Provisional	96.54
PLN00181	793	protein SPA1-RELATED; Provisional	96.54
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	96.48
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	96.47
KOG0611|consensus	668		96.33
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	96.23
KOG0610|consensus	459		96.17
KOG0661|consensus	538		96.05
KOG3653|consensus	534		96.0
KOG0690|consensus	516		95.78
KOG0585|consensus	576		95.49
KOG1187|consensus	361		95.46
PHA03210	501	serine/threonine kinase US3; Provisional	95.35
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	94.89
KOG0586|consensus	596		94.72
KOG0597|consensus	808		94.6
KOG0605|consensus	550		94.49
KOG0696|consensus	683		94.43
KOG1027|consensus	903		93.42
KOG0576|consensus	829		93.29
KOG0604|consensus	400		93.05
KOG0595|consensus	429		92.71
KOG1035|consensus	1351		92.38
KOG4158|consensus	598		91.73
KOG0660|consensus	359		91.6
KOG0671|consensus	415		89.6
KOG0659|consensus	318		89.02
KOG1151|consensus	775		88.54
KOG1165|consensus	449		87.7
KOG0606|consensus	1205		86.48
KOG0667|consensus	586		82.98
KOG0658|consensus	364		81.87
KOG1167|consensus	418		80.88

>KOG0197|consensus

Probab=99.85  E-value=1.1e-20  Score=110.18  Aligned_cols=65  Identities=35%  Similarity=0.709  Sum_probs=62.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||+++++.++++.|.+|+|++.|..||.++|++|..||+.+|.+||||..+...+..+....
T Consensus       401 G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  401 GRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             CCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            89999999999999999999999999999999999999999999999999999999999887654

>KOG1026|consensus

Probab=99.77  E-value=1.4e-18  Score=105.67  Aligned_cols=65  Identities=25%  Similarity=0.582  Sum_probs=61.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+++++||++.|++|.-++.|.+||.++|.||..||+.+|.+||+|++|...|..+.+.+
T Consensus       702 G~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  702 GKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             ccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            89999999999999999999999999999999999999999999999999999999999887643

>KOG4257|consensus

Probab=99.72  E-value=3.7e-18  Score=102.82  Aligned_cols=65  Identities=29%  Similarity=0.625  Sum_probs=61.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      -|..||.|..+.+|+..+.+|.|++.|++||+.+|.||.+||.++|.+||.|.+|...|..+++.
T Consensus       588 lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  588 LGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             hcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            48999999999999999999999999999999999999999999999999999999999988763

>KOG0196|consensus

Probab=99.72  E-value=2.3e-17  Score=100.82  Aligned_cols=66  Identities=30%  Similarity=0.588  Sum_probs=62.5

Q ss_pred             CC-cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            1 MN-RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         1 ~~-g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |+ |+-||=++++++|+..|..|+|+|.|-+||..+++||..||+.+...||.|.+|+..|++++-+
T Consensus       828 mSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  828 MSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             cccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            45 8999999999999999999999999999999999999999999999999999999999998643

>KOG4278|consensus

Probab=99.71  E-value=5.5e-17  Score=98.21  Aligned_cols=65  Identities=37%  Similarity=0.743  Sum_probs=61.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |--||+|.+..+|+..+..|+|+..|..||+.+|+||..||+.+|.+||+|++|...|+.++..+
T Consensus       463 GMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  463 GMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             CCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            66799999999999999999999999999999999999999999999999999999999988653

>KOG0200|consensus

Probab=99.67  E-value=6.2e-16  Score=93.43  Aligned_cols=63  Identities=27%  Similarity=0.568  Sum_probs=58.6

Q ss_pred             cCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEP-LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~-~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||++.. ..++++.+.+|+|+..|..|+.++|++|..||+.+|.+||+|.+++..|...+.
T Consensus       518 G~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  518 GGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             CCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            899999987 678888899999999999999999999999999999999999999999988643

>KOG1095|consensus

Probab=99.66  E-value=3.6e-16  Score=97.69  Aligned_cols=64  Identities=27%  Similarity=0.464  Sum_probs=59.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||++.++.+|...+.+|.|++.|..||..+|++|..||+.+|++||+|..|+..+..+...
T Consensus       901 G~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  901 GATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             CCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            8999999999999998988889999999999999999999999999999999999988777654

>KOG1024|consensus

Probab=99.65  E-value=7.1e-16  Score=89.29  Aligned_cols=64  Identities=28%  Similarity=0.505  Sum_probs=61.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |+.||...++.|+...+++|+|+..|-+||.+++.+|.-||...|++||+|++++..|.+|...
T Consensus       495 g~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  495 GKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             CCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence            8999999999999999999999999999999999999999999999999999999999988643

>KOG0192|consensus

Probab=99.60  E-value=9e-15  Score=84.14  Aligned_cols=66  Identities=24%  Similarity=0.485  Sum_probs=59.4

Q ss_pred             CCcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            1 MNRAEMSSDEPLADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      ++|+.||.+++..++...+ ..+.|+..|..|++.+..+|..||..+|..||+|.+|+..|..+...
T Consensus       240 ~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  240 LTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             HHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            3689999999998777766 67899999999999999999999999999999999999999887654

>KOG0199|consensus

Probab=99.54  E-value=2.4e-14  Score=87.53  Aligned_cols=57  Identities=23%  Similarity=0.533  Sum_probs=54.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      |+.||.|.+..+|++.|..|.|+++|+.|+++||++|..||..+|.+||+|..|...
T Consensus       312 GEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  312 GEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             CCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            899999999999999999999999999999999999999999999999999999743

>PHA02988 hypothetical protein; Provisional

Probab=99.47  E-value=4.2e-13  Score=74.60  Aligned_cols=64  Identities=14%  Similarity=0.214  Sum_probs=55.5

Q ss_pred             CCcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      ++|..||.+.+..++...+ ..+.++..|..++.++.+++.+||..+|.+||++.+++..|+.+.
T Consensus       216 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        216 FTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            3689999999888877776 455677777789999999999999999999999999999998775

>KOG1025|consensus

Probab=99.45  E-value=4.6e-13  Score=83.08  Aligned_cols=65  Identities=25%  Similarity=0.502  Sum_probs=61.2

Q ss_pred             CC-cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            1 MN-RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         1 ~~-g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |+ |+.||.+++..+|...++.|.|++.|+.|+.++|.+|.+||..++..||.|+++...+.++..
T Consensus       894 mTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  894 MTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             HhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            45 999999999999999999999999999999999999999999999999999999999888754

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.45  E-value=2.2e-13  Score=74.75  Aligned_cols=58  Identities=28%  Similarity=0.658  Sum_probs=51.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      |..||.+.+..++...+.++.++..+..++..+++++..||..+|.+||+|.+|+..|
T Consensus       202 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  202 GKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            6799999999999999999999888899999999999999999999999999998765

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0194|consensus

Probab=99.43  E-value=1.1e-12  Score=77.54  Aligned_cols=65  Identities=32%  Similarity=0.495  Sum_probs=60.6

Q ss_pred             CcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||+++++.++...| .+|+|.+.|...|.++..++..||..+|..||+|.++...+..+...
T Consensus       358 ~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  358 NGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             cCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            588999999999999998 88999999999999999999999999999999999999999887653

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.43  E-value=7.5e-13  Score=72.30  Aligned_cols=62  Identities=27%  Similarity=0.602  Sum_probs=56.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      |..||.+.+..++...+..+.+++.|..++.++.++|..||..+|.+||++.+|...|..++
T Consensus       195 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~  256 (257)
T cd05116         195 GQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY  256 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence            88999998888888888888888888899999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.42  E-value=1.4e-12  Score=71.62  Aligned_cols=62  Identities=29%  Similarity=0.494  Sum_probs=56.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      .|..||.+.+..+++..+.++.+++.|..++..+.+++..||..+|.+||++.+|...|.++
T Consensus       204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         204 YGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            38999999988888888888888888889999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.39  E-value=3.3e-12  Score=69.98  Aligned_cols=62  Identities=26%  Similarity=0.616  Sum_probs=56.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      |..||.+.+..++...+..|.++..|..++.++.+++..||..+|.+||++.+|...|..++
T Consensus       195 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         195 GQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             CCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            88999999888888888899888888899999999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.35  E-value=4.5e-12  Score=69.93  Aligned_cols=60  Identities=22%  Similarity=0.502  Sum_probs=55.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+.+..++...+..+.....|..++.++.+|+..||..+|.+||++.+|+..|..
T Consensus       223 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         223 GLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            888999998888888888888777888999999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.35  E-value=1.1e-11  Score=68.72  Aligned_cols=64  Identities=28%  Similarity=0.603  Sum_probs=58.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+....++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|+.++..
T Consensus       226 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         226 GGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             CCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            8899999988888888888888888888999999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.32  E-value=1.8e-11  Score=67.05  Aligned_cols=61  Identities=39%  Similarity=0.788  Sum_probs=55.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||++.+..++...+..+.+...|..++.++.+++.+||..+|.+||++.++.+.|+.+
T Consensus       202 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         202 GMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            8899999888888888888888888889999999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.32  E-value=1.6e-11  Score=67.37  Aligned_cols=61  Identities=21%  Similarity=0.469  Sum_probs=54.9

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||.+....++...+..+.+...+..++..+.+++..||..+|++||++.+++..|+.+
T Consensus       211 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         211 GQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            7889999888888888888887777788999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.32  E-value=1.4e-11  Score=67.24  Aligned_cols=60  Identities=30%  Similarity=0.626  Sum_probs=54.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+.+..++...+..+.+++.+..++.++.++|..||..+|.+||++.+++..|+.
T Consensus       201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         201 GQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            789999998888888888888888888999999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.31  E-value=2.2e-11  Score=67.14  Aligned_cols=63  Identities=29%  Similarity=0.547  Sum_probs=56.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..+.++..+..++.++.+++..||..+|.+||++.+++..|..+..
T Consensus       216 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         216 GQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            889999988878877788888877777889999999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.30  E-value=1.5e-11  Score=67.90  Aligned_cols=60  Identities=23%  Similarity=0.511  Sum_probs=54.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+....++...+.++...+.|..++.++.+++..||+.+|.+||++.+|+..|+.
T Consensus       223 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         223 GLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            778999988888888888888777788999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.29  E-value=4.8e-11  Score=66.04  Aligned_cols=64  Identities=25%  Similarity=0.483  Sum_probs=57.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+....++...+..|.++..+..++.+++.++..||..+|.+||++.++...|..+...
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         208 GAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            8899999988877777888888888888999999999999999999999999999988887643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0193|consensus

Probab=99.28  E-value=2.9e-12  Score=77.15  Aligned_cols=65  Identities=25%  Similarity=0.432  Sum_probs=56.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEA----PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~----p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |+|+.||.....++|+.+|.+|+-.+.    -.+|+.++.+|+..||.+++.+||.|.+|+..|..++.
T Consensus       587 ltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  587 LTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             HhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            579999998788899999999964332    25789999999999999999999999999998887765

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.27  E-value=5.3e-11  Score=66.37  Aligned_cols=64  Identities=31%  Similarity=0.599  Sum_probs=57.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         215 GGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            8899999988888888888887777888999999999999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.27  E-value=3.6e-11  Score=65.61  Aligned_cols=58  Identities=26%  Similarity=0.460  Sum_probs=52.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      |..||.+.+..++...+..+.++..|...+.++.+++.+||..+|.+||++.+++..|
T Consensus       198 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         198 GKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            7889999888888888888888877888899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.27  E-value=2.8e-11  Score=66.14  Aligned_cols=60  Identities=37%  Similarity=0.710  Sum_probs=54.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+.+..++...+..+.+.+.+..++.++.+++.+||..+|.+||++.++...|+.
T Consensus       200 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         200 GRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            889999988888888888888888888899999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.26  E-value=7e-11  Score=64.77  Aligned_cols=61  Identities=33%  Similarity=0.592  Sum_probs=55.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||.+....++...+..+.+.+.+..++..+.+++..||..+|.+||++.+++..|..+
T Consensus       205 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         205 GERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            8899999988888888888888777888999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.26  E-value=4.4e-11  Score=65.37  Aligned_cols=60  Identities=32%  Similarity=0.573  Sum_probs=53.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+....++...+..+.+.+.+..++.++.+++.+||..+|.+||+++++...|+.
T Consensus       201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         201 GKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            889999988888888888887777777899999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.26  E-value=3.7e-11  Score=65.57  Aligned_cols=62  Identities=32%  Similarity=0.569  Sum_probs=55.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      |..||...+..++...+..+.+.+.|..++..+++++.+||..+|.+||++.++...|..+.
T Consensus       195 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         195 GAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            88999998888888888888877888899999999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.25  E-value=6.4e-11  Score=66.56  Aligned_cols=64  Identities=22%  Similarity=0.483  Sum_probs=56.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+++.|..++.++.+++..||..+|.+||++.+++..+..+...
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         208 GSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            8899999888777777788888888888999999999999999999999999999998877643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.25  E-value=9.8e-11  Score=65.41  Aligned_cols=64  Identities=31%  Similarity=0.580  Sum_probs=58.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+...+..++.++.+++.+||..+|.+||++.+++..|.+++.-
T Consensus       236 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         236 GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             CCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            7889999988888888888888778888999999999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4721|consensus

Probab=99.24  E-value=5.2e-12  Score=76.39  Aligned_cols=63  Identities=22%  Similarity=0.404  Sum_probs=56.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      ++|+.||.+.....|++.|-.+ ..++.|..||..+.-||..||..-|.+||+|.+|+.+|+-+
T Consensus       305 LT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  305 LTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             HhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            4799999999999999988544 66889999999999999999999999999999999887654

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.24  E-value=9.8e-11  Score=64.19  Aligned_cols=61  Identities=26%  Similarity=0.514  Sum_probs=54.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||...+..++...+..+.+.+.+..++.++++++..||..+|.+||++.+++..|.++
T Consensus       207 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         207 GERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            8899988888788888887877777778999999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.23  E-value=1.2e-10  Score=63.64  Aligned_cols=63  Identities=30%  Similarity=0.532  Sum_probs=54.9

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..+.++..+..++..+.+++..||..+|.+||++.+++..|+.++.
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         199 GAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            567888888777777788887777778889999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.23  E-value=9.2e-11  Score=64.26  Aligned_cols=61  Identities=25%  Similarity=0.500  Sum_probs=55.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||.+.+..++...+..+..+..|..++.++.+++.+||..+|.+||++.+++..|..+
T Consensus       212 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         212 GQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            7899999988888888888877778889999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.23  E-value=1.2e-10  Score=64.60  Aligned_cols=65  Identities=20%  Similarity=0.463  Sum_probs=57.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...+..|.....+..++.++.+++.+||..+|.+||++.++...|+.+...+
T Consensus       219 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         219 GKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            78999998888888888888776777789999999999999999999999999999998887643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.22  E-value=8.4e-11  Score=66.55  Aligned_cols=64  Identities=28%  Similarity=0.500  Sum_probs=54.2

Q ss_pred             cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.... .+...+..|.++..|..++.++.+++..||..+|.+||++.+++..|+.++.+
T Consensus       273 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         273 GASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             CCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            88999987654 44555677777777888999999999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.22  E-value=1.7e-10  Score=64.61  Aligned_cols=65  Identities=31%  Similarity=0.588  Sum_probs=58.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|..++...
T Consensus       239 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         239 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             CCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            78899988887888778888877788889999999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.22  E-value=9e-11  Score=64.58  Aligned_cols=62  Identities=29%  Similarity=0.595  Sum_probs=55.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      |..||.+.+..++...+..+.+...+..++.++.+++.+||..+|.+||++.+++..|..++
T Consensus       208 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         208 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            88999998887877778888777777889999999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.22  E-value=1.5e-10  Score=64.20  Aligned_cols=62  Identities=34%  Similarity=0.696  Sum_probs=56.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      |..||.+.+..++...+..+.++..|..++.++.+++.+||..+|.+||++.+++..|..+.
T Consensus       231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         231 GGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            88999999888888888888888888889999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.22  E-value=1.5e-10  Score=63.59  Aligned_cols=65  Identities=29%  Similarity=0.609  Sum_probs=58.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      .|..||.+.+..+....+..+.+++.|..++.++.+++.+||..+|.+||++.+++..|..+..+
T Consensus       204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         204 LGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            38899999988777777888888888889999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.22  E-value=1.3e-10  Score=64.55  Aligned_cols=64  Identities=20%  Similarity=0.402  Sum_probs=57.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||...+..++...+..+.....+..++.++.+++..||..+|.+||++.++...|..+...
T Consensus       222 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         222 GKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            8899999888888888888877777788999999999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.22  E-value=1.2e-10  Score=63.90  Aligned_cols=61  Identities=28%  Similarity=0.520  Sum_probs=54.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||.+.+..+....+.++.+.+.+..++.++.+++.+||..+|.+||++.+++..|..+
T Consensus       206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         206 GERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            8899999888777777888887777788999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.22  E-value=8.6e-11  Score=64.62  Aligned_cols=59  Identities=31%  Similarity=0.608  Sum_probs=52.9

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+.+..++...+..+..+..|..++.++.+++..||..+|.+||++.+++..|.
T Consensus       218 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         218 AEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            88899999888888878777777788889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.21  E-value=1.9e-10  Score=63.51  Aligned_cols=64  Identities=23%  Similarity=0.480  Sum_probs=58.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+...+.|..++.++.+++.+||..+|.+||++.+++..|.++...
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         208 GAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            8999999988888888888887788888999999999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.21  E-value=1e-10  Score=64.18  Aligned_cols=61  Identities=25%  Similarity=0.482  Sum_probs=54.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||.+.+..++...+..+.+.+.+..++.++.+++..||..+|.+||++.+|+..|+.+
T Consensus       208 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         208 GERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            8899999888888888877777777888999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.21  E-value=7.8e-11  Score=64.45  Aligned_cols=60  Identities=37%  Similarity=0.696  Sum_probs=53.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+.+..++...+..+.+++.+..++..+.+++..||..+|.+||++.++...|+.
T Consensus       201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         201 GRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            889999988888887787777777778899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.20  E-value=1.1e-10  Score=63.78  Aligned_cols=60  Identities=47%  Similarity=0.878  Sum_probs=53.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||...+..++...+..+.....+..++..+.+++.+||..+|.+||++.++...|+.
T Consensus       196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         196 GRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            889999888888888888887777788899999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.20  E-value=1.1e-10  Score=63.90  Aligned_cols=60  Identities=32%  Similarity=0.622  Sum_probs=52.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+....+....+..+...+.+...+..+.+++..||..+|.+||++.+++..|+.
T Consensus       200 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         200 GRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            889999988877777777777777778899999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.19  E-value=1.2e-10  Score=63.53  Aligned_cols=59  Identities=41%  Similarity=0.805  Sum_probs=53.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+.+..+....+..+.++..+..++..+.+++..||..+|.+||++.+++..|.
T Consensus       194 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         194 GRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            88999999888888888888877777889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.19  E-value=1.5e-10  Score=63.77  Aligned_cols=59  Identities=20%  Similarity=0.494  Sum_probs=52.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+.+..++...+..|.....+..++.++.+++.+||..+|.+||++.+++..|+
T Consensus       221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         221 GKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            88999998888888888888766667789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.18  E-value=1.6e-10  Score=63.09  Aligned_cols=60  Identities=37%  Similarity=0.660  Sum_probs=53.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+.+.......+..+.+.+.+..++.++.+++.+||..+|.+||+++++...|+.
T Consensus       201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         201 GRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            889999988888888888888777788889999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG1094|consensus

Probab=99.18  E-value=6.8e-11  Score=71.65  Aligned_cols=61  Identities=30%  Similarity=0.475  Sum_probs=51.6

Q ss_pred             cCCCCCCCCHHHHHHHHHc----C---CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEK----G---YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~----g---~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      .+.||+.++..++++....    +   ..+..|..||.+++++|..||+.+..+||+|++++..|...
T Consensus       737 ~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  737 REQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            5789999999998876532    1   23667899999999999999999999999999999887653

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.18  E-value=1.8e-10  Score=63.08  Aligned_cols=60  Identities=33%  Similarity=0.656  Sum_probs=53.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+.+..++...+..+...+.+...+.++.+++.+||..+|.+||++.++...|+.
T Consensus       200 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         200 GRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            889999988887777788887777778899999999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.17  E-value=2e-10  Score=63.56  Aligned_cols=60  Identities=25%  Similarity=0.537  Sum_probs=53.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+.+..++...+..+..++.+..++.++.+++..||..+|.+||++.+|...|..
T Consensus       223 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         223 GLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            788999988888888888887777788899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.17  E-value=3.8e-10  Score=63.93  Aligned_cols=64  Identities=30%  Similarity=0.577  Sum_probs=57.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+...+..++.++.+++.+||..+|.+||++.+++..|..+...
T Consensus       233 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         233 GGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            7889999988888888888888788888999999999999999999999999999999988744

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.17  E-value=3e-10  Score=62.37  Aligned_cols=62  Identities=34%  Similarity=0.596  Sum_probs=54.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      |..||.+....++...+..+.+.+.+..++..+.+++.+||..+|.+||++.+++..|+.++
T Consensus       200 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         200 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            78899998888877777777766667789999999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.17  E-value=4.7e-10  Score=63.04  Aligned_cols=63  Identities=30%  Similarity=0.592  Sum_probs=56.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..+.++..|..++.++.+++.+||..+|.+||++.+++..|..+..
T Consensus       233 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         233 GGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            788999988888888888887777788899999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.17  E-value=2.4e-10  Score=62.45  Aligned_cols=58  Identities=31%  Similarity=0.553  Sum_probs=52.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++.+||..+|.+||++.+++..|
T Consensus       198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         198 GKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            7899998888888888888888888888999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.17  E-value=2.1e-10  Score=62.78  Aligned_cols=58  Identities=24%  Similarity=0.395  Sum_probs=51.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      |..||...+..++...+..+.+...+...+..+.+++..||..+|.+||++.+|+..+
T Consensus       198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         198 GKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            7889998888788888888888777788899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.16  E-value=3.4e-10  Score=62.48  Aligned_cols=59  Identities=25%  Similarity=0.562  Sum_probs=52.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+.+..++...+..+.+...|..++..+.+++..||..+|.+||++.+++..|.
T Consensus       218 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         218 GYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            88999998888888778777777778889999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.15  E-value=4e-10  Score=62.20  Aligned_cols=63  Identities=25%  Similarity=0.487  Sum_probs=55.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.....+...+..+.+.+.+..++.++.+++..||..+|..||++.+++..+..+..
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         208 GAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            788999888877777788888777788899999999999999999999999999988877643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.15  E-value=3.1e-10  Score=61.90  Aligned_cols=60  Identities=55%  Similarity=1.005  Sum_probs=53.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||...+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|+.
T Consensus       196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         196 GRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            788999888888888787787777788899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.15  E-value=3.1e-10  Score=61.60  Aligned_cols=58  Identities=40%  Similarity=0.715  Sum_probs=53.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|
T Consensus       204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         204 GATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            6899999998888888888888888889999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.15  E-value=5.8e-10  Score=62.40  Aligned_cols=64  Identities=22%  Similarity=0.479  Sum_probs=56.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+....++...+..+.+++.+..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         208 GGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            7899999887777777788887777788999999999999999999999999999998887643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.14  E-value=3.4e-10  Score=66.03  Aligned_cols=62  Identities=26%  Similarity=0.550  Sum_probs=52.8

Q ss_pred             cCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLAD-VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~-i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      |..||......+ ....+..|.++..|..++.++.+++.+||..+|.+||++.+|+..|+.++
T Consensus       338 g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         338 GGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            788998876554 34556778888888889999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.14  E-value=2.9e-10  Score=61.97  Aligned_cols=59  Identities=14%  Similarity=0.205  Sum_probs=51.1

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|..||...+.......+..+...+.|..++.++.+++.+||..+|.+||++.+|+..
T Consensus       194 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         194 CTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             hhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            36889999888777777788887777778899999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.14  E-value=3.6e-10  Score=62.56  Aligned_cols=59  Identities=22%  Similarity=0.568  Sum_probs=52.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||...+..+....+..+.....|..++..+.+++..||..+|.+||++.+|...|.
T Consensus       221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         221 GKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             CCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            78899888887777778788777778889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.14  E-value=3.9e-10  Score=61.67  Aligned_cols=60  Identities=35%  Similarity=0.588  Sum_probs=52.9

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      |..||.+.+..++...+..+.+.+.+...+.++.+++.+||..+|.+||++.++...|+.
T Consensus       200 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         200 GRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            788999988878777777777777788899999999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.14  E-value=3.6e-10  Score=61.91  Aligned_cols=59  Identities=29%  Similarity=0.617  Sum_probs=52.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||...+..++...+..+.+...+..+|..+.+++..||..+|.+||++.++...|.
T Consensus       210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         210 GQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            78899988887877777777777778889999999999999999999999999998775

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.13  E-value=4.6e-10  Score=62.22  Aligned_cols=59  Identities=29%  Similarity=0.535  Sum_probs=52.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+.+..++...+..+..+..|..++.++++++..||..+|.+||++.+++..|+
T Consensus       229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         229 GMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            67899888888888888888777777889999999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.13  E-value=6.3e-10  Score=62.33  Aligned_cols=64  Identities=28%  Similarity=0.566  Sum_probs=56.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.++..+..++.++.+++.+||..+|.+||++.+++..+..+...
T Consensus       220 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         220 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             CCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            8899998888777777777777777778899999999999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0195|consensus

Probab=99.12  E-value=1.3e-10  Score=65.66  Aligned_cols=63  Identities=17%  Similarity=0.265  Sum_probs=56.3

Q ss_pred             CcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +++.||.++++.++--+| .+|.|..+|+.++..+..||.-|...+|.+||.|..|+-.|+++.
T Consensus       384 trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  384 TREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            578999999998764444 889999999999999999999999999999999999998887753

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.12  E-value=3.7e-10  Score=65.12  Aligned_cols=61  Identities=30%  Similarity=0.599  Sum_probs=51.7

Q ss_pred             cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||.+.... .+...+..+.+...|...+.++.+++..||..+|.+||++.+|+..|+..
T Consensus       313 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         313 GSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            78899887654 55566677887777788899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.12  E-value=8e-10  Score=60.02  Aligned_cols=58  Identities=33%  Similarity=0.696  Sum_probs=52.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      |..||.+.....+...+..+.+...+..++.++.+++.+||..+|.+||++.++...|
T Consensus       191 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l  248 (250)
T cd05085         191 GVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL  248 (250)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence            7889999988887778888888777888999999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.10  E-value=7e-10  Score=63.18  Aligned_cols=64  Identities=27%  Similarity=0.499  Sum_probs=54.0

Q ss_pred             cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.... ++...+..+.++..|..+++++.+++..||..+|.+||++.+|+..|..+++.
T Consensus       278 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         278 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            78899887544 44555677777777778899999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.10  E-value=1e-09  Score=60.22  Aligned_cols=61  Identities=26%  Similarity=0.542  Sum_probs=53.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||.+....++...+..+..+..+..++..+.+++..||..+|++||++.+++..|+.+
T Consensus       212 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         212 GQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            7889988887777777777776666778899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.09  E-value=6.9e-10  Score=64.04  Aligned_cols=62  Identities=32%  Similarity=0.600  Sum_probs=51.8

Q ss_pred             cCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLAD-VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~-i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      |..||.+..... +...+..+.++..|...+.++.+++..||..+|.+||++.++++.|..++
T Consensus       311 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         311 GKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            889998876543 34455667777777788999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.09  E-value=1e-09  Score=60.95  Aligned_cols=66  Identities=26%  Similarity=0.502  Sum_probs=56.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhc
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSL   68 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~~   68 (69)
                      |..||.+.+..++...+..+.....+..++.++.+++..||..+|.+||++.+++..+...+...+
T Consensus       218 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  283 (288)
T cd05061         218 AEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF  283 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence            678999988888887777777677778889999999999999999999999999999887765543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.09  E-value=5.2e-10  Score=65.25  Aligned_cols=63  Identities=22%  Similarity=0.497  Sum_probs=53.7

Q ss_pred             cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.... .+...+..+.++..+..++.++.+++..||..+|.+||++.++.+.|..++.
T Consensus       336 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         336 GGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             CCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            78899887554 4455667787888888899999999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.08  E-value=8.6e-10  Score=59.93  Aligned_cols=59  Identities=32%  Similarity=0.628  Sum_probs=51.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+.........+..+.+...|..++.++.+++.+||..+|.+||++.+++..|.
T Consensus       192 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         192 GDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            78899988877777777777777778889999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.08  E-value=9.6e-10  Score=60.66  Aligned_cols=59  Identities=24%  Similarity=0.587  Sum_probs=51.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+.+..++...+..+.....+..++..+.+++..||..+|.+||++.+++..|+
T Consensus       218 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         218 AEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            67899998888877777777666677889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.07  E-value=1.3e-09  Score=59.39  Aligned_cols=58  Identities=26%  Similarity=0.532  Sum_probs=51.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      |..||......++...+..+.++..|...+.++++++..||..+|.+||++.+++..|
T Consensus       198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         198 GKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            7889988887788888888888777888899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.06  E-value=1e-09  Score=59.67  Aligned_cols=57  Identities=11%  Similarity=0.065  Sum_probs=49.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||...+..+....+..+..+..+..++.++.+++.+||..+|++||++.+++.
T Consensus       196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         196 TGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             hCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            688999988877777777778777777788999999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.06  E-value=1.4e-09  Score=59.16  Aligned_cols=59  Identities=25%  Similarity=0.555  Sum_probs=51.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||...+.......+..+.+...+..++..+.+++.+||..+|.+||++.++...|.
T Consensus       193 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         193 GAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            78899888887777777777777778889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.04  E-value=1.9e-09  Score=61.47  Aligned_cols=64  Identities=30%  Similarity=0.512  Sum_probs=53.3

Q ss_pred             cCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLAD-VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~-i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+....+ ....+..+.+...|..++.++.+++.+||..+|.+||++.+++..|..+++.
T Consensus       272 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         272 GASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             CCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            788998865543 3445567777777788899999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.02  E-value=1.5e-09  Score=59.15  Aligned_cols=58  Identities=12%  Similarity=0.173  Sum_probs=50.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||......++...+..|..+..+..++.++.+++..||+.+|.+||++.+++.+
T Consensus       196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         196 TLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            6888998877777777777787777788899999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.01  E-value=3.4e-09  Score=58.07  Aligned_cols=62  Identities=13%  Similarity=0.120  Sum_probs=47.3

Q ss_pred             CcCCCCCCCC--HHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            2 NRAEMSSDEP--LADVVKHVEKGYQMEAP-EGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         2 ~g~~Py~~~~--~~~i~~~v~~g~r~~~p-~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      +|..||....  ..++...+..+..++.+ ...+..+.+++.+||..+|.+||++.+++..++.+
T Consensus       201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         201 ALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             cCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            5788886543  23555566555444433 46788999999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.00  E-value=4.1e-09  Score=57.43  Aligned_cols=59  Identities=32%  Similarity=0.623  Sum_probs=49.9

Q ss_pred             cCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVE-KGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~-~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+.+..++...+. .+.....+...+.++.+++..||..+|.+||++.+++..|.
T Consensus       197 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         197 GEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            889999888877776664 45666667788999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=98.99  E-value=3.8e-09  Score=59.22  Aligned_cols=61  Identities=30%  Similarity=0.597  Sum_probs=50.4

Q ss_pred             cCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLAD-VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~-i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||.+....+ +...+..+.+...+...+.++.+++.+||..+|.+||++.+++..|.++
T Consensus       240 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         240 GSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            888998877653 4445566766666777899999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=98.99  E-value=3.3e-09  Score=57.61  Aligned_cols=57  Identities=37%  Similarity=0.714  Sum_probs=51.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      |..||.+.+..++...+..+.+...+..++.++.+++.+||..+|.+||++.+++..
T Consensus       201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  257 (258)
T smart00219      201 GESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI  257 (258)
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence            788999888888888888888888888899999999999999999999999998865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=98.98  E-value=3.2e-09  Score=58.17  Aligned_cols=58  Identities=14%  Similarity=0.237  Sum_probs=48.3

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.+..+.+..+..+..+..|..++.++.+++..||..+|.+||++.+++.
T Consensus       206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         206 LTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            3688999988766555556666667777889999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=98.96  E-value=5.4e-09  Score=57.12  Aligned_cols=63  Identities=16%  Similarity=0.139  Sum_probs=48.6

Q ss_pred             CcCCCCCCC--CHHHHHHHHHcCCCCCCCC-CCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            2 NRAEMSSDE--PLADVVKHVEKGYQMEAPE-GCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         2 ~g~~Py~~~--~~~~i~~~v~~g~r~~~p~-~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +|..||.+.  +..++...+..+...+.|. ..+.++.+++..||..+|.+||++.+|+..+..+.
T Consensus       201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         201 ALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            577788544  3335555566666665555 78889999999999999999999999999887753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=98.95  E-value=6.2e-09  Score=58.21  Aligned_cols=59  Identities=25%  Similarity=0.441  Sum_probs=45.6

Q ss_pred             cCCCCCCCCHHHHHHHHHc----C---CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEK----G---YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~----g---~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      +..||.+.+..++...+..    .   .....|..++..+.+++..||..+|.+||++.+|...|.
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            6789998887766554422    1   123346678999999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=98.95  E-value=3.8e-09  Score=57.48  Aligned_cols=57  Identities=14%  Similarity=0.233  Sum_probs=50.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+.....+...+.++.+++..||..+|.+||++.+|+.
T Consensus       205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         205 ALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            588999988877777778877766777889999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=98.94  E-value=6.3e-09  Score=57.11  Aligned_cols=61  Identities=10%  Similarity=0.103  Sum_probs=47.4

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAP-EGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p-~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      ++|..||.......+...+..+...+.+ ..++.++.+++..||..+|.+||++.++...+.
T Consensus       207 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         207 CTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            3578899877766666666555544433 367899999999999999999999999987663

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=98.93  E-value=3.7e-09  Score=57.46  Aligned_cols=57  Identities=18%  Similarity=0.274  Sum_probs=47.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.......+..+...+.+..++.++.+++..||..+|.+||++.+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         196 SLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             hCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            578899888776666666666666667789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=98.92  E-value=7.8e-09  Score=57.21  Aligned_cols=46  Identities=35%  Similarity=0.811  Sum_probs=39.0

Q ss_pred             HHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925           19 VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus        19 v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +..+.+++.|..++.++.+++..||..+|.+||++++++..|..+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            3445555667788999999999999999999999999999887764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=98.90  E-value=7.1e-09  Score=61.96  Aligned_cols=58  Identities=21%  Similarity=0.249  Sum_probs=51.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..+++..+..+...+.|..++.++.+++..||..+|.+||++.+++..
T Consensus       240 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        240 TLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            5889999988888888888887777788999999999999999999999999998753

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=98.90  E-value=7.9e-09  Score=56.28  Aligned_cols=58  Identities=19%  Similarity=0.292  Sum_probs=48.4

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.+.......+..+..+..+...+.++.+++..||..+|.+||++.+++.
T Consensus       196 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         196 ATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            4688899887776666666677665666788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=98.90  E-value=7.7e-09  Score=57.09  Aligned_cols=58  Identities=17%  Similarity=0.132  Sum_probs=47.1

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.....+...+..+..+..+..++.++.+++..||..+|.+||++.+++.
T Consensus       195 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         195 AKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             HhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            3588898877766666666666555556678899999999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=98.89  E-value=4.8e-09  Score=57.94  Aligned_cols=58  Identities=17%  Similarity=0.150  Sum_probs=48.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+.......+..+..+..+..++.++.+++.+||..+|.+||++.+++..
T Consensus       196 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         196 KGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            5888998888776666666666655666788999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=98.89  E-value=1.3e-08  Score=56.70  Aligned_cols=59  Identities=25%  Similarity=0.540  Sum_probs=45.7

Q ss_pred             cCCCCCCCCHHHHHHHHHc-----C--CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEK-----G--YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~-----g--~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||...+..++...+..     +  ...+.+..++..+.+++..||..+|.+||++.+|...|.
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         230 KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             CCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            6789988877666544321     1  223446678999999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=98.88  E-value=8.6e-09  Score=56.06  Aligned_cols=58  Identities=14%  Similarity=0.255  Sum_probs=47.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||...+..+....+..+...+.++..+.++.+++..||..+|++||++.+++..
T Consensus       197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         197 TLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             hCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            5788998877766665566666555667789999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=98.87  E-value=1.4e-08  Score=56.08  Aligned_cols=58  Identities=16%  Similarity=0.147  Sum_probs=48.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+.......+..+..+..+..++.++.+++..||..+|.+||++.+++..
T Consensus       196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         196 KGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            5889998887766666666666666667789999999999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=98.86  E-value=1.5e-08  Score=56.11  Aligned_cols=57  Identities=21%  Similarity=0.309  Sum_probs=42.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      +|..||.+.+..+....+....+  .|...+.++.++|.+||..+|.+||+|.+|+..|
T Consensus       217 ~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         217 DGEVPLKERTPSEKERFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             CCCCCccccChHHHHHHHHhccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            47888888776655444333332  2344567899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=98.84  E-value=1.4e-08  Score=55.37  Aligned_cols=58  Identities=14%  Similarity=0.143  Sum_probs=48.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..+....+..|...+.+..++.++.+++..||..+|.+||++.+++..
T Consensus       196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         196 TLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            5788998877777777777776666667789999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=98.84  E-value=1.9e-08  Score=54.66  Aligned_cols=57  Identities=19%  Similarity=0.287  Sum_probs=49.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||...+..++...+..+..+..+...+.++.+++.+||..+|.+||++.+++.
T Consensus       196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         196 TFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             hCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            588999988887777777777766677788999999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=98.84  E-value=2.1e-08  Score=54.94  Aligned_cols=63  Identities=11%  Similarity=0.085  Sum_probs=46.7

Q ss_pred             CcCCCCCCCCH--HHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPL--ADVVKHVEKGYQMEA-PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         2 ~g~~Py~~~~~--~~i~~~v~~g~r~~~-p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +|..||.+...  .+....+..+..++. +...+.++.+++.+||..+|.+||++.+|...+.++.
T Consensus       201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         201 ALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            57888876543  244444544433333 3568899999999999999999999999999887763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=98.84  E-value=1.7e-08  Score=59.97  Aligned_cols=58  Identities=19%  Similarity=0.182  Sum_probs=50.9

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.+..++...+..|...+.|..++.++.+++..||..+|.+||++.+++.
T Consensus       265 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        265 LTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            3688999998888888888778776777889999999999999999999999999864

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=98.83  E-value=2.4e-08  Score=54.91  Aligned_cols=58  Identities=22%  Similarity=0.325  Sum_probs=42.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCC--CCCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGY--QMEAP---EGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~--r~~~p---~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||......+.......+.  +.+.|   ...+..+.++|..|| .+|++||++.+|+..|.
T Consensus       206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         206 GSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            889999888776654433322  22222   346788999999999 58999999999997653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=98.83  E-value=1.5e-08  Score=55.78  Aligned_cols=57  Identities=21%  Similarity=0.280  Sum_probs=40.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      +|..||.+....+...........  ....+.++.++|.+||..+|.+||+|.+|+..+
T Consensus       205 ~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         205 NGEIPLKDKTLAEKERFYEGQCML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             CCCCCCCCcchhHHHHHHhcCccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            467777776655443332222222  223467899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=98.83  E-value=2.4e-08  Score=55.00  Aligned_cols=48  Identities=27%  Similarity=0.686  Sum_probs=40.3

Q ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925           16 VKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus        16 ~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      ...+..+.+.+.+..++.++.+++..||..+|.+||++.+|+..|..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            344456666666778999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=98.82  E-value=2.8e-08  Score=55.40  Aligned_cols=59  Identities=22%  Similarity=0.388  Sum_probs=45.2

Q ss_pred             cCCCCCCCCHHHHHHHHHc-----CC--CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEK-----GY--QMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~-----g~--r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||...+..++...+..     +.  ....+..++..+.+++.+||..+|.+||++.+|+..|.
T Consensus       229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         229 KEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            6779988887766554421     11  23345678999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=98.82  E-value=2.8e-08  Score=53.81  Aligned_cols=57  Identities=19%  Similarity=0.232  Sum_probs=48.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||...+..++...+..+.....|..++.++.+++..||..+|++||++.+++.
T Consensus       198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         198 TLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             cCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            588899888777777766666666667789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=98.81  E-value=2.6e-08  Score=54.41  Aligned_cols=57  Identities=19%  Similarity=0.257  Sum_probs=47.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+..+..+..++.++.++|..||..+|.+||++.+++.
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         200 CLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             hCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            577888777666666666667666667788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=98.80  E-value=2.2e-08  Score=54.68  Aligned_cols=59  Identities=10%  Similarity=0.213  Sum_probs=46.3

Q ss_pred             CCcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..+....+ ........|..++.++.+++..||..+|.+||++.+++..
T Consensus       201 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         201 LTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            4688999887665444344 3345556778899999999999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=98.80  E-value=2.6e-08  Score=54.84  Aligned_cols=58  Identities=14%  Similarity=0.080  Sum_probs=47.1

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEG-CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~-~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.+..++...+..+..+..+.. ++.++.+++..||..+|++||++.+++.
T Consensus       192 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         192 AKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            368899988777666666666665555544 8899999999999999999999999965

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0581|consensus

Probab=98.80  E-value=3.2e-08  Score=57.08  Aligned_cols=57  Identities=18%  Similarity=0.173  Sum_probs=50.3

Q ss_pred             CcCCCCCCC-----CHHHHHHHHHcCCCCCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDE-----PLADVVKHVEKGYQMEAPEG-CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~-----~~~~i~~~v~~g~r~~~p~~-~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .|..||+.-     ...+.+..|..+..|..|.. +++++..++..|++.+|.+||+..+++.
T Consensus       272 ~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  272 IGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             hCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            488999874     55688888999988888886 9999999999999999999999999875

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=98.78  E-value=4.9e-08  Score=53.75  Aligned_cols=59  Identities=27%  Similarity=0.570  Sum_probs=48.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQ-MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r-~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+....++...+..+.. ...+..++..+.+++..||..+|.+||++.+++..|.
T Consensus       215 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         215 GELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            6789988877777776665542 3345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=98.76  E-value=5.9e-08  Score=53.92  Aligned_cols=59  Identities=27%  Similarity=0.477  Sum_probs=45.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcC-----C--CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKG-----Y--QMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g-----~--r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||...+..++...+...     .  ..+.+..++.++.+++..||..+|.+||++.+|+..|+
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         230 REQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            67888888777666555332     1  12345667899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=98.76  E-value=4.1e-08  Score=54.21  Aligned_cols=58  Identities=14%  Similarity=0.142  Sum_probs=47.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..+....+..+..+.  .|..++.++.+++..||..+|.+||++.+++..
T Consensus       203 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         203 QMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             hCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            5889999888777666666665432  456789999999999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=98.75  E-value=8.5e-08  Score=52.84  Aligned_cols=57  Identities=26%  Similarity=0.331  Sum_probs=42.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcC--CC---CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKG--YQ---MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g--~r---~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      |..||...+..+++..+..+  ..   +..+...+..+++++..|| .+|++||++.+|++.|
T Consensus       205 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         205 AAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             CCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            67799888777666655332  22   2234457889999999999 6799999999998766

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=98.74  E-value=4.1e-08  Score=53.37  Aligned_cols=58  Identities=17%  Similarity=0.145  Sum_probs=45.3

Q ss_pred             CCcCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEK-GYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~-g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||......+....+.. +..+..|..++.++.+++.+||..+|.+||++.+++.
T Consensus       196 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         196 ATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            368899987765544444433 4555567788999999999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=98.74  E-value=3.6e-08  Score=54.00  Aligned_cols=55  Identities=20%  Similarity=0.294  Sum_probs=40.3

Q ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            4 AEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         4 ~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      ..||...+..........  +...|...+.++.+++..||+.+|.+||++.+|+..|
T Consensus       203 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         203 DKPLSALDSQKKLQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             CCChhhccHHHHHHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            466666665543332222  3344556778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=98.74  E-value=5.6e-08  Score=53.77  Aligned_cols=47  Identities=30%  Similarity=0.746  Sum_probs=39.6

Q ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925           17 KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus        17 ~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      ..+..+.+++.+..++.++.+++..||..+|.+||++.+|+..|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            33455666666778999999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=98.74  E-value=6.2e-08  Score=52.88  Aligned_cols=57  Identities=21%  Similarity=0.294  Sum_probs=43.6

Q ss_pred             CcCCCCCCCCH-HHHHHHHHcCCCCCCCCC--CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPL-ADVVKHVEKGYQMEAPEG--CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~-~~i~~~v~~g~r~~~p~~--~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+... ..+...+..+..+..|..  ++..+.+++.+||..+|.+||++.+++.
T Consensus       201 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         201 TGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             hCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            58899987643 344445555655555654  4899999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=98.74  E-value=4.8e-08  Score=54.06  Aligned_cols=57  Identities=14%  Similarity=0.112  Sum_probs=44.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ--MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r--~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+..  ...|..++.++.+++..||..+|.+||++.+++.
T Consensus       203 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         203 QIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             cCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            58889988877665555544432  2345678999999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.73  E-value=7.7e-08  Score=50.05  Aligned_cols=67  Identities=13%  Similarity=0.136  Sum_probs=44.6

Q ss_pred             CCcCCCCCCCCHH-HHHHHHHcCCCCC------CCCCCCH--HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            1 MNRAEMSSDEPLA-DVVKHVEKGYQME------APEGCPP--EEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         1 ~~g~~Py~~~~~~-~i~~~v~~g~r~~------~p~~~~~--~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      ++|..||...... .....+..+....      .+...+.  ++.+++..||..+|.+||++.+++..+.....+.
T Consensus        98 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750       98 LDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             HhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence            3688899765432 3333333332211      1122333  6899999999999999999999999887776544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=98.73  E-value=5.4e-08  Score=53.43  Aligned_cols=58  Identities=12%  Similarity=-0.004  Sum_probs=42.7

Q ss_pred             CCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVE-KGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~-~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||...........+. ...+...+..++.++.+++.+||..+|.+||++.+++.
T Consensus       210 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         210 AEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            35888888776654443333 23333334568899999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=98.70  E-value=9.6e-08  Score=52.23  Aligned_cols=57  Identities=14%  Similarity=0.261  Sum_probs=42.2

Q ss_pred             CcCCCCCCCC-----HHHHHHHHHcCCCCCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEP-----LADVVKHVEKGYQMEAPEG-CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~-----~~~i~~~v~~g~r~~~p~~-~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||....     ..+....+..+..+..+.. ++.++.++|..||..+|.+||++.+++.
T Consensus       194 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         194 TGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            5788887652     2234444445555555544 8899999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=98.70  E-value=5.6e-08  Score=53.75  Aligned_cols=57  Identities=11%  Similarity=-0.010  Sum_probs=41.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ-MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r-~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+....+....+..... ...+..++.++.++|..||..+|.+||++.+|+.
T Consensus       221 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         221 EGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            57888887766544433433322 2233568999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=98.69  E-value=9.1e-08  Score=52.43  Aligned_cols=57  Identities=11%  Similarity=0.097  Sum_probs=44.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEK--GYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~--g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||...+..+....+..  +..+..+...+.++.+++.+||..+|.+||++.+++.
T Consensus       203 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         203 TGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            68899988766543333332  3445567789999999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=98.69  E-value=9.8e-08  Score=52.87  Aligned_cols=58  Identities=19%  Similarity=0.283  Sum_probs=45.1

Q ss_pred             CcCCCCCCCCHHHHHH---HHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVK---HVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~---~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.......+..   .+..+..+..|..++.++.+++.+||..+|.+||++.+++..
T Consensus       202 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         202 LGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             hCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            5888997765544333   334555556677799999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=98.68  E-value=7.2e-08  Score=52.66  Aligned_cols=58  Identities=17%  Similarity=0.099  Sum_probs=42.8

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCC-----CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAP-----EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p-----~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.+..+....+..+.....+     ..++.++.+++.+||..+|.+||++.+++.
T Consensus       201 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         201 ATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            3688999888776555444333222111     257889999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=98.68  E-value=9e-08  Score=52.95  Aligned_cols=58  Identities=17%  Similarity=0.186  Sum_probs=42.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ--MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r--~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..+....+..+..  ...|..++.++.+++.+||..+|.+||++.+++..
T Consensus       224 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         224 DGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            57888887765443333333322  22355678899999999999999999999999865

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=98.68  E-value=1.3e-07  Score=53.18  Aligned_cols=59  Identities=12%  Similarity=0.044  Sum_probs=45.7

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQME-APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~-~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..+....+..+..+. .+...+..+.++|.+||..+|.+||++.+++..
T Consensus       208 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         208 AERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            35888988877666555565555444 345688899999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=98.67  E-value=1.7e-07  Score=52.02  Aligned_cols=47  Identities=34%  Similarity=0.773  Sum_probs=40.4

Q ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925           17 KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus        17 ~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      ..+..+.+.+.+..++.++.+++..||..+|.+||++.+++..++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            34456666666778999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0198|consensus

Probab=98.66  E-value=1e-07  Score=54.49  Aligned_cols=60  Identities=20%  Similarity=0.244  Sum_probs=47.1

Q ss_pred             CCcCCCCCC-CCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            1 MNRAEMSSD-EPLAD-VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         1 ~~g~~Py~~-~~~~~-i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      ++|..||.+ ....+ +......+.-|..|..++.+..+++.+|+..+|..||++.+++.+.
T Consensus       216 ~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  216 LTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             cCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            468999998 34333 3333345556678999999999999999999999999999998754

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=98.66  E-value=1.7e-07  Score=51.12  Aligned_cols=58  Identities=14%  Similarity=0.159  Sum_probs=45.9

Q ss_pred             CcCCCCCCCC---HHHHHHHHHcCCCCCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEP---LADVVKHVEKGYQMEAPEG-CPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~---~~~i~~~v~~g~r~~~p~~-~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||....   ..+....+..+..+..+.. ++..+.+++..||..+|.+||++.+++..
T Consensus       195 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         195 LGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             hCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            5888998774   3455555665555555666 89999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=98.65  E-value=1.2e-07  Score=52.74  Aligned_cols=57  Identities=14%  Similarity=0.047  Sum_probs=43.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM--EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~--~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||......+.+..+..+..+  ..+...+.++.+++.+||..+|.+||++.+|+.
T Consensus       228 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         228 DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            588899888765545455444332  234567789999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=98.65  E-value=1.9e-07  Score=51.96  Aligned_cols=58  Identities=19%  Similarity=0.193  Sum_probs=44.0

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQM--EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~--~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.+..+....+..+..+  ..+..++.++.+++.+||..+|++||++.+++.
T Consensus       209 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         209 AQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             hcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            3588898887765555444444332  235678899999999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=98.64  E-value=1.4e-07  Score=52.95  Aligned_cols=58  Identities=10%  Similarity=0.071  Sum_probs=43.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEA-PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~-p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+.......+..+..+.. +..++.++.+++.+||..+|.+||++.+|+..
T Consensus       209 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         209 ERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             cCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            57888888776554444444433332 34578899999999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA02882 putative serine/threonine kinase; Provisional

Probab=98.64  E-value=1.1e-07  Score=53.19  Aligned_cols=58  Identities=12%  Similarity=0.100  Sum_probs=42.1

Q ss_pred             CCcCCCCCCCCH-HHHH--------HHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            1 MNRAEMSSDEPL-ADVV--------KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         1 ~~g~~Py~~~~~-~~i~--------~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      ++|..||.+.+. .+++        ..+..+..  .+..++.++.+++..||..++.+||++.+|...|
T Consensus       227 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        227 AGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhCCCCCCccccchHHHHHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            368999988833 3322        22222221  2356789999999999999999999999998765

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=98.63  E-value=1.4e-07  Score=54.05  Aligned_cols=58  Identities=16%  Similarity=-0.012  Sum_probs=43.6

Q ss_pred             CcCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPL---ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~---~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.....   ..+...+..+..+..+..++.++.+++..||..+|.+||++.+++.+
T Consensus       268 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        268 LGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             hCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            57888874322   23333344455566677899999999999999999999999999864

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=98.62  E-value=1.1e-07  Score=53.31  Aligned_cols=60  Identities=10%  Similarity=0.010  Sum_probs=45.7

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQ--MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r--~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      ++|..||.+.+..++...+..+..  +..+..++.++.+++.+||..+|.+||++..+...+
T Consensus       210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         210 LVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence            368899999888888877766542  222346899999999999999999999975554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=98.62  E-value=1.7e-07  Score=51.32  Aligned_cols=58  Identities=14%  Similarity=0.227  Sum_probs=46.0

Q ss_pred             CCcCCCCCCCC--HHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            1 MNRAEMSSDEP--LADVVKHVEK-GYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~--~~~i~~~v~~-g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      ++|..||.+..  ..++...+.. ...+..|..++.++.+++.+||..+|.+|++     +++++.
T Consensus       186 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         186 LTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            36889998776  5566666654 3556667778999999999999999999999     888775

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=98.62  E-value=9.6e-08  Score=51.93  Aligned_cols=57  Identities=21%  Similarity=0.236  Sum_probs=41.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGY--QMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~--r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||...+..+....+....  ....+..++.++.+++.+||..+|.+||++.+++.
T Consensus       194 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         194 EGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            5788888776655444443322  12234567889999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=98.62  E-value=1.4e-07  Score=52.00  Aligned_cols=57  Identities=14%  Similarity=0.067  Sum_probs=41.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPE-GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~-~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.........+.....+..+. ..+.++.+++..||..+|.+||++.+++.
T Consensus       197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         197 TGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             hCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            5888998876654443333332233333 37889999999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=98.61  E-value=2.1e-07  Score=52.51  Aligned_cols=59  Identities=12%  Similarity=0.088  Sum_probs=45.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ-MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r-~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      +|..||.+.........+..+.. ...+..++..+.+++.+||..+|.+||++.+++...
T Consensus       219 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         219 ERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             hCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            57889888776665655544433 333456888999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=98.61  E-value=2.1e-07  Score=51.65  Aligned_cols=57  Identities=19%  Similarity=0.208  Sum_probs=42.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.......+..+....  .+..++.++.+++..||..+|.+||++.+++.
T Consensus       211 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         211 EGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            5888998877665444444333322  23348999999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=98.61  E-value=1.8e-07  Score=51.86  Aligned_cols=58  Identities=17%  Similarity=0.161  Sum_probs=40.4

Q ss_pred             CcCCCCCCCCHH-----------HHHHHHHcCCCCCCCC-CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLA-----------DVVKHVEKGYQMEAPE-GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~-----------~i~~~v~~g~r~~~p~-~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||......           +....+.....+..+. .++.++.+++..||..+|.+||++.+++..
T Consensus       197 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         197 LGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             hCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            588898765431           2222232333333333 388899999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=98.61  E-value=2.4e-07  Score=51.91  Aligned_cols=58  Identities=12%  Similarity=0.153  Sum_probs=43.9

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQ--MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r--~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.+..+....+..+..  +..+..++..+.++|.+||..+|.+||++.+|+.
T Consensus       209 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         209 VEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            368889988776544444433322  2345678999999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=98.61  E-value=9e-08  Score=52.59  Aligned_cols=56  Identities=7%  Similarity=0.097  Sum_probs=42.5

Q ss_pred             CcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+....+..... ..+..+..|..++..+.+++ .||..+|.+||++++|+.
T Consensus       204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         204 TEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            588899887665433333 34445556777889999998 799899999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=98.60  E-value=1.5e-07  Score=51.76  Aligned_cols=57  Identities=14%  Similarity=0.114  Sum_probs=41.4

Q ss_pred             CcCCCCCCCCHH-HHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||...... .....+ ..+..+..|..++.++.+++..||..+|.+||++.+++.
T Consensus       206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         206 TGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            577888765433 222222 223344567788999999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=98.60  E-value=2.2e-07  Score=50.07  Aligned_cols=58  Identities=19%  Similarity=0.171  Sum_probs=42.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||...+..+....+........+  ..++.++.+++..||..+|.+||++.+++.
T Consensus       191 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         191 AEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            3688899888665554444433333333  334899999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=98.60  E-value=2.1e-07  Score=50.46  Aligned_cols=57  Identities=25%  Similarity=0.311  Sum_probs=45.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.......+..+.....+..++..+.+++..||..+|++||++.+++.
T Consensus       194 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         194 TGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             hCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            477888877765555555555555667788999999999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=98.59  E-value=2.4e-07  Score=51.59  Aligned_cols=58  Identities=14%  Similarity=0.180  Sum_probs=44.2

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.+..+....+..+..+.  .+..++..+.+++..||..+|.+||++.+++.
T Consensus       209 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         209 VDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            35788988777666666665553322  23447899999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=98.59  E-value=1.9e-07  Score=51.16  Aligned_cols=57  Identities=12%  Similarity=0.120  Sum_probs=42.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.......+..+....  .+..++.++.+++..||..+|.+||++.+++.
T Consensus       213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         213 DGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            5888998776654444454443322  23447889999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=98.59  E-value=2.2e-07  Score=51.88  Aligned_cols=58  Identities=16%  Similarity=0.219  Sum_probs=41.8

Q ss_pred             CcCCCCCCCCH-HHHHHHHHcCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPL-ADVVKHVEKGYQMEAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~-~~i~~~v~~g~r~~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||..... .+++..+..+.....+  ..++.++.+++..||..+|.+||++.+++..
T Consensus       213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         213 TGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             hCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            58889876433 2445444444333333  3478999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=98.58  E-value=2.2e-07  Score=50.58  Aligned_cols=56  Identities=21%  Similarity=0.402  Sum_probs=39.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      |..||...+..+.........+.+.+.  ...+.+++..||..+|.+||++.+++..|
T Consensus       203 ~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         203 GEEPLSTLSSSEKERFYQDQHRLPMPD--CAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CCCCcccCCchhHHHHHhcCCCCCCCC--chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            466777765444433334333333333  48999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=98.58  E-value=5.2e-07  Score=49.60  Aligned_cols=57  Identities=26%  Similarity=0.380  Sum_probs=42.7

Q ss_pred             cCCCCCCCCHHHHHHHH-HcCC-CCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHV-EKGY-QME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v-~~g~-r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      |..||......++...+ ..+. ..+   .+..++..+.+++..|| .+|++||++++|+..|
T Consensus       206 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         206 ADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            78899988876665544 3332 222   23468889999999999 5999999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=98.56  E-value=1.7e-07  Score=50.96  Aligned_cols=59  Identities=15%  Similarity=0.232  Sum_probs=45.3

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGC--PPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~--~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      ++|..||......++...+..+. ...|..+  +..+.+++..||..+|.+||++..+...+
T Consensus       195 ~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         195 LVGIPPFHGETPEEIFQNILNGK-IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             HhCCCCCCCCCHHHHHHHHhcCC-cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            35889998888877777776644 3445554  99999999999999999999995554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0201|consensus

Probab=98.56  E-value=4.3e-08  Score=57.77  Aligned_cols=58  Identities=17%  Similarity=0.170  Sum_probs=48.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|+.||.++++..++..|-....|..-..+++.+.+++..|+..+|..||+..+++++
T Consensus       206 ~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  206 KGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            6999999999977766665555444445789999999999999999999999999763

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=98.54  E-value=1.9e-07  Score=50.90  Aligned_cols=57  Identities=16%  Similarity=0.168  Sum_probs=41.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKG-YQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g-~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+... ....   .+...+.++.+++.+||..+|..||++.+|+.
T Consensus       199 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         199 ELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            688899888766544444332 2222   23345778999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=98.54  E-value=4.5e-07  Score=50.76  Aligned_cols=58  Identities=12%  Similarity=0.168  Sum_probs=42.7

Q ss_pred             CCcCCCCCCCCHHHHHHHH-HcCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHV-EKGYQ-MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v-~~g~r-~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.+.......+ ..+.. ...+...+..+.+++.+||..+|.+||++.+++.
T Consensus       210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         210 IEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            3688999877665333223 33332 2235678899999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=98.54  E-value=2.2e-07  Score=51.49  Aligned_cols=58  Identities=14%  Similarity=0.105  Sum_probs=40.1

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcCCCCCCC----CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKGYQMEAP----EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g~r~~~p----~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||...... +....+..+..+..+    ..++.++.+++..||..+|.+||++.+|+..
T Consensus       205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         205 TGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             hCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            588898776521 222233333322222    2478999999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=98.52  E-value=3.6e-07  Score=50.25  Aligned_cols=58  Identities=21%  Similarity=0.302  Sum_probs=41.3

Q ss_pred             CcCCCCCCCCHHHHHHHHH-cCCCCCCC----CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVE-KGYQMEAP----EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~-~g~r~~~p----~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||......+....+. ....+..+    ..++.++.+++..||..+|.+||++.+++.+
T Consensus       207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         207 AGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             hCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            5788887766554443332 22333333    2468899999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=98.52  E-value=6.3e-07  Score=47.92  Aligned_cols=57  Identities=19%  Similarity=0.226  Sum_probs=42.6

Q ss_pred             CcCCCCCC-CCHHHHHHHHHcCCCCCCCCC--CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSD-EPLADVVKHVEKGYQMEAPEG--CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~-~~~~~i~~~v~~g~r~~~p~~--~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.. .....+...+..+.....+..  ++.++.+++..||..+|.+||++.+++.
T Consensus       181 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      181 TGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             hCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            47788877 444455555555554433322  8899999999999999999999999875

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=98.51  E-value=3.9e-07  Score=51.53  Aligned_cols=57  Identities=11%  Similarity=0.165  Sum_probs=46.6

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF-----RQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~-----~~i~~   58 (69)
                      ++|..||.+.+..++...+..+. ...|..++.++.+++.+||..+|.+||+.     .+++.
T Consensus       190 ~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         190 LAGQSPFEGDDEDELFQSILEDE-VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             hhCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            46899999888777777666554 34567889999999999999999999998     77654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=98.51  E-value=4e-07  Score=51.73  Aligned_cols=57  Identities=9%  Similarity=0.079  Sum_probs=47.6

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      ++|..||.+.+..++...+..+. +..|..++..+.+++..||..+|.+|++     +.+++.
T Consensus       209 ltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        209 IAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            36899999988888887777764 5667789999999999999999999986     677764

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=98.50  E-value=1e-07  Score=52.31  Aligned_cols=58  Identities=12%  Similarity=0.087  Sum_probs=39.1

Q ss_pred             CcCCCCCCCCHHHHHHHH-HcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHV-EKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v-~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..+....+ .....++.   +...+.++.+++..||..+|.+||++.+|+..
T Consensus       204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         204 ELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             hCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            467787666554322222 22222221   23467899999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=98.50  E-value=1.5e-07  Score=52.64  Aligned_cols=57  Identities=9%  Similarity=0.073  Sum_probs=41.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM--EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~--~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+..+  ..|...+..+.+++.+||..+|.+||++.+++.
T Consensus       210 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         210 EGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             hCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            578888776554332223222222  245678899999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=98.50  E-value=4.3e-07  Score=49.24  Aligned_cols=53  Identities=15%  Similarity=0.125  Sum_probs=43.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQ   55 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~   55 (69)
                      +|..||...+..++...+.. .....|...+.++.+++..||..+|.+||++.+
T Consensus       188 ~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         188 TGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            58889988776666666655 446677788999999999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=98.49  E-value=4.1e-07  Score=50.23  Aligned_cols=29  Identities=10%  Similarity=0.248  Sum_probs=26.1

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.+++..||..+|.+||++.+++.
T Consensus       254 ~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         254 NISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            45788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=98.49  E-value=5.3e-07  Score=48.74  Aligned_cols=57  Identities=21%  Similarity=0.235  Sum_probs=43.5

Q ss_pred             CcCCCCCCCCH-HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPL-ADVVKHVEK-GYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~-~~i~~~v~~-g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||..... ......+.. +.....|...+.++.+++..||..+|.+||++.+++.
T Consensus       198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         198 TGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            57888887762 233444433 3445567788999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=98.47  E-value=4.3e-07  Score=49.60  Aligned_cols=56  Identities=13%  Similarity=0.137  Sum_probs=41.7

Q ss_pred             CCcCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH--HHHH
Q psy925            1 MNRAEMSSDEPL---ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF--RQLK   57 (69)
Q Consensus         1 ~~g~~Py~~~~~---~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~--~~i~   57 (69)
                      ++|..||...+.   .++...... .....|..++.++.+++.+||..+|.+||++  .+++
T Consensus       193 ~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         193 LRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            358899988774   333333222 4455677889999999999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=98.47  E-value=2.3e-07  Score=51.88  Aligned_cols=58  Identities=12%  Similarity=0.087  Sum_probs=41.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..+.+..+..+..+.  .+...+..+.+++..||..+|.+||++.+++..
T Consensus       210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         210 EGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             hCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            5788888776543333333232222  234567899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=98.45  E-value=4e-07  Score=51.34  Aligned_cols=53  Identities=13%  Similarity=0.245  Sum_probs=43.0

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR   54 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~   54 (69)
                      ++|..||.+.+..++...+..+. ...|..++.++.+++.+||..+|.+|+++.
T Consensus       187 ~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~~~~  239 (312)
T cd05585         187 LTGLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAKDLLIGLLSRDPTRRLGYN  239 (312)
T ss_pred             HhCCCCcCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence            46899999988877777665543 455678999999999999999999998653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=98.44  E-value=1.1e-06  Score=49.21  Aligned_cols=59  Identities=10%  Similarity=0.135  Sum_probs=44.9

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..+....+.......  .....+..+.+++..||..+|.+||++.+++..
T Consensus       212 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         212 IDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            35889998887766665555443322  223578899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=98.43  E-value=8.1e-07  Score=49.64  Aligned_cols=58  Identities=10%  Similarity=0.084  Sum_probs=47.8

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~~   59 (69)
                      ++|..||.+.+..++...+..+. +..|...+..+.+++.+||..+|.+|++     +.+++.+
T Consensus       192 ~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         192 LVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            46899999988888887776664 4567778999999999999999999995     7777643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=98.42  E-value=7e-07  Score=49.06  Aligned_cols=56  Identities=18%  Similarity=0.192  Sum_probs=43.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF----RQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~----~~i~~   58 (69)
                      +|..||...+..+....+..+. ...|...++.+.+++.+||..+|.+||++    .+++.
T Consensus       217 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         217 TGKPPFRGSNEYLTFQKILKLE-YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             hCCCCCCCccHHHHHHHHHhcC-CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            5888998877665555554433 34567789999999999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=98.42  E-value=1.4e-06  Score=49.17  Aligned_cols=53  Identities=13%  Similarity=0.167  Sum_probs=43.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR   54 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~   54 (69)
                      ++|..||.+.+..++...+..+. ...|..++.++.+++..||..+|.+||+..
T Consensus       192 ~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~P~~R~~a~  244 (318)
T cd05582         192 LTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKRNPANRLGAG  244 (318)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence            46899999988777777665554 345778899999999999999999999943

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=98.41  E-value=1.3e-06  Score=49.53  Aligned_cols=57  Identities=16%  Similarity=0.277  Sum_probs=47.3

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      ++|..||.+.+..+....+..+. ...|..++.++.+++.+||..+|.+|+     +..+++.
T Consensus       194 l~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         194 LTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            46899999988777777776664 456778899999999999999999999     6777654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=98.41  E-value=1.3e-06  Score=48.19  Aligned_cols=57  Identities=16%  Similarity=0.137  Sum_probs=40.7

Q ss_pred             CcCCCCCCCCH-HHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPL-ADVVKHVEKGYQMEAP-EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~-~~i~~~v~~g~r~~~p-~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||..... .+....+..+..+..| ..++.++.+++..||..+|.+||++.+++.
T Consensus       202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         202 TGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             hCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            57888875432 2223333444444443 457899999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=98.40  E-value=6.7e-07  Score=48.89  Aligned_cols=53  Identities=17%  Similarity=0.172  Sum_probs=40.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM---EAPEGCPPEEYEMMRQAWSLQPELRPTFR   54 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~---~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~   54 (69)
                      +|..||...+..++...+..+...   ..+..++.++.+++.+||..+|++||+..
T Consensus       188 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~  243 (260)
T cd05611         188 FGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN  243 (260)
T ss_pred             HCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCC
Confidence            588999988877777666554321   22346899999999999999999999554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=98.40  E-value=1e-06  Score=48.55  Aligned_cols=29  Identities=17%  Similarity=0.327  Sum_probs=26.6

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.+++.+||..+|.+||++.+++.
T Consensus       250 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         250 NASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            46789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=98.40  E-value=1.6e-06  Score=49.15  Aligned_cols=57  Identities=16%  Similarity=0.167  Sum_probs=45.6

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      ++|..||.+.+..++...+..+. ...|..++.++.+++.+||..+|.+||     +..+++.
T Consensus       195 ~~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         195 LVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            36899999988877777776654 345678899999999999999999999     4555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4645|consensus

Probab=98.39  E-value=4.6e-07  Score=59.22  Aligned_cols=58  Identities=19%  Similarity=0.234  Sum_probs=52.8

Q ss_pred             CCcCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|.-||..+++. +|..+|..|..|..|..++.+=.+++..|+..||..|-+..||+.
T Consensus      1435 ~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1435 ATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             ecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            5799999999775 999999999999999999999999999999999999987777664

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=98.39  E-value=2e-06  Score=47.88  Aligned_cols=57  Identities=14%  Similarity=0.058  Sum_probs=38.9

Q ss_pred             CcCCCCCCC-----CHHHHHHHHHcCCCCCCC------CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDE-----PLADVVKHVEKGYQMEAP------EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~-----~~~~i~~~v~~g~r~~~p------~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||...     ...+....+.+...+..+      ...++++.+++..||..+|.+||++.+++.
T Consensus       198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            577888755     223444444443322222      124578999999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=98.39  E-value=1.1e-06  Score=48.86  Aligned_cols=57  Identities=7%  Similarity=0.053  Sum_probs=40.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCC--------------------------CCCCCHHHHHHHHHhccCCCCCCCCHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEA--------------------------PEGCPPEEYEMMRQAWSLQPELRPTFRQ   55 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~--------------------------p~~~~~~~~~l~~~cw~~~p~~Rp~~~~   55 (69)
                      +|..||.+.+..+.+..+.++...+.                          .+.++..+.+++.+|+..+|.+||+..+
T Consensus       204 ~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  283 (290)
T cd07862         204 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  283 (290)
T ss_pred             cCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence            58889988876655554433211110                          1246778899999999999999999999


Q ss_pred             HHH
Q psy925           56 LKA   58 (69)
Q Consensus        56 i~~   58 (69)
                      ++.
T Consensus       284 ~l~  286 (290)
T cd07862         284 ALS  286 (290)
T ss_pred             Hhc
Confidence            875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=98.39  E-value=1.4e-06  Score=49.37  Aligned_cols=57  Identities=11%  Similarity=0.114  Sum_probs=46.3

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      ++|..||.+.+..++...+..+. ...|..++.++.+++..||..+|.+|+     +..+++.
T Consensus       189 ltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         189 MCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            46899999887777666665553 455778999999999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=98.38  E-value=2.1e-06  Score=48.46  Aligned_cols=57  Identities=11%  Similarity=0.053  Sum_probs=42.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEA-PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~-p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.......+..+..+.. ...++..+.+++..||+.+|.+||++.+++.
T Consensus       215 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         215 ERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            57888888766544444444333322 3457788999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=98.36  E-value=1.8e-06  Score=48.91  Aligned_cols=57  Identities=12%  Similarity=0.087  Sum_probs=46.7

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-------CHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-------TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-------~~~~i~~   58 (69)
                      ++|..||.+.+..++...+..+. ...|..++.++.+++..|+..+|.+|+       +..+++.
T Consensus       190 ~tg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         190 MAGQPPFEADNEDDLFESILHDD-VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            46899999998888887777665 344667899999999999999999999       6666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=98.35  E-value=1.8e-06  Score=48.82  Aligned_cols=55  Identities=9%  Similarity=0.114  Sum_probs=45.1

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR-QL   56 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~-~i   56 (69)
                      ++|..||.+.+..++...+... ++..|..++.++.+++..||..+|.+|+++. ++
T Consensus       190 l~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l  245 (316)
T cd05592         190 LIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDI  245 (316)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence            3689999998887777766544 4556778999999999999999999999875 44

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0588|consensus

Probab=98.35  E-value=1.8e-06  Score=53.59  Aligned_cols=58  Identities=17%  Similarity=0.311  Sum_probs=52.9

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|+.||.+-+...++.+|++|.. ..|..++.+..+|+.+.+..||.+|-+..+|.++
T Consensus       206 LtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  206 LTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             HhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            479999999888899999999973 5679999999999999999999999999999875

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=98.35  E-value=2.9e-06  Score=47.54  Aligned_cols=58  Identities=14%  Similarity=0.155  Sum_probs=44.6

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+....+....+..+....  ....++.++.+++..||..+|.+||++.+++.
T Consensus       210 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         210 VDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            35888998877666655555443322  33567899999999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0578|consensus

Probab=98.34  E-value=1.7e-06  Score=52.32  Aligned_cols=57  Identities=14%  Similarity=0.153  Sum_probs=48.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .|+.||-.-++...++.+....++.  .|..++.++.+++..|+..|+..|++..+++.
T Consensus       464 eGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  464 EGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            4999999888877777775544444  57889999999999999999999999999976

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=98.33  E-value=1.5e-06  Score=49.24  Aligned_cols=28  Identities=21%  Similarity=0.343  Sum_probs=25.6

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+.++.+++..||..+|.+||++.+++.
T Consensus       279 ~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         279 FSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            4678999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=98.33  E-value=1.5e-06  Score=49.27  Aligned_cols=52  Identities=10%  Similarity=0.107  Sum_probs=43.9

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      ++|..||.+.+..++...+..+. ...|..++.++.+++..|+..+|.+|++.
T Consensus       190 ~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         190 LCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             hhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            36899999998888887776654 34567789999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=98.32  E-value=1.9e-06  Score=47.47  Aligned_cols=29  Identities=24%  Similarity=0.359  Sum_probs=26.5

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.++|..||..+|.+||++.+++.
T Consensus       251 ~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         251 NASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            46789999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=98.32  E-value=4.1e-06  Score=46.99  Aligned_cols=58  Identities=10%  Similarity=0.178  Sum_probs=43.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ--MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r--~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||...+..+....+.....  ...+...+.++.+++..||..+|.+||++.+++..
T Consensus       212 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         212 DGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             hCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            58889887776655555543321  12234678899999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=98.31  E-value=2.8e-06  Score=48.42  Aligned_cols=29  Identities=17%  Similarity=0.195  Sum_probs=26.4

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.+++.+||..+|.+||++.+++.
T Consensus       270 ~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         270 VFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             CcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence            35788999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=98.31  E-value=2.2e-06  Score=48.55  Aligned_cols=56  Identities=9%  Similarity=0.126  Sum_probs=45.6

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR-QLK   57 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~-~i~   57 (69)
                      ++|..||.+.+..++...+..+. +..|..++.++.+++.+||..+|.+|+++. ++.
T Consensus       190 ~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         190 LIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            36899999988888777776554 345667899999999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=98.30  E-value=1.2e-06  Score=48.72  Aligned_cols=57  Identities=18%  Similarity=0.127  Sum_probs=41.1

Q ss_pred             CCcCCCCCCCCHHHH----HHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            1 MNRAEMSSDEPLADV----VKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i----~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      ++|..||.+.+....    ...+.. .....+...+..+.+++..||..+|.+||     ++.+++.
T Consensus       195 ~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         195 IEGKSPFRQRKEKVKREEVERRVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             HHCCCCCCCCchhhHHHHHHHHhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            358899988765322    222332 23344567899999999999999999999     7778754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0575|consensus

Probab=98.29  E-value=2.8e-06  Score=51.83  Aligned_cols=57  Identities=11%  Similarity=0.200  Sum_probs=49.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .|..||...+..+.+..|..... ..|..++.+-.+||...++.+|.+||+..+|+..
T Consensus       213 ~G~PPFetk~vkety~~Ik~~~Y-~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  213 VGRPPFETKTVKETYNKIKLNEY-SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             hCCCCcccchHHHHHHHHHhcCc-ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            59999999999999999976653 3467899999999999999999999999999863

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=98.28  E-value=2.3e-06  Score=48.73  Aligned_cols=58  Identities=7%  Similarity=0.056  Sum_probs=46.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~~   59 (69)
                      ++|..||.+.+..++...+..+. ...|..++.++.+++.+||..+|.+|+     +..+++.+
T Consensus       189 ltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         189 MCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             hhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            46899999888777766665443 345778999999999999999999997     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=98.27  E-value=2.7e-06  Score=47.25  Aligned_cols=60  Identities=10%  Similarity=0.079  Sum_probs=42.3

Q ss_pred             CcCCCCCCCC----HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            2 NRAEMSSDEP----LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         2 ~g~~Py~~~~----~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      +|..||....    ..++...+..+. .+.|..++.++++++.+||..+|.+||++.++...|+.
T Consensus       203 tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         203 TGASPFTVDGEQNSQSEISRRILKSK-PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             hCCCCcccCcccchHHHHHHHHHccC-CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            5788885432    223333343333 45567789999999999999999999998877665543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=98.27  E-value=4.4e-06  Score=47.45  Aligned_cols=58  Identities=12%  Similarity=0.028  Sum_probs=45.2

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC----CHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp----~~~~i~~   58 (69)
                      ++|..||.+.+..++...+..+........++.++.+++..||..+|.+||    +..+++.
T Consensus       191 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         191 CCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            468999999888887777776653333346789999999999999999998    4666554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=98.27  E-value=3.5e-06  Score=47.69  Aligned_cols=55  Identities=7%  Similarity=0.108  Sum_probs=44.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR-QLK   57 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~-~i~   57 (69)
                      +|..||.+.+..++...+..+. +..|..++.++.+++..||..+|.+|++.. ++.
T Consensus       191 ~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         191 IGQSPFHGDDEDELFESIRVDT-PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             hCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            5899999888877777766554 445677899999999999999999999974 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=98.26  E-value=3.3e-06  Score=47.89  Aligned_cols=57  Identities=11%  Similarity=0.116  Sum_probs=46.1

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      ++|..||.+.+..++...+..+. ...|..+++++.+++..||..+|.+|+     +..+++.
T Consensus       190 ~tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         190 MCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ccCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            46899999888777766665543 445678899999999999999999996     8888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=98.26  E-value=4.2e-06  Score=47.82  Aligned_cols=30  Identities=13%  Similarity=0.247  Sum_probs=26.6

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ..+.++.+++..||..+|.+||++.+++.+
T Consensus       268 ~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         268 KASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            467789999999999999999999999853

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=98.25  E-value=3.6e-06  Score=48.12  Aligned_cols=29  Identities=24%  Similarity=0.389  Sum_probs=26.3

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.+++.+||..+|.+||++.+++.
T Consensus       269 ~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         269 GANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             cCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            35789999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=98.25  E-value=4.4e-06  Score=46.21  Aligned_cols=30  Identities=7%  Similarity=0.147  Sum_probs=26.8

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ...+.++.+++.+||..+|.+||++.+++.
T Consensus       250 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         250 PNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            456788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=98.23  E-value=2.6e-06  Score=47.26  Aligned_cols=29  Identities=17%  Similarity=0.060  Sum_probs=26.4

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++.+|+..+|.+||++++++.
T Consensus       255 ~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         255 ILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            36788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=98.23  E-value=2.1e-06  Score=47.61  Aligned_cols=57  Identities=12%  Similarity=0.052  Sum_probs=39.1

Q ss_pred             CCcCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy925            1 MNRAEMSSDEPL----ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK   57 (69)
Q Consensus         1 ~~g~~Py~~~~~----~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~   57 (69)
                      ++|..||.+...    .++......+........++.++.+++.+||..+|.+||++.++.
T Consensus       188 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         188 VAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             HhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence            358889976532    233333333332223356899999999999999999999996654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=98.23  E-value=3.8e-06  Score=47.54  Aligned_cols=29  Identities=21%  Similarity=0.386  Sum_probs=26.5

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++.+||..+|.+||++.+++.
T Consensus       261 ~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         261 NADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             CCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            46788999999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=98.23  E-value=5.6e-06  Score=47.13  Aligned_cols=45  Identities=13%  Similarity=0.198  Sum_probs=34.5

Q ss_pred             HHHHHHcCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           15 VVKHVEKGYQMEAP-EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        15 i~~~v~~g~r~~~p-~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ....+....++..+ ...+.++.+++.+||..+|.+||++.+++.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         256 LLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             HHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            33344445555544 3578999999999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=98.22  E-value=4.5e-06  Score=46.17  Aligned_cols=29  Identities=14%  Similarity=0.177  Sum_probs=26.2

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++.+||..+|.+||++.+++.
T Consensus       252 ~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         252 PLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            46788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=98.22  E-value=5.5e-06  Score=46.14  Aligned_cols=57  Identities=12%  Similarity=0.196  Sum_probs=44.2

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      ++|..||.+.+..+....+..+. ...|...+..+.+++.+||..+|.+|+     +.++++.
T Consensus       192 ~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         192 LAGYPPFFDDNPIQIYEKILEGK-VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HhCCCCCCCCCHHHHHHHHhcCC-ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            36889998887666665555443 456778899999999999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=98.21  E-value=6.2e-06  Score=46.40  Aligned_cols=58  Identities=9%  Similarity=0.111  Sum_probs=41.9

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHhccCCCCCCCC----HHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAPEGCPPEEYEMMRQAWSLQPELRPT----FRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~----~~~i~~   58 (69)
                      ++|..||.+.+..+....+... ...+.....+.++.+++..||..+|.+||+    ..+++.
T Consensus       226 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         226 LYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            3688999888776555444332 222222337899999999999999999999    777665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=98.21  E-value=8.6e-06  Score=46.08  Aligned_cols=30  Identities=23%  Similarity=0.432  Sum_probs=27.1

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ..+.++.+++..||..+|.+||++.+++..
T Consensus       260 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         260 GASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            367889999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=98.20  E-value=3.4e-06  Score=47.91  Aligned_cols=57  Identities=11%  Similarity=0.104  Sum_probs=45.0

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      ++|..||.+.+..+....+..+. ...|..++.++.+++..||..+|.+|+     +..+++.
T Consensus       189 l~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         189 MCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            36889998887776666655443 345678899999999999999999998     7777764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=98.20  E-value=7.3e-06  Score=46.59  Aligned_cols=59  Identities=7%  Similarity=0.076  Sum_probs=44.9

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCC-CCCCCC------CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGY-QMEAPE------GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~-r~~~p~------~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..++...+.... ....|.      .++.++.+++..||..+|.+||++.+++.+
T Consensus       192 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         192 LCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             hhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            36899999988877766664432 122221      468999999999999999999999998854

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=98.19  E-value=6e-06  Score=46.04  Aligned_cols=29  Identities=17%  Similarity=0.244  Sum_probs=26.6

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++..+.+++..||..+|.+||++.+++.
T Consensus       270 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         270 FIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            46889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=98.19  E-value=9.1e-06  Score=44.61  Aligned_cols=57  Identities=14%  Similarity=0.074  Sum_probs=38.5

Q ss_pred             CcCCCCCCCCHHHHHHHH-HcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHV-EKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v-~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||............ .....++.   ...++..+.+++.+||..+|.+||++.+|+.
T Consensus       204 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         204 ELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            577788766554333322 22222221   1246788999999999999999999998875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0983|consensus

Probab=98.19  E-value=7.1e-06  Score=46.87  Aligned_cols=57  Identities=14%  Similarity=0.173  Sum_probs=46.5

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKGYQMEAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g~r~~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||++.+.+ +++..|.+...+..|  ...++.+.+++..|+..++.+||...+++.
T Consensus       289 Tg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  289 TGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            689999997654 788888775544444  348999999999999999999999999875

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=98.19  E-value=8.2e-06  Score=45.37  Aligned_cols=29  Identities=14%  Similarity=0.307  Sum_probs=26.5

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.++|..||..+|.+||++.+++.
T Consensus       262 ~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         262 DLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            47888999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=98.19  E-value=6.2e-06  Score=46.81  Aligned_cols=29  Identities=21%  Similarity=0.318  Sum_probs=26.1

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++..||..+|.+||++.+++.
T Consensus       279 ~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         279 TFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            45678999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0591|consensus

Probab=98.18  E-value=9e-06  Score=46.53  Aligned_cols=53  Identities=21%  Similarity=0.291  Sum_probs=46.6

Q ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy925            4 AEMSSDEPLADVVKHVEKGYQMEAP-EGCPPEEYEMMRQAWSLQPELRPTFRQL   56 (69)
Q Consensus         4 ~~Py~~~~~~~i~~~v~~g~r~~~p-~~~~~~~~~l~~~cw~~~p~~Rp~~~~i   56 (69)
                      ..||.|-+..++...|.+|..++.| ...+.++..||..|...+++.||+...+
T Consensus       225 ~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~  278 (375)
T KOG0591|consen  225 QSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPY  278 (375)
T ss_pred             CCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence            6799999888999999999888888 6789999999999999999999984333

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=98.18  E-value=8.7e-06  Score=44.60  Aligned_cols=57  Identities=21%  Similarity=0.236  Sum_probs=41.2

Q ss_pred             CcCCCCCCCCHH---HHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA---DVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~---~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||......   .....+ ..+..+..|...+.++.+++..||..+|.+||++.+++.
T Consensus       203 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         203 TAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             hCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            578888654432   222222 223445566778999999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=98.17  E-value=6.8e-06  Score=45.45  Aligned_cols=30  Identities=20%  Similarity=0.284  Sum_probs=27.0

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.++..+.+++..||..+|.+||++.+|+.
T Consensus       253 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         253 PKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             CCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            356889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=98.17  E-value=4.6e-06  Score=47.28  Aligned_cols=52  Identities=10%  Similarity=0.125  Sum_probs=43.4

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      ++|..||.+.+..++...+..+. ...|..++.++.+++.+||..+|.+|++.
T Consensus       195 ltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         195 LAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            36899999988887777776554 44567889999999999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=98.17  E-value=8.3e-06  Score=46.81  Aligned_cols=58  Identities=10%  Similarity=-0.006  Sum_probs=47.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~~   59 (69)
                      ++|..||.+.+...+...+..+.. ..|..++.++.+++.+|+..+|.+|+     ++++++.+
T Consensus       222 l~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        222 LVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             hcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            468999999887777777777753 45678899999999999999999995     78887653

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=98.16  E-value=3.3e-06  Score=47.08  Aligned_cols=58  Identities=17%  Similarity=0.185  Sum_probs=40.3

Q ss_pred             CCcCCCCCCCCHH---HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            1 MNRAEMSSDEPLA---DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~---~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      ++|..||.+....   +....+........+..++.++.+++..||..+|.+|++     +.+++.
T Consensus       195 ~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         195 IAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            3688999875432   222222222223345678999999999999999999999     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=98.16  E-value=8.2e-06  Score=45.46  Aligned_cols=57  Identities=9%  Similarity=-0.034  Sum_probs=40.9

Q ss_pred             CCcCCCCCCCCHHHHHHHH----HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHV----EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v----~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      ++|..||.+.........+    ..+. ...+..++.++.+++..||..+|.+||+     +.+++.
T Consensus       195 ~~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         195 IEGQSPFRGRKEKVKREEVDRRVLETE-EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHhhhccc-cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            3688999887664333333    2222 2345678899999999999999999999     666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=98.16  E-value=1.1e-05  Score=45.75  Aligned_cols=57  Identities=7%  Similarity=0.086  Sum_probs=44.2

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCC-CCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQ-MEAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r-~~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++|..||.+.+..+....+..+.+ ...|  ..++.++.+|+..|+. +|.+|+++.+++.
T Consensus       203 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         203 IYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            368999998887777766655433 2223  3578999999999997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=98.15  E-value=7.7e-06  Score=45.34  Aligned_cols=58  Identities=10%  Similarity=-0.014  Sum_probs=38.8

Q ss_pred             CcCCCCCCCCH-------HHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPL-------ADVVKHVEKGYQMEA-PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~-------~~i~~~v~~g~r~~~-p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.....       .+....+........ ....+.++.+++.+||..+|.+||++.+++..
T Consensus       188 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         188 LGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             hCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            57888865322       122333333322222 23578899999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=98.14  E-value=9.4e-06  Score=44.89  Aligned_cols=30  Identities=7%  Similarity=0.181  Sum_probs=26.9

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+++.+||..+|.+||++.+++.
T Consensus       252 ~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         252 KNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            347889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=98.13  E-value=7.1e-06  Score=46.21  Aligned_cols=30  Identities=13%  Similarity=0.276  Sum_probs=27.1

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .++.++.+++.+||..+|++||++.+++..
T Consensus       258 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         258 AFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            367889999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=98.13  E-value=1.6e-05  Score=43.92  Aligned_cols=27  Identities=26%  Similarity=0.486  Sum_probs=25.1

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.++.+++.+||..+|.+||++.+++.
T Consensus       253 ~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         253 SPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             CHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            678999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=98.12  E-value=1.8e-05  Score=44.43  Aligned_cols=27  Identities=22%  Similarity=0.265  Sum_probs=24.4

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.++.+++..||..+|.+||++.+++.
T Consensus       268 ~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         268 SEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             HHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            357889999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=98.12  E-value=1.3e-05  Score=44.21  Aligned_cols=28  Identities=18%  Similarity=0.322  Sum_probs=25.7

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++.++.+++..||..+|.+||++.+++.
T Consensus       256 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         256 IDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            3889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0582|consensus

Probab=98.11  E-value=1.3e-05  Score=47.95  Aligned_cols=57  Identities=18%  Similarity=0.076  Sum_probs=44.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC-----C----CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME-----A----PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~-----~----p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||..+.+.+++-.-.+|..+.     .    -...+..++.++..|+..||.+||+.+++++
T Consensus       227 ~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  227 HGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            6999999999988775544454321     1    1336778999999999999999999999875

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=98.11  E-value=1.5e-05  Score=45.44  Aligned_cols=58  Identities=14%  Similarity=0.260  Sum_probs=44.1

Q ss_pred             CCcCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEK---GYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-FRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~---g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-~~~i~~~   59 (69)
                      ++|..||.+.+..+....+..   ....+....++.++.+++..|+. +|.+|++ +.+++.+
T Consensus       224 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         224 LYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            468999999887776666644   22232223469999999999997 9999999 9998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG1023|consensus

Probab=98.11  E-value=1.2e-05  Score=48.46  Aligned_cols=63  Identities=29%  Similarity=0.452  Sum_probs=46.8

Q ss_pred             cCCCCCCC----CHHHHHHHHHc-CCCCCCCC-----CCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDE----PLADVVKHVEK-GYQMEAPE-----GCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~----~~~~i~~~v~~-g~r~~~p~-----~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      .+.||...    ...+++..|.. |..+.+|.     ..++++..++..||..+|..||+++.|...+..+..
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            45566542    33478888877 55445553     355689999999999999999999999988877655

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=98.11  E-value=1.2e-05  Score=44.13  Aligned_cols=56  Identities=9%  Similarity=0.143  Sum_probs=41.8

Q ss_pred             CcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.......+ ..+..+..|...+..+.+++.+||. +|..||++.+|+.
T Consensus       204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         204 TEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             hCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            588999887665444333 3334455667778889999999994 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=98.11  E-value=1.3e-05  Score=44.67  Aligned_cols=29  Identities=21%  Similarity=0.367  Sum_probs=26.5

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.+++.+||..+|.+||++.+++.
T Consensus       253 ~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         253 AASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            45788999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=98.10  E-value=7e-06  Score=46.73  Aligned_cols=30  Identities=17%  Similarity=0.376  Sum_probs=26.7

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ..+.++.+++.+||..+|.+||++.+++..
T Consensus       263 ~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         263 NADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             ccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            357789999999999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=98.10  E-value=1.9e-05  Score=45.19  Aligned_cols=29  Identities=24%  Similarity=0.370  Sum_probs=26.5

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.+++..||..+|.+||++.+++.
T Consensus       271 ~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         271 GVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            56788999999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=98.10  E-value=1.7e-05  Score=45.17  Aligned_cols=30  Identities=10%  Similarity=0.252  Sum_probs=27.3

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .++.++.+++..||..+|.+||++.+++..
T Consensus       266 ~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         266 KASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            378899999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=98.09  E-value=1.1e-05  Score=45.36  Aligned_cols=29  Identities=10%  Similarity=0.114  Sum_probs=26.1

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .+.+..++|..|+..+|.+||++.+++.+
T Consensus       262 ~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         262 LSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            47788999999999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PTZ00036 glycogen synthase kinase; Provisional

Probab=98.09  E-value=9.2e-06  Score=48.16  Aligned_cols=31  Identities=23%  Similarity=0.327  Sum_probs=27.7

Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           28 PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        28 p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      |...+.++.+|+..||..+|.+|++..+++.
T Consensus       320 p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        320 PKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            4457889999999999999999999999874

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=98.09  E-value=9.4e-06  Score=45.64  Aligned_cols=29  Identities=10%  Similarity=0.098  Sum_probs=26.6

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.+..+++.+|+..+|.+|++..+++.
T Consensus       257 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         257 RLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            46788999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=98.09  E-value=7e-06  Score=45.74  Aligned_cols=56  Identities=16%  Similarity=0.089  Sum_probs=40.1

Q ss_pred             CcCCCCCCCCHHH----HHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            2 NRAEMSSDEPLAD----VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~----i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      +|..||.+.+...    +...+..+ ....+...+.++.+|+..||..+|.+|++     +++++.
T Consensus       196 ~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         196 QGQSPFRKRKERVKREEVDRRVKED-QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             hCCCCCCCCCcchhHHHHHHHhhcc-cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            5889998765432    22222222 23445678999999999999999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=98.08  E-value=1.5e-05  Score=44.05  Aligned_cols=30  Identities=13%  Similarity=0.283  Sum_probs=26.7

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ..+.++.+++.+|+..+|.+||++++++.+
T Consensus       253 ~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         253 DASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            457899999999999999999999998753

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=98.07  E-value=1.2e-05  Score=51.99  Aligned_cols=56  Identities=13%  Similarity=0.153  Sum_probs=42.2

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||...... +++..+..+..++ ....+.++.+||..||..+|.+||++.+++.
T Consensus       238 TGk~PF~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        238 SGKTPFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HCCCCCCcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            588999766543 4555555553332 2457899999999999999999999999874

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=98.06  E-value=1.7e-05  Score=44.44  Aligned_cols=29  Identities=7%  Similarity=0.077  Sum_probs=26.6

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++.+|+..+|.+||++.+++.
T Consensus       257 ~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         257 RLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            46888999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=98.06  E-value=1.6e-05  Score=44.23  Aligned_cols=28  Identities=7%  Similarity=0.221  Sum_probs=25.9

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+..+.+++..||..+|++||++.+++.
T Consensus       262 ~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         262 LSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             CChHHHHHHHHHhccCccccCCHHHHhc
Confidence            5888999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=98.05  E-value=2.2e-05  Score=43.15  Aligned_cols=56  Identities=13%  Similarity=0.169  Sum_probs=43.2

Q ss_pred             CcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+....+.+..+ ..+.++..|...+.++.+++..||. ++..||+..+++.
T Consensus       204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         204 TEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             hCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            588999887665444333 3445566788899999999999998 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=98.05  E-value=1.3e-05  Score=44.26  Aligned_cols=29  Identities=21%  Similarity=0.342  Sum_probs=25.9

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++..||..+|.+||++.+++.
T Consensus       252 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         252 HADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            45778899999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=98.03  E-value=2e-05  Score=44.70  Aligned_cols=52  Identities=10%  Similarity=0.121  Sum_probs=43.7

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      ++|..||.+.+..++...+..+. ...|...+.++.+++.+|+..+|.+|++.
T Consensus       195 ltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         195 LAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            36899999998888877776654 34567889999999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=98.03  E-value=2.3e-05  Score=44.53  Aligned_cols=29  Identities=10%  Similarity=0.226  Sum_probs=26.4

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++..||..+|.+||++.+++.
T Consensus       284 ~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        284 NASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            45788999999999999999999999875

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=98.03  E-value=2.2e-05  Score=44.56  Aligned_cols=53  Identities=4%  Similarity=-0.041  Sum_probs=42.7

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR   54 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~   54 (69)
                      ++|..||.+.+..++...+..+. ...+...+.++.+++.+|+..+|.+||+..
T Consensus       190 l~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         190 LYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            36899999988877777776554 334556799999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=98.03  E-value=1.5e-05  Score=45.44  Aligned_cols=31  Identities=16%  Similarity=0.267  Sum_probs=28.1

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +.++.++.+++.+||..+|.+||++.+++.+
T Consensus       261 ~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         261 PHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             ccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            4578899999999999999999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=98.02  E-value=1.1e-05  Score=44.89  Aligned_cols=57  Identities=11%  Similarity=0.114  Sum_probs=39.7

Q ss_pred             CcCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            2 NRAEMSSDEPLA--DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~--~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      +|..||.+....  ..............|..++.++.+++..||..+|.+|+     ++++++.
T Consensus       191 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         191 RGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             hCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            588898765322  22222222233445677899999999999999999999     5887765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0583|consensus

Probab=98.00  E-value=4.6e-05  Score=44.65  Aligned_cols=56  Identities=16%  Similarity=0.274  Sum_probs=48.3

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCC-CHHHHHHHHHhccCCCCCCCCHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGC-PPEEYEMMRQAWSLQPELRPTFRQLK   57 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~-~~~~~~l~~~cw~~~p~~Rp~~~~i~   57 (69)
                      +.|..||.+.+.......+..|. ...|..+ +.+...|+.+|+..+|..|++..+|+
T Consensus       217 l~G~~PF~d~~~~~l~~ki~~~~-~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  217 LCGRLPFDDSNVPNLYRKIRKGE-FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HhCCCCCCCccHHHHHHHHhcCC-ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            36999999987777777777775 4557777 99999999999999999999999998

>KOG0584|consensus

Probab=98.00  E-value=1.3e-05  Score=49.33  Aligned_cols=56  Identities=18%  Similarity=0.145  Sum_probs=47.5

Q ss_pred             CcCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDE-PLADVVKHVEKGYQME-APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~-~~~~i~~~v~~g~r~~-~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +++.||..- ++.+|+.+|..|..|. ....-.+++.++|.+|+.. ..+|++..+++.
T Consensus       238 T~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  238 TSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            589999755 5579999999998765 3455688999999999998 999999999885

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=97.99  E-value=2.4e-05  Score=43.31  Aligned_cols=53  Identities=15%  Similarity=0.184  Sum_probs=35.8

Q ss_pred             CcCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q psy925            2 NRAEMSSDEPL----ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQ   55 (69)
Q Consensus         2 ~g~~Py~~~~~----~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~   55 (69)
                      +|..||.+...    .++...+. ......|...+.++.+++.+||..+|.+||++.+
T Consensus       189 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         189 AGRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             hCCCCCCCCcccccHHHHHhccc-cccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence            57888876543    22222221 2233445678999999999999999999995444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=97.98  E-value=2e-05  Score=43.62  Aligned_cols=29  Identities=7%  Similarity=0.060  Sum_probs=26.4

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++..||..+|.+||++.+++.
T Consensus       252 ~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         252 KLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            46788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=97.97  E-value=3.5e-05  Score=43.81  Aligned_cols=57  Identities=18%  Similarity=0.201  Sum_probs=40.9

Q ss_pred             CCcCCCCCCCC----HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            1 MNRAEMSSDEP----LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~----~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      ++|..||....    ..++...+... .+..|..++..+.+++.+||..+|.+|+     +..+++.
T Consensus       201 ltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         201 LTGASPFTLEGERNTQSEVSRRILKC-DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             hcCCCCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            46889996432    22344444333 3456678899999999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=97.97  E-value=4.5e-05  Score=44.10  Aligned_cols=30  Identities=13%  Similarity=0.179  Sum_probs=26.9

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ...+.++.+++.+|+..+|.+||++.+++.
T Consensus       258 ~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         258 SQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             CCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            346789999999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=97.97  E-value=2.6e-05  Score=43.10  Aligned_cols=28  Identities=11%  Similarity=0.188  Sum_probs=24.8

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+..+.+++..||..+|.+||++.+++.
T Consensus       256 ~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         256 ICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            4567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=97.97  E-value=2.1e-05  Score=48.90  Aligned_cols=58  Identities=16%  Similarity=0.170  Sum_probs=45.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGY--QMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~--r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+....++...+..+.  .+.....++.++.+++..||..+|.+||++.+++.+
T Consensus       575 tG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h  634 (669)
T cd05610         575 TGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQH  634 (669)
T ss_pred             HCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcCHHHHHhC
Confidence            5889999988887777664432  222334678899999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=97.96  E-value=3.2e-05  Score=42.59  Aligned_cols=28  Identities=14%  Similarity=0.288  Sum_probs=25.6

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+.++.+++..||..+|.+||++.+++.
T Consensus       251 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         251 LDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            4778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=97.94  E-value=4e-05  Score=42.79  Aligned_cols=29  Identities=3%  Similarity=0.013  Sum_probs=26.2

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.+..+++.+|+..+|.+|+++++++.
T Consensus       256 ~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         256 RLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            45778999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=97.93  E-value=4.3e-05  Score=43.52  Aligned_cols=29  Identities=28%  Similarity=0.417  Sum_probs=26.6

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.+++..||+.+|.+||++.+++.
T Consensus       265 ~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         265 KASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            46889999999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=97.93  E-value=2.1e-05  Score=44.62  Aligned_cols=54  Identities=4%  Similarity=-0.025  Sum_probs=42.9

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQ   55 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~   55 (69)
                      ++|..||.+.+..+....+..+. ...+..++.++.+++.+|+..+|.+|++..+
T Consensus       190 ~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         190 LYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             hcCCCCCCCCCHHHHHHHHHhCC-cCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence            36899999988877776665543 3345578999999999999999999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=97.92  E-value=3.8e-05  Score=43.68  Aligned_cols=52  Identities=10%  Similarity=0.125  Sum_probs=43.1

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      ++|..||.+.+..++...+..+. ...|..++.++.+++.+||..+|.+|++.
T Consensus       195 ltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         195 LAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            36899999988887777776554 34567889999999999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=97.92  E-value=2.7e-05  Score=44.34  Aligned_cols=57  Identities=14%  Similarity=0.165  Sum_probs=38.9

Q ss_pred             CCcCCCCCCCC--------HH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHHH
Q psy925            1 MNRAEMSSDEP--------LA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT------FRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~--------~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~------~~~i~~   58 (69)
                      ++|..||....        .. .+.+.+..+ ....|..++.++.+++..|+..+|.+|++      +.+++.
T Consensus       190 ~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         190 MAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHCCCCcccccccccccccchHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            35888886321        11 223333333 34567788999999999999999999987      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=97.90  E-value=2e-05  Score=43.60  Aligned_cols=57  Identities=4%  Similarity=0.100  Sum_probs=39.3

Q ss_pred             CcCCCCCCCCHHHHH-HHH-H-cCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHHH
Q psy925            2 NRAEMSSDEPLADVV-KHV-E-KGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-FRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~-~~v-~-~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-~~~i~~   58 (69)
                      +|..||.+.....+. ..+ . .......++.++..+.+++..||+.+|.+|++ +++++.
T Consensus       201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        201 TGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            588899865443221 111 1 12333445678999999999999999999995 688874

>KOG4279|consensus

Probab=97.90  E-value=1.9e-05  Score=50.04  Aligned_cols=57  Identities=14%  Similarity=0.103  Sum_probs=45.9

Q ss_pred             CcCCCCCCCCH-HHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPL-ADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~-~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||-.+.. +.....| .-..-|++|..++.+-.++|.+|+..+|.+||+..+++.
T Consensus       773 TGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  773 TGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            59999988854 4445555 333447788999999999999999999999999999874

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=97.89  E-value=3.9e-05  Score=43.77  Aligned_cols=52  Identities=10%  Similarity=0.047  Sum_probs=36.0

Q ss_pred             CCcCCCCCCCC--------H-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            1 MNRAEMSSDEP--------L-ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         1 ~~g~~Py~~~~--------~-~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      ++|..||....        . ..+...+.. .....|..++.++.+++.+||..+|.+|++.
T Consensus       190 ~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         190 MAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             hhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            46888985321        1 122333333 3345677889999999999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=97.85  E-value=6.5e-05  Score=41.98  Aligned_cols=28  Identities=25%  Similarity=0.298  Sum_probs=24.7

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ...++.+++..|+..+|.+||+..+++.
T Consensus       280 ~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         280 LGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            4467889999999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=97.85  E-value=4.6e-05  Score=43.38  Aligned_cols=53  Identities=11%  Similarity=-0.004  Sum_probs=36.4

Q ss_pred             CCcCCCCCCC------CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            1 MNRAEMSSDE------PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         1 ~~g~~Py~~~------~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      ++|..||...      ...+....+........|..++..+.+++.+|+..+|.+|++.
T Consensus       190 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         190 MAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            3688899532      2222332222233344677889999999999999999999973

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=97.85  E-value=8.3e-05  Score=41.44  Aligned_cols=29  Identities=21%  Similarity=0.285  Sum_probs=26.5

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.+++.+|+..+|.+||++.+++.
T Consensus       255 ~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        255 TLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             CCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            46788999999999999999999999885

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=97.84  E-value=3.9e-05  Score=44.19  Aligned_cols=28  Identities=4%  Similarity=0.146  Sum_probs=24.9

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +.++.+++.+|+..+|.+||+..+++.+
T Consensus       291 ~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         291 ASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             cHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            4578899999999999999999998763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=97.83  E-value=7e-05  Score=42.99  Aligned_cols=28  Identities=11%  Similarity=0.223  Sum_probs=25.5

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+..+.+++.+||..+|.+||++.+++.
T Consensus       283 ~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         283 KASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             chhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            4667899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=97.83  E-value=4.1e-05  Score=43.50  Aligned_cols=53  Identities=6%  Similarity=0.043  Sum_probs=42.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR   54 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~   54 (69)
                      ++|..||.+.+..++...+..+. +..+...+.++.+++.+|+..+|.+||+..
T Consensus       190 ~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         190 LYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence            36899999988888777776654 333456889999999999999999999775

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=97.82  E-value=2e-05  Score=43.56  Aligned_cols=29  Identities=14%  Similarity=0.292  Sum_probs=26.3

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++..||..+|++||++++++.
T Consensus       256 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         256 KVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            45889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=97.80  E-value=8.3e-05  Score=42.77  Aligned_cols=29  Identities=7%  Similarity=0.215  Sum_probs=26.1

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .+.++.+++.+||..+|.+||++.+++.+
T Consensus       287 ~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         287 KTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             cchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            46788999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0589|consensus

Probab=97.78  E-value=0.00015  Score=43.26  Aligned_cols=56  Identities=14%  Similarity=0.273  Sum_probs=50.4

Q ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            4 AEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         4 ~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +.+|.+.+..+.+..+.++...+.|...+.++..+|..|++.+|..||+..+++..
T Consensus       203 k~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  203 KPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            56788888888888898888788899999999999999999999999999999864

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=97.78  E-value=9.5e-05  Score=41.10  Aligned_cols=56  Identities=11%  Similarity=0.124  Sum_probs=41.4

Q ss_pred             CcCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            2 NRAEMSSDEPL---ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~---~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      +|..||.+...   .++. .......+..|..++.++.+++.+|+..+|.+|+     +..+++.
T Consensus       191 ~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         191 RGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             hCCCCCCCCCccchHHHH-HHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            58889987632   2222 2223344556777899999999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=97.78  E-value=0.0001  Score=42.03  Aligned_cols=30  Identities=13%  Similarity=0.305  Sum_probs=27.0

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .++.++.++|.+||..+|.+||++.+++..
T Consensus       259 ~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         259 NADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            467899999999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0580|consensus

Probab=97.78  E-value=0.00013  Score=40.93  Aligned_cols=57  Identities=9%  Similarity=0.092  Sum_probs=48.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .|..||...+-.+.+..|..-. ...|..++.+..++|..|...+|.+|-...+++.+
T Consensus       217 vg~ppFes~~~~etYkrI~k~~-~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  217 VGLPPFESQSHSETYKRIRKVD-LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             hcCCchhhhhhHHHHHHHHHcc-ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            4889999998778887775543 45578999999999999999999999999998764

>KOG0615|consensus

Probab=97.78  E-value=4.4e-05  Score=45.43  Aligned_cols=59  Identities=17%  Similarity=0.220  Sum_probs=48.8

Q ss_pred             CCcCCCCCCCCHHH-HHHHHHcCCCCCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLAD-VVKHVEKGYQMEAP---EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~-i~~~v~~g~r~~~p---~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|-.||++..-.. ..+.|..|.....|   ..++.+..++|...+..+|++||+..+.+.+
T Consensus       375 LsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  375 LSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             eccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            46899999876554 77888888766655   3578899999999999999999999998753

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=97.77  E-value=7.2e-05  Score=42.94  Aligned_cols=29  Identities=7%  Similarity=0.190  Sum_probs=25.8

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .+.++.+++.+|+..+|.+||++.+++.+
T Consensus       283 ~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         283 KASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             cchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            35678999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=97.77  E-value=5.7e-05  Score=42.01  Aligned_cols=57  Identities=11%  Similarity=0.157  Sum_probs=38.6

Q ss_pred             CCcCCCCCCCCHH----HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            1 MNRAEMSSDEPLA----DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~----~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      ++|..||...+..    ++...+..+ ....|..++.++.+++..||..+|.+|+     +.++++.
T Consensus       191 ~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         191 IAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            3588899765432    222222222 2334567899999999999999999999     4566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=97.76  E-value=0.00013  Score=41.32  Aligned_cols=53  Identities=6%  Similarity=0.052  Sum_probs=42.7

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR   54 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~   54 (69)
                      ++|..||.+.+..++...+..+. ...|...+.++.+++..|+..+|.+|++..
T Consensus       190 ~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         190 LYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             hcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            36899999988777777665553 455677899999999999999999998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=97.76  E-value=4.1e-05  Score=48.97  Aligned_cols=32  Identities=16%  Similarity=0.152  Sum_probs=29.3

Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925           34 EEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus        34 ~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      ++.+++..||..+|.+||++.++++.|..+..
T Consensus       922 ~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        922 EVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             HHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            57789999999999999999999999998865

>KOG1989|consensus

Probab=97.76  E-value=3.8e-05  Score=48.36  Aligned_cols=60  Identities=12%  Similarity=0.195  Sum_probs=45.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKG-YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g-~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +..||++.....    |.+| +..|..+..+..+.+||..|+..+|++||++-+++..+..+...
T Consensus       254 ~t~PFe~sg~la----Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  254 FTTPFEESGKLA----ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             hCCCcCcCccee----EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence            356777664432    3344 33333367899999999999999999999999999988877654

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=97.75  E-value=9.9e-05  Score=41.23  Aligned_cols=27  Identities=15%  Similarity=0.247  Sum_probs=24.3

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +..+.+++..||..+|.+||++++++.
T Consensus       280 ~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         280 DPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            567789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0592|consensus

Probab=97.73  E-value=0.00015  Score=44.48  Aligned_cols=57  Identities=19%  Similarity=0.225  Sum_probs=49.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .|..||.+.+..-+.+.|..-. ..+|+..++.+.+|+.+-+..+|.+|.+..+|..+
T Consensus       282 aG~PPFra~NeyliFqkI~~l~-y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  282 AGQPPFRAANEYLIFQKIQALD-YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             cCCCCCccccHHHHHHHHHHhc-ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            5999999998888888887765 35678899999999999999999999999998753

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=97.73  E-value=0.00013  Score=40.46  Aligned_cols=29  Identities=7%  Similarity=0.070  Sum_probs=26.1

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++.+|+..+|.+||++.+++.
T Consensus       256 ~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         256 EIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            46778899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=97.70  E-value=0.00022  Score=40.60  Aligned_cols=29  Identities=10%  Similarity=0.289  Sum_probs=26.2

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+..+.+++.+|+..+|.+||++.+++.
T Consensus       263 ~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         263 NANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            35789999999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=97.70  E-value=0.00017  Score=40.13  Aligned_cols=57  Identities=12%  Similarity=0.165  Sum_probs=39.2

Q ss_pred             CCcCCCCCCCC----HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            1 MNRAEMSSDEP----LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~----~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      ++|..||....    ..++...+..+. ++.|..++..+.+++.+||..+|.+|+     +..+++.
T Consensus       202 l~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         202 LTGASPFTVDGEKNSQAEISRRILKSE-PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             hcCCCCCCcCCccccHHHHHHHhhccC-CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            36788886432    223333333333 445677899999999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=97.70  E-value=5.8e-06  Score=44.99  Aligned_cols=57  Identities=14%  Similarity=0.198  Sum_probs=36.8

Q ss_pred             CcCCCCCCCCHH---HHHHHHHcCC-C--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA---DVVKHVEKGY-Q--MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~---~i~~~v~~g~-r--~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+....   .......... .  .......+.++.+++..||+.+|.+||++.+++.
T Consensus       194 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  194 TGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            578888887433   2222221111 0  1111223489999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=97.69  E-value=8e-05  Score=42.52  Aligned_cols=29  Identities=14%  Similarity=0.231  Sum_probs=25.6

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .++.+.+++.+|+..+|.+||+..+++.+
T Consensus       270 ~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         270 ANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            45678899999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0033|consensus

Probab=97.67  E-value=0.00017  Score=40.86  Aligned_cols=57  Identities=18%  Similarity=0.236  Sum_probs=47.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC-CCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ-MEAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r-~~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .|..||.+.+...+++.|..|.. .+.|  ++++++-.+|+.+.+..+|.+|-+..+.+.
T Consensus       207 ~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  207 VGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             hCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            58899999998999999988843 2222  578899999999999999999999988754

>KOG0579|consensus

Probab=97.62  E-value=0.00022  Score=45.17  Aligned_cols=57  Identities=14%  Similarity=0.131  Sum_probs=48.7

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++.|...+++..|+-.|.....|.  .|+.++..+.+++..|+..+|+.||+.++++.+
T Consensus       231 iEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  231 IEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             cCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            678999999988888886655433  588899999999999999999999999998753

>PTZ00284 protein kinase; Provisional

Probab=97.61  E-value=0.00012  Score=43.61  Aligned_cols=26  Identities=12%  Similarity=0.097  Sum_probs=23.5

Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           33 PEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        33 ~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.+||..|+..||.+||+.++++.
T Consensus       412 ~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        412 DLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            45679999999999999999999986

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=97.60  E-value=0.00032  Score=40.75  Aligned_cols=59  Identities=7%  Similarity=0.086  Sum_probs=45.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAPE--GCPPEEYEMMRQAWSLQPEL--RPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p~--~~~~~~~~l~~~cw~~~p~~--Rp~~~~i~~~   59 (69)
                      ++|..||.+.+.......+.++ ..+..|.  .++.++.+++..|+..+|.+  |++..+++.+
T Consensus       241 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         241 LVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            3689999998877777766554 2333443  57999999999999988887  9999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=97.56  E-value=0.0001  Score=42.28  Aligned_cols=30  Identities=23%  Similarity=0.309  Sum_probs=26.5

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ..+.++.+++..|+..+|.+||+..+++.+
T Consensus       271 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         271 GANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            357889999999999999999999998753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0596|consensus

Probab=97.56  E-value=9.4e-05  Score=45.58  Aligned_cols=56  Identities=11%  Similarity=0.081  Sum_probs=40.5

Q ss_pred             cCCCCCCCCHH-HHHHHHHc-CCCCCCCCCCCHH-HHHHHHHhccCCCCCCCCHHHHHH
Q psy925            3 RAEMSSDEPLA-DVVKHVEK-GYQMEAPEGCPPE-EYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~-g~r~~~p~~~~~~-~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      |+.||....+. .-+..|.+ +...+.|...+.. +.++|..|+..||.+||+..+++.
T Consensus       568 gktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  568 GKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             cCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            78899888654 33344433 4545555444433 899999999999999999999875

>KOG1006|consensus

Probab=97.55  E-value=0.00033  Score=40.11  Aligned_cols=57  Identities=11%  Similarity=-0.021  Sum_probs=42.9

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcCCCCC--CCCC---CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKGYQME--APEG---CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g~r~~--~p~~---~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ||..||.+++.- +-+..|..|..+.  .+..   .+..+..+|..|+-.+-.+||++.++++
T Consensus       264 tG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  264 TGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            699999999762 2233455665433  3333   6889999999999999999999999864

>KOG2052|consensus

Probab=97.53  E-value=0.00027  Score=42.57  Aligned_cols=62  Identities=18%  Similarity=0.200  Sum_probs=46.1

Q ss_pred             CCCCCCCC-----HHHHHHHH-HcCCCCCCCCCCC-----HHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            4 AEMSSDEP-----LADVVKHV-EKGYQMEAPEGCP-----PEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         4 ~~Py~~~~-----~~~i~~~v-~~g~r~~~p~~~~-----~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      ..||-++-     ..+...-| .+..||..|.-..     ..+..+|..||..+|..|-+.--|.+.|.++.+
T Consensus       433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            57887662     23444444 4567888775432     368899999999999999999999999888874

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=97.45  E-value=0.0003  Score=39.54  Aligned_cols=28  Identities=7%  Similarity=0.018  Sum_probs=24.9

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+.++.+++.+|+..+|.+|++..+++.
T Consensus       260 ~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         260 YVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CChHHHHHHHHHhccCchhccCHHHHhc
Confidence            3467889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=97.43  E-value=0.00045  Score=39.65  Aligned_cols=30  Identities=20%  Similarity=0.193  Sum_probs=26.8

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+++.+|+..+|.+||++.+++.
T Consensus       268 ~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         268 PNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             cCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            357788999999999999999999999874

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG2345|consensus

Probab=97.41  E-value=8.3e-05  Score=41.93  Aligned_cols=35  Identities=20%  Similarity=0.373  Sum_probs=31.8

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      -.++.+.+++..|++.+|..||+..+++..++.+.
T Consensus       267 ~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  267 RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            38999999999999999999999999999887653

>KOG0598|consensus

Probab=97.41  E-value=0.00047  Score=40.32  Aligned_cols=57  Identities=14%  Similarity=0.175  Sum_probs=49.1

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCC----CCHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELR----PTFRQLK   57 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~R----p~~~~i~   57 (69)
                      ++|..||.+-+..++...|..+..+..|...+.+..+++.+.+..+|+.|    -.+.+|.
T Consensus       219 L~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik  279 (357)
T KOG0598|consen  219 LTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK  279 (357)
T ss_pred             hhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence            36999999999899999998888777778899999999999999999999    4555554

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=97.33  E-value=0.0008  Score=43.74  Aligned_cols=64  Identities=13%  Similarity=0.085  Sum_probs=41.4

Q ss_pred             CcCCCCCCCCHHHHHHHHH--cCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVE--KGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-TFRQLKAKLLTFML   65 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~--~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-~~~~i~~~l~~~~~   65 (69)
                      +|..||.+....++.....  ..........+|..+.+++.+||..+|.+|+ ++.++...+..+..
T Consensus       226 TG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        226 TLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             HCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            5788887755443332211  1111111246789999999999999999995 56667777766654

>KOG4717|consensus

Probab=97.31  E-value=0.00047  Score=42.75  Aligned_cols=56  Identities=7%  Similarity=0.130  Sum_probs=49.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .|+.||..-+..+.+-+|.+.. ...|...+.+..+||...+..+|.+|.+.++|..
T Consensus       214 CGq~PFqeANDSETLTmImDCK-YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  214 CGQPPFQEANDSETLTMIMDCK-YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hCCCccccccchhhhhhhhccc-ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            5899999988888888887765 3557899999999999999999999999999864

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=97.28  E-value=0.00085  Score=37.37  Aligned_cols=27  Identities=19%  Similarity=0.278  Sum_probs=24.5

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.++.+++.+|+..+|.+||++.+++.
T Consensus       261 ~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         261 PPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            568899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PHA03209 serine/threonine kinase US3; Provisional

Probab=97.28  E-value=0.00023  Score=41.09  Aligned_cols=30  Identities=10%  Similarity=0.265  Sum_probs=25.7

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .++.+..++|.+||..+|.+||++.+++.+
T Consensus       322 ~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        322 NLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            356677789999999999999999998763

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=97.23  E-value=0.0019  Score=37.65  Aligned_cols=59  Identities=12%  Similarity=0.073  Sum_probs=41.8

Q ss_pred             CCcCCCCCCCCHHHHHHHHHc-CCCCCCC--CCCCHHHHHHHHH--hccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEK-GYQMEAP--EGCPPEEYEMMRQ--AWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~-g~r~~~p--~~~~~~~~~l~~~--cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..+....+.. ......|  ..++.+..+++.+  |+..++..|+++.+++.+
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            468999998877655554533 2223333  3578999999987  666777789999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=97.21  E-value=0.0016  Score=36.22  Aligned_cols=26  Identities=15%  Similarity=0.188  Sum_probs=23.8

Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           33 PEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        33 ~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+..+++.+|+..+|.+||++.+++.
T Consensus       262 ~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         262 PHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhHHHHHHHHhccCcccccCHHHHhc
Confidence            77889999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=97.18  E-value=0.002  Score=37.12  Aligned_cols=57  Identities=11%  Similarity=0.200  Sum_probs=42.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhccCCCCCCCC---HHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAPE--GCPPEEYEMMRQAWSLQPELRPT---FRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p~--~~~~~~~~l~~~cw~~~p~~Rp~---~~~i~~   58 (69)
                      ++|..||.+.+..+....+..+ .....|.  .++.++.+++.+|+. +|.+|++   ..+++.
T Consensus       233 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            4689999998887777666543 2333333  468999999999996 8999998   777654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0577|consensus

Probab=97.17  E-value=0.0017  Score=41.00  Aligned_cols=56  Identities=13%  Similarity=0.070  Sum_probs=47.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAP-EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p-~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+.|+.+++....+..|..+..|..+ ..++..+.+++..|++.-|.+||+.++++.
T Consensus       221 RkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  221 RKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             cCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            47899999988778888777666654 468889999999999999999999998865

>KOG0603|consensus

Probab=97.17  E-value=0.00061  Score=42.29  Aligned_cols=56  Identities=14%  Similarity=0.268  Sum_probs=44.6

Q ss_pred             CCcCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|..||...... ++...+..|..   ...++.+-.+|++.+++.+|.+|+++.++...
T Consensus       507 L~G~tp~~~~P~~~ei~~~i~~~~~---s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  507 LTGRTLFAAHPAGIEIHTRIQMPKF---SECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             HhCCCccccCCchHHHHHhhcCCcc---ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            3688999887766 56655555532   36889999999999999999999999998753

>KOG0574|consensus

Probab=97.10  E-value=0.00013  Score=42.44  Aligned_cols=56  Identities=20%  Similarity=0.110  Sum_probs=45.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      |..||.+.++...+.+|...-.+.  .|..++.++.+++..|+-..|+.|.+..++..
T Consensus       225 G~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  225 GRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            899999999977666665443333  36778999999999999999999999888765

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=97.09  E-value=0.00079  Score=37.78  Aligned_cols=29  Identities=14%  Similarity=0.251  Sum_probs=26.0

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.+++.+|+..+|.+||++.+++.
T Consensus       284 ~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         284 KPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            45678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=96.99  E-value=0.0042  Score=35.51  Aligned_cols=59  Identities=8%  Similarity=0.116  Sum_probs=41.9

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCC---CCCCHHHHHHHHHhccC--CCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAP---EGCPPEEYEMMRQAWSL--QPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p---~~~~~~~~~l~~~cw~~--~p~~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..+....+... .+...|   ..++.++.+++.+|+..  ++..|+++.+++.+
T Consensus       202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         202 LYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             hcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            4689999998887777766543 333333   46799999999998754  44447888888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=96.93  E-value=0.00066  Score=36.94  Aligned_cols=27  Identities=22%  Similarity=0.283  Sum_probs=24.0

Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925           27 APEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus        27 ~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      .|..++..+.+++.+||..+|.+|++.
T Consensus       197 ~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         197 IPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            456678899999999999999999985

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=96.90  E-value=0.0049  Score=35.68  Aligned_cols=59  Identities=10%  Similarity=0.009  Sum_probs=41.6

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHH--hccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAPE--GCPPEEYEMMRQ--AWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p~--~~~~~~~~l~~~--cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..+....+..+ ..+..|.  .++.+..+++.+  |...++..||++.+|+.+
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            3689999998888877777653 2333333  467888999876  444455678999998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0032|consensus

Probab=96.90  E-value=0.0077  Score=35.77  Aligned_cols=59  Identities=12%  Similarity=0.057  Sum_probs=48.3

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +.|..||.+.+..+....|..|....   .=+..+....+++..+...+|..|.+..+++.+
T Consensus       232 L~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  232 LSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             hhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            35889999999888888888874311   114578999999999999999999999998874

>KOG0694|consensus

Probab=96.90  E-value=0.004  Score=39.28  Aligned_cols=52  Identities=15%  Similarity=0.118  Sum_probs=43.4

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      |.|+.||+|.+-+++...|..-.. .-|..++.+..+||.+.+..+|++|=-.
T Consensus       562 L~Gq~PF~gddEee~FdsI~~d~~-~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  562 LVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HcCCCCCCCCCHHHHHHHHhcCCC-CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            469999999999999988866542 2367899999999999999999999544

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=96.88  E-value=0.0036  Score=36.34  Aligned_cols=57  Identities=14%  Similarity=0.057  Sum_probs=41.3

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHhccCCCCCCC---CHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAP--EGCPPEEYEMMRQAWSLQPELRP---TFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p--~~~~~~~~~l~~~cw~~~p~~Rp---~~~~i~~   58 (69)
                      ++|..||.+.+..+....+... .....|  ..++.+..+++.+++ .+|.+|+   +..+++.
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            4689999998877666555443 222222  468899999999876 4999999   8888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=96.86  E-value=0.001  Score=40.13  Aligned_cols=29  Identities=14%  Similarity=0.102  Sum_probs=25.7

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .+.++.+|+.+|+..+|.+||++.+++.+
T Consensus       427 ~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        427 LDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            34578999999999999999999999864

>KOG0593|consensus

Probab=96.84  E-value=0.0056  Score=35.83  Aligned_cols=29  Identities=14%  Similarity=0.258  Sum_probs=25.4

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+..+.+++.+|+..||++|.+.++++.
T Consensus       255 ~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  255 KISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            35667889999999999999999999874

>KOG0587|consensus

Probab=96.81  E-value=0.0011  Score=42.79  Aligned_cols=57  Identities=12%  Similarity=0.113  Sum_probs=47.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ--MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r--~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .|..|+.++.+...+..|.+.-+  +..|..++.++.++|..|+..+-..||+..+++.
T Consensus       223 dG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  223 EGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            48999999999877777755543  3357889999999999999999999999998764

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=96.77  E-value=0.0081  Score=35.08  Aligned_cols=59  Identities=8%  Similarity=0.063  Sum_probs=42.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhccCCCC--CCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAPE--GCPPEEYEMMRQAWSLQPE--LRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p~--~~~~~~~~l~~~cw~~~p~--~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..+....+..+ ..+..|.  .++....+++..|+...+.  .|++..+++.+
T Consensus       241 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         241 LVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            3689999988877666666543 3344444  4688999999999975443  38899998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=96.77  E-value=0.008  Score=35.09  Aligned_cols=59  Identities=8%  Similarity=0.061  Sum_probs=42.4

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHhccCCCC--CCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGY-QMEAP--EGCPPEEYEMMRQAWSLQPE--LRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~-r~~~p--~~~~~~~~~l~~~cw~~~p~--~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+.......+..+. .+..|  ...+.+..+++..|+...+.  .|+++.+|+.+
T Consensus       241 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         241 LVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            36899999888777777775542 23333  46899999999999974333  37888888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=96.73  E-value=0.0012  Score=38.85  Aligned_cols=28  Identities=14%  Similarity=0.208  Sum_probs=25.7

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+.++.+|+.+|+..+|.+||+..+++.
T Consensus       348 ~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        348 LPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            4678999999999999999999999985

>KOG0614|consensus

Probab=96.70  E-value=0.0025  Score=39.55  Aligned_cols=52  Identities=13%  Similarity=0.151  Sum_probs=45.2

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGY-QMEAPEGCPPEEYEMMRQAWSLQPELRPT   52 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~-r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~   52 (69)
                      |+|..||.+.++...+..|..|. ...+|..++..-.+||.+....+|.+|--
T Consensus       613 L~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  613 LTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             HcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            58999999999999999998884 56788999999999999888899988754

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=96.67  E-value=0.0023  Score=36.13  Aligned_cols=27  Identities=15%  Similarity=0.288  Sum_probs=24.3

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.+..+++.+|+..+|.+|+++++++.
T Consensus       287 ~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         287 DSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             ChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=96.66  E-value=0.002  Score=36.28  Aligned_cols=27  Identities=15%  Similarity=0.249  Sum_probs=24.2

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +..+.+|+.+|+..+|.+||+..+++.
T Consensus       287 ~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         287 DSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             ChHHHHHHHHHhccCcccccCHHHHhc
Confidence            456889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=96.65  E-value=0.0087  Score=34.26  Aligned_cols=58  Identities=9%  Similarity=0.141  Sum_probs=39.8

Q ss_pred             CCcCCCCCCCCHHHHHHHHHc-CCCCCCCC---CCCHHHHHHHHHhccCCCCC--CCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEK-GYQMEAPE---GCPPEEYEMMRQAWSLQPEL--RPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~-g~r~~~p~---~~~~~~~~l~~~cw~~~p~~--Rp~~~~i~~   58 (69)
                      ++|..||.+.+..+....+.. +.+.+.|.   .++.++.+++.+|+...+..  |+++.+++.
T Consensus       202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         202 LYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             hhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            368999998887776666644 34444443   46899999999998754433  457777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0599|consensus

Probab=96.61  E-value=0.003  Score=36.57  Aligned_cols=58  Identities=9%  Similarity=0.040  Sum_probs=43.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAP---EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p---~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .|..||-+-...-.+.+|.+|..-...   .+.+.+..+||.+|+..+|.+|-+.++.+.+
T Consensus       223 aGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  223 AGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             cCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            467777654333445677888643332   4678899999999999999999999998753

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=96.60  E-value=0.012  Score=34.06  Aligned_cols=57  Identities=11%  Similarity=0.062  Sum_probs=40.1

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhccCCCCCCCC---HHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAPE--GCPPEEYEMMRQAWSLQPELRPT---FRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p~--~~~~~~~~l~~~cw~~~p~~Rp~---~~~i~~   58 (69)
                      ++|..||.+.+..+....+... .....|.  ..+.+..+++.++. .+|.+|++   +.+++.
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            4699999999888777777553 2333333  36889999998765 48888885   566553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0616|consensus

Probab=96.56  E-value=0.0057  Score=35.57  Aligned_cols=48  Identities=8%  Similarity=0.152  Sum_probs=43.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCC
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELR   50 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~R   50 (69)
                      .|..||.+.+..+++++|..|. ...|...+.++.+|+.+.++.|-.+|
T Consensus       236 aG~pPF~~~~~~~iY~KI~~~~-v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  236 AGYPPFYDDNPIQIYEKILEGK-VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cCCCCCcCCChHHHHHHHHhCc-ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            5899999999999999999987 56788999999999999999888877

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=96.56  E-value=0.0025  Score=33.10  Aligned_cols=27  Identities=26%  Similarity=0.549  Sum_probs=24.4

Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           33 PEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        33 ~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ..+.+++..|+..+|.+||+..+++..
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            678899999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PHA03207 serine/threonine kinase US3; Provisional

Probab=96.54  E-value=0.0026  Score=37.27  Aligned_cols=29  Identities=10%  Similarity=0.222  Sum_probs=25.9

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .+.++.++|..|+..+|.+||++.+++..
T Consensus       347 ~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        347 MHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            46788999999999999999999998863

>PLN00181 protein SPA1-RELATED; Provisional

Probab=96.54  E-value=0.0036  Score=39.93  Aligned_cols=27  Identities=22%  Similarity=0.290  Sum_probs=23.8

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ......++..||..+|.+||++.+++.
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            456678999999999999999999975

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=96.48  E-value=0.02  Score=32.82  Aligned_cols=59  Identities=12%  Similarity=0.142  Sum_probs=39.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCC---CCCCHHHHHHHHHhccC--CCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAP---EGCPPEEYEMMRQAWSL--QPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p---~~~~~~~~~l~~~cw~~--~p~~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..+....+... .+...|   ..++.++.+++..|+..  ++..|+++.+++.+
T Consensus       202 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         202 LYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             hhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            3689999988877666655432 222222   35789999999987643  44457888887653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=96.47  E-value=0.014  Score=33.99  Aligned_cols=58  Identities=12%  Similarity=0.107  Sum_probs=41.1

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhccCCCCC---CCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAPE--GCPPEEYEMMRQAWSLQPEL---RPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p~--~~~~~~~~l~~~cw~~~p~~---Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..+....+... ..+..|.  .++.++.+++.+|+. +|.+   |++..+++.+
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         242 LIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            4689999988777666666443 3344443  578999999999997 5665   4688887653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0611|consensus

Probab=96.33  E-value=0.017  Score=35.34  Aligned_cols=55  Identities=16%  Similarity=0.285  Sum_probs=43.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      |..||.|.+-..++..|.+|-.-..  ..|.+..-||.-.+..+|++|.++.+|..+
T Consensus       249 GtMPFDG~Dhk~lvrQIs~GaYrEP--~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  249 GTMPFDGRDHKRLVRQISRGAYREP--ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             cccccCCchHHHHHHHhhcccccCC--CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            7889999988888888888843332  336666788888899999999999998654

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=96.23  E-value=0.017  Score=33.64  Aligned_cols=57  Identities=16%  Similarity=0.122  Sum_probs=39.0

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHhccCCCCCCCC---HHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKG-YQMEAP--EGCPPEEYEMMRQAWSLQPELRPT---FRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g-~r~~~p--~~~~~~~~~l~~~cw~~~p~~Rp~---~~~i~~   58 (69)
                      ++|..||.+.+..+....+... .....|  ...+.+..+++.++. .+|.+|++   ..+++.
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            4699999998877665555432 223333  457888899887754 58999987   777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0610|consensus

Probab=96.17  E-value=0.014  Score=35.22  Aligned_cols=56  Identities=7%  Similarity=0.105  Sum_probs=42.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHhccCCCCCCCC----HHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEK-GYQMEAPEGCPPEEYEMMRQAWSLQPELRPT----FRQLK   57 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~-g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~----~~~i~   57 (69)
                      -|.+||.|.++.+.+..|.. ..+-+.-+..+....+||.+.+-.||.+|--    ..+|.
T Consensus       330 yG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  330 YGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             hCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            48999999999888877633 3332222367889999999999999999987    55554

>KOG0661|consensus

Probab=96.05  E-value=0.0083  Score=36.76  Aligned_cols=30  Identities=20%  Similarity=0.337  Sum_probs=27.2

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .++.+..++|..|...||.+||+..+.++.
T Consensus       262 ~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  262 NASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            488999999999999999999999998763

>KOG3653|consensus

Probab=96.00  E-value=0.018  Score=35.38  Aligned_cols=61  Identities=16%  Similarity=0.228  Sum_probs=44.1

Q ss_pred             CCCCC---CCC--HHHHHHHH-HcCCCCCCCCCC-----CHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            4 AEMSS---DEP--LADVVKHV-EKGYQMEAPEGC-----PPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         4 ~~Py~---~~~--~~~i~~~v-~~g~r~~~p~~~-----~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +.||.   |.+  ..++...| ....||.+|+.+     ..-+.+.++.||+.|++.|=+...+-.++..+.
T Consensus       433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            45665   232  33555544 667888887543     346789999999999999999998888777664

>KOG0690|consensus

Probab=95.78  E-value=0.019  Score=34.15  Aligned_cols=50  Identities=12%  Similarity=0.108  Sum_probs=41.6

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP   51 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp   51 (69)
                      |.|..||.+.+...+.+.|..+. +..|..++++...|+...+..+|.+|-
T Consensus       362 mCGRLPFyn~dh~kLFeLIl~ed-~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  362 MCGRLPFYNKDHEKLFELILMED-LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             HhccCcccccchhHHHHHHHhhh-ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            67999999988777777776554 456789999999999999999999873

>KOG0585|consensus

Probab=95.49  E-value=0.034  Score=34.39  Aligned_cols=56  Identities=16%  Similarity=0.198  Sum_probs=44.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPE--GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~--~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      |+.||.+..-.+....|.+.- +.+|.  ...+++.+||.+.+..||..|-+..+|..+
T Consensus       315 G~~PF~~~~~~~l~~KIvn~p-L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  315 GQLPFFDDFELELFDKIVNDP-LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             ccCCcccchHHHHHHHHhcCc-ccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            889999987778777775432 44443  478999999999999999999999988654

>KOG1187|consensus

Probab=95.46  E-value=0.04  Score=32.53  Aligned_cols=30  Identities=23%  Similarity=0.312  Sum_probs=25.4

Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925           35 EYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus        35 ~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +..+...|.+.++.+||++.+++..|+.+.
T Consensus       324 ~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  324 LAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            557778999999999999999988885543

>PHA03210 serine/threonine kinase US3; Provisional

Probab=95.35  E-value=0.027  Score=34.37  Aligned_cols=28  Identities=21%  Similarity=0.197  Sum_probs=25.0

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+.++.+++.+|+..+|.+||+..+++.
T Consensus       426 ~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        426 LPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             CChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            5667788899999999999999999975

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=94.89  E-value=0.027  Score=35.05  Aligned_cols=26  Identities=12%  Similarity=0.229  Sum_probs=23.0

Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           34 EEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        34 ~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ..++|+..|+..+|.+||+..+++.+
T Consensus       425 ~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        425 AGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhCC
Confidence            45689999999999999999999763

>KOG0586|consensus

Probab=94.72  E-value=0.03  Score=35.11  Aligned_cols=56  Identities=18%  Similarity=0.255  Sum_probs=45.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKG-YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g-~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .|..||.|.+..+....+..| +|.  |-.++.+..+++.+.+-.+|.+|++.++|...
T Consensus       250 ~GsLPFDG~~lk~Lr~rvl~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  250 EGSLPFDGQNLKELRPRVLRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ecccccCCcccccccchheeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            488999998887777777666 444  45677888999999999999999999999764

>KOG0597|consensus

Probab=94.60  E-value=0.07  Score=33.96  Aligned_cols=57  Identities=14%  Similarity=0.160  Sum_probs=45.6

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      |.|..||-..+..+.+..|.... ...|...+.+..+++..-+..||..|-+-.+++.
T Consensus       194 ~~G~PPF~a~si~~Lv~~I~~d~-v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  194 YVGQPPFYARSITQLVKSILKDP-VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             hcCCCCchHHHHHHHHHHHhcCC-CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            46899998888777777764433 2345689999999999999999999999888764

>KOG0605|consensus

Probab=94.49  E-value=0.096  Score=32.64  Aligned_cols=55  Identities=15%  Similarity=0.167  Sum_probs=42.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhccCCCCCCCC---HHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKG-YQMEAPE--GCPPEEYEMMRQAWSLQPELRPT---FRQLK   57 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g-~r~~~p~--~~~~~~~~l~~~cw~~~p~~Rp~---~~~i~   57 (69)
                      .|=.||.+.++.++...|.+. ..+.+|.  .++.+.++||.+|+. +|.+|--   +.+|.
T Consensus       383 vGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  383 VGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            478999999999999988654 3455553  578899999999997 8888753   55554

>KOG0696|consensus

Probab=94.43  E-value=0.19  Score=31.10  Aligned_cols=49  Identities=10%  Similarity=0.150  Sum_probs=39.7

Q ss_pred             CCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCC
Q psy925            1 MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELR   50 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~R   50 (69)
                      |.|+.||.|.+-.++.+.|.+.. ..-|+.++.+..++...-+-..|.+|
T Consensus       544 laGQpPFdGeDE~elF~aI~ehn-vsyPKslSkEAv~ickg~ltK~P~kR  592 (683)
T KOG0696|consen  544 LAGQPPFDGEDEDELFQAIMEHN-VSYPKSLSKEAVAICKGLLTKHPGKR  592 (683)
T ss_pred             HcCCCCCCCCCHHHHHHHHHHcc-CcCcccccHHHHHHHHHHhhcCCccc
Confidence            45999999999999999987654 23368889999999888888888776

>KOG1027|consensus

Probab=93.42  E-value=0.11  Score=34.02  Aligned_cols=52  Identities=17%  Similarity=0.347  Sum_probs=35.9

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCC-CC--CC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQ-ME--AP-EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r-~~--~p-~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      |..||.+.-..+  ..|..|.. +.  .| ..+  +..+||...++.+|..||+..+++.
T Consensus       711 G~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  711 GSHPFGDSLERQ--ANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             CccCCCchHHhh--hhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            688998864433  23444432 21  11 222  7789999999999999999999864

>KOG0576|consensus

Probab=93.29  E-value=0.34  Score=31.46  Aligned_cols=55  Identities=16%  Similarity=0.115  Sum_probs=42.3

Q ss_pred             CCCCCCCCHHHHHHHH-HcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            4 AEMSSDEPLADVVKHV-EKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         4 ~~Py~~~~~~~i~~~v-~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.|-.++.+.++.... +.|+.++.   +..+++.+.+++..|+..+|.+||+.+-++.
T Consensus       212 qpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  212 QPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            4566777777766655 66776663   3457889999999999999999999886654

>KOG0604|consensus

Probab=93.05  E-value=0.17  Score=29.97  Aligned_cols=57  Identities=11%  Similarity=0.095  Sum_probs=41.3

Q ss_pred             CcCCCCCCCCHH----HHHHHHHcCCCCCC-C--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA----DVVKHVEKGYQMEA-P--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~----~i~~~v~~g~r~~~-p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .|=.||-.++-.    .....|..|+.-.. |  +..+++..++|...+..+|.+|-++.+++.
T Consensus       258 CGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  258 CGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            466777655332    44556777865332 2  346788999999999999999999999875

>KOG0595|consensus

Probab=92.71  E-value=0.31  Score=29.63  Aligned_cols=56  Identities=14%  Similarity=0.147  Sum_probs=45.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ--MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK   57 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r--~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~   57 (69)
                      +|..||...+..+....++.|..  +..+..++.+..+|+..-...++.+|-+|.+..
T Consensus       209 ~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  209 TGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             hCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence            69999999999999988877743  445666777878888888889998888887654

>KOG1035|consensus

Probab=92.38  E-value=0.54  Score=32.41  Aligned_cols=45  Identities=29%  Similarity=0.374  Sum_probs=31.7

Q ss_pred             HHHHHHHcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           14 DVVKHVEKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        14 ~i~~~v~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++..+++|..+..   ...--+.-..+|....+.+|.+||+..+++.
T Consensus       823 ~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  823 SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            45566677765544   2222334478888899999999999999875

>KOG4158|consensus

Probab=91.73  E-value=0.55  Score=29.07  Aligned_cols=38  Identities=16%  Similarity=0.142  Sum_probs=31.7

Q ss_pred             CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925           24 QMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus        24 r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      -+..|+.+|+.+.+++..-++.+|.+|++-...-..++
T Consensus       475 LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  475 LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            35678999999999999999999999999876554443

>KOG0660|consensus

Probab=91.60  E-value=0.93  Score=27.15  Aligned_cols=30  Identities=17%  Similarity=0.274  Sum_probs=27.1

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.+++.-.+|+.+.+..+|.+|.|.++.+.
T Consensus       280 p~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  280 PNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            467888899999999999999999999875

>KOG0671|consensus

Probab=89.60  E-value=0.34  Score=29.30  Aligned_cols=26  Identities=19%  Similarity=0.445  Sum_probs=23.7

Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           33 PEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        33 ~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.+|+.+.+.+||.+|.++.|++.
T Consensus       380 ~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  380 VQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             hHHHHHHHHHHccCccccccHHHHhc
Confidence            36889999999999999999999875

>KOG0659|consensus

Probab=89.02  E-value=0.53  Score=27.44  Aligned_cols=31  Identities=13%  Similarity=0.247  Sum_probs=26.9

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +.++.+..+|+.+.|.++|.+|.+..+.++.
T Consensus       251 ~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  251 PAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            3467788999999999999999999998753

>KOG1151|consensus

Probab=88.54  E-value=1.1  Score=28.20  Aligned_cols=54  Identities=15%  Similarity=0.136  Sum_probs=37.1

Q ss_pred             cCCCCCCCCH-HHHHHH--HHcC---CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy925            3 RAEMSSDEPL-ADVVKH--VEKG---YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK   57 (69)
Q Consensus         3 g~~Py~~~~~-~~i~~~--v~~g---~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~   57 (69)
                      |..||.+.-. +.|++.  |...   ..|+. +..+.+..++|.+|+.+.-++|-...++.
T Consensus       680 GrKPFGhnqsQQdILqeNTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  680 GRKPFGHNQSQQDILQENTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             cCCCCCCchhHHHHHhhhchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            7899987644 355543  2111   22322 46788899999999999999888777664

>KOG1165|consensus

Probab=87.70  E-value=4.6  Score=24.66  Aligned_cols=64  Identities=13%  Similarity=0.056  Sum_probs=48.0

Q ss_pred             CcCCCCCCCCHH---HHHHHHHcCCCCCC----CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLA---DVVKHVEKGYQMEA----PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         2 ~g~~Py~~~~~~---~i~~~v~~g~r~~~----p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      -|..||.|+...   +-++.|-+..|...    -...|.++...+.-.-+.+-.+-|..+.+...|..++.
T Consensus       231 RGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  231 RGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             cCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            489999999554   55566654444332    25678899999988888888999999999888887764

>KOG0606|consensus

Probab=86.48  E-value=1.4  Score=30.25  Aligned_cols=50  Identities=18%  Similarity=0.158  Sum_probs=39.7

Q ss_pred             CcCCCCCCCCHHHHHHHH--HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q psy925            2 NRAEMSSDEPLADVVKHV--EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP   51 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v--~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp   51 (69)
                      -|.+||.|-++.+++..|  ....-+......+++.++++...++.+|..|-
T Consensus       253 VgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  253 VGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             eeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            378999999999888766  33455555566889999999999999998774

>KOG0667|consensus

Probab=82.98  E-value=1.2  Score=28.40  Aligned_cols=26  Identities=15%  Similarity=0.100  Sum_probs=23.3

Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           33 PEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        33 ~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.+++.+|+..+|..|.+..+.+.
T Consensus       476 ~~F~dflk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  476 KLFIDFLKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             HHHHHHHHHHhccCchhcCCHHHHhc
Confidence            46789999999999999999998875

>KOG0658|consensus

Probab=81.87  E-value=2.2  Score=25.70  Aligned_cols=30  Identities=17%  Similarity=0.341  Sum_probs=26.6

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ...+++..+++.+++.++|.+|-+..+++.
T Consensus       276 ~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  276 KRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            457899999999999999999998888764

>KOG1167|consensus

Probab=80.88  E-value=2  Score=26.34  Aligned_cols=30  Identities=17%  Similarity=0.248  Sum_probs=26.2

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +..+...+++..+|+..+|.+|-+.++.++
T Consensus       351 d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  351 DVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            445678999999999999999999998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	69
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-06
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-05
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-05
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-05
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-05
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-05
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-05
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-05
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-04
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-04
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-04
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-04
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-04
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-04
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-04

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 28/50 (56%), Positives = 37/50 (74%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L   +RP+F QL+ +L
Sbjct: 219 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 28/50 (56%), Positives = 37/50 (74%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L   +RP+F QL+ +L
Sbjct: 204 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 253

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 28/50 (56%), Positives = 37/50 (74%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L   +RP+F QL+ +L
Sbjct: 210 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 259

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 28/50 (56%), Positives = 36/50 (72%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           PL DVV  VEKGY+M+AP+GCPP  Y++M+  W L    RPTF QL+ +L
Sbjct: 391 PLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 25/56 (44%), Positives = 33/56 (58%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           L+ V   +EKGY+ME PEGCPP+ YE+MR  W   P  RP+F +      T   +S
Sbjct: 237 LSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETMFHDS 292

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 213 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 263

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 214 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 264

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 219 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 269

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 223 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 273

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 224 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 274

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 220 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 270

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 227 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 277

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 226 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 276

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 224 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 274

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 35/51 (68%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F 
Sbjct: 228 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 278

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 425 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 220 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 223 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 464 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 231 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 223 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 220 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 223 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 223 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 219 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 219 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 223 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 220 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 12  LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 225 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 248 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 298

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 220 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/50 (42%), Positives = 33/50 (66%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           +V++ +E+GY+M  PE CP E Y +M + W  +PE RPTF  +++ L  F
Sbjct: 393 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 220 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 21/50 (42%), Positives = 33/50 (66%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           +V++ +E+GY+M  PE CP E Y +M + W  +PE RPTF  +++ L  F
Sbjct: 377 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 223 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 273

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 220 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 220 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 222 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 272

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 21/50 (42%), Positives = 33/50 (66%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           +V++ +E+GY+M  PE CP E Y +M + W  +PE RPTF  +++ L  F
Sbjct: 220 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 269

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 217 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 600 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 20/51 (39%), Positives = 30/51 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 600 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           + V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 217 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           + V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 217 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           + V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++
Sbjct: 217 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 33/54 (61%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L  +  ++
Sbjct: 389 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 33/54 (61%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L  +  ++
Sbjct: 472 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 33/54 (61%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L  +  ++
Sbjct: 389 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 33/54 (61%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L  +  ++
Sbjct: 389 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 20/47 (42%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V++ VE+GY+M  P+ CP   +E+M   W   PE RPTF  L++ L
Sbjct: 214 EVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFL 260

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 33/54 (61%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L  +  ++
Sbjct: 213 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 266

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 256 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 314

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 310 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 33/54 (61%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L  +  ++
Sbjct: 220 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 273

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 33/54 (61%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L  +  ++
Sbjct: 216 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 269

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 251 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 309

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 33/54 (61%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L  +  ++
Sbjct: 220 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 273

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 253 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 311

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL
Sbjct: 257 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK---AKLLTFMLN 66
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL     ++LT   N
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 20/50 (40%), Positives = 30/50 (60%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL   L
Sbjct: 298 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL
Sbjct: 257 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL
Sbjct: 257 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL
Sbjct: 257 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL
Sbjct: 250 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 295

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL
Sbjct: 249 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 294

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL
Sbjct: 246 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 291

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 390 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 443

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 214 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 267

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 223 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 223 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 223 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 223 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 223 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 223 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 212 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 265

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 223 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/51 (41%), Positives = 31/51 (60%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           ADV+  + +GY+M   E CP E Y++M+  W  + E RPTF  L++ L  F
Sbjct: 218 ADVMTALSQGYRMPRVENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDF 268

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 32/54 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           +V+  VE+GY+M  P  CP   +++M Q W   PE RPTF  L+A L  +  ++
Sbjct: 223 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 16/40 (40%), Positives = 27/40 (67%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K +++G++M +PE  P E Y++M+  W   P  RPTF+Q+
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 21/51 (41%), Positives = 31/51 (60%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           ADV+  + +GY+M   E CP E Y++M+  W  + E RPTF  L++ L  F
Sbjct: 217 ADVMSALSQGYRMPRMENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDF 267

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 16/40 (40%), Positives = 27/40 (67%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K +++G++M +PE  P E Y++M+  W   P  RPTF+Q+
Sbjct: 277 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 316

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 16/40 (40%), Positives = 27/40 (67%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K +++G++M +PE  P E Y++M+  W   P  RPTF+Q+
Sbjct: 282 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 321

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 16/40 (40%), Positives = 27/40 (67%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K +++G++M +PE  P E Y++M+  W   P  RPTF+Q+
Sbjct: 275 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 314

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 16/40 (40%), Positives = 27/40 (67%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K +++G++M +PE  P E Y++M+  W   P  RPTF+Q+
Sbjct: 282 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 321

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/40 (45%), Positives = 25/40 (62%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K V+ GYQM  P   P   Y +M+  W+L+P  RPTF+Q+
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/40 (45%), Positives = 25/40 (62%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K V+ GYQM  P   P   Y +M+  W+L+P  RPTF+Q+
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/40 (45%), Positives = 25/40 (62%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K V+ GYQM  P   P   Y +M+  W+L+P  RPTF+Q+
Sbjct: 266 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/40 (45%), Positives = 25/40 (62%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K V+ GYQM  P   P   Y +M+  W+L+P  RPTF+Q+
Sbjct: 272 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/40 (45%), Positives = 25/40 (62%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K V+ GYQM  P   P   Y +M+  W+L+P  RPTF+Q+
Sbjct: 274 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 30/48 (62%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           A++ + + +GY++E P  C  E Y++MRQ W  +P  RP+F Q+   L
Sbjct: 248 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 30/48 (62%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           A++ + + +GY++E P  C  E Y++MRQ W  +P  RP+F Q+   L
Sbjct: 245 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 292

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 30/48 (62%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           A++ + + +GY++E P  C  E Y++MRQ W  +P  RP+F Q+   L
Sbjct: 238 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 285

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/40 (45%), Positives = 25/40 (62%)
Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           K V+ GYQM  P   P   Y +M+  W+L+P  RPTF+Q+
Sbjct: 280 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 31/57 (54%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  + + 
Sbjct: 215 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 271

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 31/57 (54%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  + + 
Sbjct: 221 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 277

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 31/57 (54%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  + + 
Sbjct: 221 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 277

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 31/57 (54%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  + + 
Sbjct: 217 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 17/47 (36%), Positives = 28/47 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+   + +G ++  PE CP   Y++M+Q W   P +RPTFR L  ++
Sbjct: 236 DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 31/57 (54%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  + + 
Sbjct: 235 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 291

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 31/57 (54%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  + + 
Sbjct: 227 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 31/57 (54%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  + + 
Sbjct: 237 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 293

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 31/57 (54%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  + + 
Sbjct: 237 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 293

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 31/57 (54%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  + + 
Sbjct: 580 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 636

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 31/57 (54%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  + + 
Sbjct: 579 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 635

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 18/47 (38%), Positives = 27/47 (57%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           DV+  VE+GY++ AP GCP   +++M   W      RP F Q+ + L
Sbjct: 262 DVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 18/47 (38%), Positives = 27/47 (57%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           DV+  VE+GY++ AP GCP   +++M   W      RP F Q+ + L
Sbjct: 262 DVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 224 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279
Query: 65  LN 66
            N
Sbjct: 280 RN 281

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 224 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279
Query: 65  LN 66
            N
Sbjct: 280 RN 281

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 241 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 296
Query: 65  LN 66
            N
Sbjct: 297 RN 298

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 253 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
Query: 65  LN 66
            N
Sbjct: 309 RN 310

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 253 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
Query: 65  LN 66
            N
Sbjct: 309 RN 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 253 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
Query: 65  LN 66
            N
Sbjct: 309 RN 310

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 253 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
Query: 65  LN 66
            N
Sbjct: 309 RN 310

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 253 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
Query: 65  LN 66
            N
Sbjct: 309 RN 310

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 18/47 (38%), Positives = 26/47 (55%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           DV+  +EKG ++  P+ CPP  Y +M + W   P  RP F +L   L
Sbjct: 222 DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 253 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
Query: 65  LN 66
            N
Sbjct: 309 RN 310

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 253 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
Query: 65  LN 66
            N
Sbjct: 309 RN 310

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 253 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
Query: 65  LN 66
            N
Sbjct: 309 RN 310

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 253 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
Query: 65  LN 66
            N
Sbjct: 309 RN 310

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
           EMS+     DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   +
Sbjct: 251 EMSNQ----DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306
Query: 65  LN 66
            N
Sbjct: 307 RN 308

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 18/47 (38%), Positives = 26/47 (55%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           DV+  +EKG ++  P+ CPP  Y +M + W   P  RP F +L   L
Sbjct: 218 DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 264

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 18/47 (38%), Positives = 26/47 (55%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           DV+  +EKG ++  P+ CPP  Y +M + W   P  RP F +L   L
Sbjct: 234 DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 280

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/47 (31%), Positives = 28/47 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           + +  + +G ++E P  CPPE Y +MR  W  +P+ R + + + A+L
Sbjct: 268 EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/48 (31%), Positives = 28/48 (58%)
Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            + +  + +G ++E P  CPPE Y +MR  W  +P+ R + + + A+L
Sbjct: 244 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/47 (31%), Positives = 28/47 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           + +  + +G ++E P  CPPE Y +MR  W  +P+ R + + + A+L
Sbjct: 239 EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 243 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 245 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 291

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 246 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 292

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 246 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 292

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 245 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 250 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 296

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 304 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/42 (35%), Positives = 25/42 (59%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           V+K V  G  ++ P+ CP    ++MR  W   P++RPTF ++
Sbjct: 238 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 279

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/42 (35%), Positives = 25/42 (59%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           V+K V  G  ++ P+ CP    ++MR  W   P++RPTF ++
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 244 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 290

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 243 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 289

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/42 (35%), Positives = 25/42 (59%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           V+K V  G  ++ P+ CP    ++MR  W   P++RPTF ++
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/42 (35%), Positives = 25/42 (59%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           V+K V  G  ++ P+ CP    ++MR  W   P++RPTF ++
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 263 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 309

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/42 (35%), Positives = 25/42 (59%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           V+K V  G  ++ P+ CP    ++MR  W   P++RPTF ++
Sbjct: 240 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 281

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 240 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 245 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 291

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 244 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 290

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 242 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 264 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 310

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 245 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 291

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/47 (31%), Positives = 30/47 (63%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 237 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 283

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/53 (33%), Positives = 29/53 (54%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN 66
           DV+K VE+GY++ +P  CP   Y++M   W  +   RP F ++   L   + N
Sbjct: 235 DVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/42 (35%), Positives = 24/42 (57%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           V+K V  G  ++ P+ CP    ++MR  W   P +RPTF ++
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 260 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 299

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 254 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 293

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 271 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 310

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 294 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 333

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/47 (38%), Positives = 25/47 (53%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V+ +V  G  +  PE CP E Y +MR  WS  P  RP+F  +   L
Sbjct: 284 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 254 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 293

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 268 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 307

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 254 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 293

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 270 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 309

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 268 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 307

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 280 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 319

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 268 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 307

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 253 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 292

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 245 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 284

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F
Sbjct: 253 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 292

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/42 (35%), Positives = 24/42 (57%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           V+K V  G  ++ P+ CP    ++MR  W   P +RPTF ++
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/42 (35%), Positives = 24/42 (57%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           V+K V  G  ++ P+ CP    ++MR  W   P +RPTF ++
Sbjct: 242 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 283

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/53 (33%), Positives = 29/53 (54%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN 66
           DV+K +E+GY++ AP  CP   +++M   W  +   RP F Q+   L   + N
Sbjct: 256 DVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRN 308

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 14/46 (30%), Positives = 29/46 (63%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 271 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 316

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 14/46 (30%), Positives = 29/46 (63%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 243 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 14/46 (30%), Positives = 29/46 (63%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 242 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 14/46 (30%), Positives = 29/46 (63%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 239 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 284

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 27/42 (64%)
Query: 20  EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           ++G ++  PE CP + Y +M Q W+ +PE RPTF  L+  LL
Sbjct: 233 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 274

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 14/46 (30%), Positives = 29/46 (63%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 240 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 285

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 14/46 (30%), Positives = 29/46 (63%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 242 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 14/46 (30%), Positives = 29/46 (63%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 243 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 14/46 (30%), Positives = 29/46 (63%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 249 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 27/42 (64%)
Query: 20  EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           ++G ++  PE CP + Y +M Q W+ +PE RPTF  L+  LL
Sbjct: 233 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 274

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 27/42 (64%)
Query: 20  EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           ++G ++  PE CP + Y +M Q W+ +PE RPTF  L+  LL
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 27/42 (64%)
Query: 20  EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           ++G ++  PE CP + Y +M Q W+ +PE RPTF  L+  LL
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 14/46 (30%), Positives = 29/46 (63%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 236 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 27/42 (64%)
Query: 20  EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           ++G ++  PE CP + Y +M Q W+ +PE RPTF  L+  LL
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 30/48 (62%), Gaps = 1/48 (2%)
Query: 15  VVKHVEK-GYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           ++  ++K G ++  PE CP + Y +M Q W+ +PE RPTF  L+  LL
Sbjct: 233 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 14/46 (30%), Positives = 29/46 (63%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 249 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 30/48 (62%), Gaps = 1/48 (2%)
Query: 15  VVKHVEK-GYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           ++  ++K G ++  PE CP + Y +M Q W+ +PE RPTF  L+  LL
Sbjct: 233 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 15/42 (35%), Positives = 26/42 (61%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           +V  +++G ++  P  CP E Y++MR+ W  QP  R +F+ L
Sbjct: 240 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 281

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 15/42 (35%), Positives = 26/42 (61%)
Query: 15  VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           +V  +++G ++  P  CP E Y++MR+ W  QP  R +F+ L
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF 53
           +V+  +E+G +ME P  CPPE Y +M   W  + E RP F
Sbjct: 221 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDF 260

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 17/47 (36%), Positives = 28/47 (59%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +V+  +E+G +ME P  CPPE Y +M   W  + E RP F  ++ ++
Sbjct: 547 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 16/47 (34%), Positives = 26/47 (55%)
Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML 65
           ++ G++ME P+ C  E Y +M Q W  +P+ RP F  +   L   M+
Sbjct: 265 LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 16/47 (34%), Positives = 26/47 (55%)
Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML 65
           ++ G++ME P+ C  E Y +M Q W  +P+ RP F  +   L   M+
Sbjct: 265 LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 16/47 (34%), Positives = 26/47 (55%)
Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML 65
           ++ G++ME P+ C  E Y +M Q W  +P+ RP F  +   L   M+
Sbjct: 265 LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 15/43 (34%), Positives = 25/43 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           DV+K +E+GY++  P  CP   +++M   W  +   RP F Q+
Sbjct: 221 DVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQI 263

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 16/42 (38%), Positives = 25/42 (59%)
Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           VEKG ++  PE CP   + +M Q W+ +P  RP+F  +  +L
Sbjct: 328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 15/43 (34%), Positives = 25/43 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           DV+K +E+GY++  P  CP   +++M   W  +   RP F Q+
Sbjct: 227 DVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQI 269

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 16/42 (38%), Positives = 25/42 (59%)
Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           VEKG ++  PE CP   + +M Q W+ +P  RP+F  +  +L
Sbjct: 328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 15/43 (34%), Positives = 25/43 (58%)
Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQL 56
           DV+K +E+GY++  P  CP   +++M   W  +   RP F Q+
Sbjct: 242 DVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQI 284

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	69
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-18
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-17
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-17
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-17
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-16
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-16
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-16
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-16
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-16
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-14
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-12
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-10
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-10
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-10
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-09
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-08
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-08
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-08
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-07

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 77.1 bits (190), Expect = 7e-19
 Identities = 21/57 (36%), Positives = 33/57 (57%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
              +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L  +  ++
Sbjct: 386 VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 76.1 bits (188), Expect = 7e-19
 Identities = 29/59 (49%), Positives = 39/59 (66%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L   +RP+F QL+ +L     + L 
Sbjct: 219 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELH 277

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 77.1 bits (190), Expect = 8e-19
 Identities = 21/57 (36%), Positives = 34/57 (59%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
              +V++ +E+GY+M  PE CP E Y +M + W  +PE RPTF  +++ L  F   +
Sbjct: 390 SNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 77.0 bits (190), Expect = 9e-19
 Identities = 29/59 (49%), Positives = 38/59 (64%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           PL DVV  VEKGY+M+AP+GCPP  Y++M+  W L    RPTF QL+ +L     + L 
Sbjct: 391 PLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHELH 449

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 76.8 bits (189), Expect = 1e-18
 Identities = 21/57 (36%), Positives = 33/57 (57%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
              +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L  +  ++
Sbjct: 469 VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 75.4 bits (186), Expect = 2e-18
 Identities = 23/57 (40%), Positives = 32/57 (56%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
            L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++     T    S
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 74.9 bits (185), Expect = 2e-18
 Identities = 22/57 (38%), Positives = 36/57 (63%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
              +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L  F   +
Sbjct: 215 TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 76.0 bits (187), Expect = 2e-18
 Identities = 23/57 (40%), Positives = 32/57 (56%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
            L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++     T    S
Sbjct: 424 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 74.6 bits (184), Expect = 3e-18
 Identities = 13/54 (24%), Positives = 27/54 (50%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
             ++  +H+ +G ++  P     + Y +M   W  + + RPTF+ L + +L  M
Sbjct: 226 TNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 74.2 bits (183), Expect = 3e-18
 Identities = 15/58 (25%), Positives = 28/58 (48%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSL 68
             ++VV+ +  G+++  P       Y++M   W  +PE RP F +L  +L     + L
Sbjct: 210 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 74.1 bits (183), Expect = 4e-18
 Identities = 16/54 (29%), Positives = 27/54 (50%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
             ++VV  V +G+++  P       Y++M   W   PE RPTF+QL + +    
Sbjct: 210 TNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 74.3 bits (183), Expect = 7e-18
 Identities = 20/57 (35%), Positives = 32/57 (56%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL   L   +  +
Sbjct: 298 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 72.7 bits (179), Expect = 2e-17
 Identities = 16/54 (29%), Positives = 27/54 (50%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
                 + VEKG ++  PE CP   + +M Q W+ +P  RP+F  +  +L +  
Sbjct: 320 SNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 72.3 bits (178), Expect = 2e-17
 Identities = 15/57 (26%), Positives = 29/57 (50%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           P +++   +EKG ++  P  C  + Y +MR+ W +  + RP FR+L  +      + 
Sbjct: 224 PASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 72.0 bits (177), Expect = 3e-17
 Identities = 17/55 (30%), Positives = 28/55 (50%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
            +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F  +  ++     + 
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.9 bits (177), Expect = 3e-17
 Identities = 19/64 (29%), Positives = 32/64 (50%), Gaps = 3/64 (4%)

Query: 6   MSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML 65
           M  D       K +++G++M +PE  P E Y++M+  W   P  RPTF+Q+   +   + 
Sbjct: 251 MPVDS---KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

Query: 66  NSLQ 69
            S  
Sbjct: 308 ESTN 311

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 71.9 bits (177), Expect = 3e-17
 Identities = 15/54 (27%), Positives = 28/54 (51%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           + +  + +G ++E P  CPPE Y +MR  W  +P+ R + + + A+L       
Sbjct: 268 EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 71.9 bits (177), Expect = 4e-17
 Identities = 17/57 (29%), Positives = 29/57 (50%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
            +  + +++G +M AP+   PE Y+ M   W  +P  RPTF +L   L   +  + Q
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 71.1 bits (175), Expect = 5e-17
 Identities = 18/54 (33%), Positives = 30/54 (55%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN 66
           ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L  +  +
Sbjct: 227 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 71.6 bits (176), Expect = 5e-17
 Identities = 16/54 (29%), Positives = 27/54 (50%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
            +  + + +E+G ++  P+ CP E Y +M+  W  +   RPTF  L   L T  
Sbjct: 256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 71.7 bits (176), Expect = 5e-17
 Identities = 17/55 (30%), Positives = 28/55 (50%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
            +V++ V  G +M+ P+ CP   Y +M Q W  QPE RP F  +  ++     + 
Sbjct: 293 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 71.5 bits (176), Expect = 5e-17
 Identities = 19/57 (33%), Positives = 29/57 (50%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           +   K V+ GYQM  P   P   Y +M+  W+L+P  RPTF+Q+ + L        +
Sbjct: 274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 71.6 bits (176), Expect = 5e-17
 Identities = 18/55 (32%), Positives = 29/55 (52%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
            DV+  VE+GY++ AP GCP   +++M   W      RP F Q+ + L   + + 
Sbjct: 261 RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 71.1 bits (175), Expect = 5e-17
 Identities = 13/55 (23%), Positives = 27/55 (49%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
            +V++ + +G  +E P  CP E Y++M   W  +P+ R   +++   L      +
Sbjct: 242 TEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 71.1 bits (175), Expect = 6e-17
 Identities = 17/57 (29%), Positives = 28/57 (49%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           P   +   ++ G++ME P+ C  E Y +M Q W  +P+ RP F  +   L   M+  
Sbjct: 257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 70.7 bits (174), Expect = 7e-17
 Identities = 17/54 (31%), Positives = 29/54 (53%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN 66
            +V+  +E+G +ME P  CPPE Y +M   W  + E RP F  ++ ++     +
Sbjct: 220 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 71.2 bits (175), Expect = 7e-17
 Identities = 18/57 (31%), Positives = 33/57 (57%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
            L+ +++ +E+G ++ AP  CP E +E+M+  W+  P+ RP+F  L  +L      S
Sbjct: 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 71.2 bits (175), Expect = 8e-17
 Identities = 18/57 (31%), Positives = 31/57 (54%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
             A++ + + +GY++E P  C  E Y++MRQ W  +P  RP+F Q+   L   +   
Sbjct: 246 TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 71.5 bits (175), Expect = 8e-17
 Identities = 17/48 (35%), Positives = 28/48 (58%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            +V+  +E+G +ME P  CPPE Y +M   W  + E RP F  ++ ++
Sbjct: 546 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 71.4 bits (175), Expect = 9e-17
 Identities = 20/54 (37%), Positives = 30/54 (55%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +   
Sbjct: 600 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 70.8 bits (174), Expect = 1e-16
 Identities = 18/55 (32%), Positives = 26/55 (47%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
            +V+ +V  G  +  PE CP E Y +MR  WS  P  RP+F  +   L      +
Sbjct: 283 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 70.4 bits (173), Expect = 1e-16
 Identities = 14/57 (24%), Positives = 29/57 (50%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
            +  +++ ++   ++  P+GCP E Y +M + W+     RP+FR L  ++     N 
Sbjct: 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 70.3 bits (173), Expect = 1e-16
 Identities = 14/50 (28%), Positives = 26/50 (52%)

Query: 14  DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF 63
           DVV+ +     +  P+ CP   Y +M + W+  P  RP F+ + ++L  +
Sbjct: 238 DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.8 bits (174), Expect = 1e-16
 Identities = 14/62 (22%), Positives = 29/62 (46%), Gaps = 3/62 (4%)

Query: 6   MSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML 65
           +  D    +  K ++ G++M+ P     E Y +M+  W+     RP+F  L + L   + 
Sbjct: 278 IPVDA---NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334

Query: 66  NS 67
           ++
Sbjct: 335 DA 336

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 70.0 bits (172), Expect = 2e-16
 Identities = 15/54 (27%), Positives = 28/54 (51%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
            +  +V  +++G ++  P  CP E Y++MR+ W  QP  R +F+ L       +
Sbjct: 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 70.1 bits (172), Expect = 2e-16
 Identities = 13/54 (24%), Positives = 28/54 (51%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
            +  +++ ++   ++  P+GCP E Y +M + W+     RP+FR L  ++    
Sbjct: 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 69.6 bits (171), Expect = 2e-16
 Identities = 20/52 (38%), Positives = 30/52 (57%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
            DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 224 NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 70.0 bits (172), Expect = 2e-16
 Identities = 16/52 (30%), Positives = 28/52 (53%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
            ++  ++  G++++ PE C  E YE+M   W   P  RPTF  L+ +L   +
Sbjct: 256 HEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 69.1 bits (170), Expect = 2e-16
 Identities = 18/52 (34%), Positives = 26/52 (50%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
            DV+  +EKG ++  P+ CPP  Y +M + W   P  RP F +L   L    
Sbjct: 221 KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 69.6 bits (171), Expect = 3e-16
 Identities = 20/57 (35%), Positives = 32/57 (56%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL   L   +  +
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 69.7 bits (171), Expect = 3e-16
 Identities = 16/48 (33%), Positives = 29/48 (60%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           A++  ++  G +++ P  C  E Y++M Q WS  P+ RP+F  L+ +L
Sbjct: 246 AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 69.7 bits (171), Expect = 3e-16
 Identities = 20/57 (35%), Positives = 32/57 (56%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
           P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL   L   +  +
Sbjct: 310 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 69.2 bits (170), Expect = 3e-16
 Identities = 15/48 (31%), Positives = 30/48 (62%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 239 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 69.8 bits (171), Expect = 3e-16
 Identities = 15/57 (26%), Positives = 31/57 (54%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
            D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++       + 
Sbjct: 303 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 69.2 bits (170), Expect = 3e-16
 Identities = 17/48 (35%), Positives = 28/48 (58%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            D+   + +G ++  PE CP   Y++M+Q W   P +RPTFR L  ++
Sbjct: 235 FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 69.2 bits (170), Expect = 3e-16
 Identities = 15/57 (26%), Positives = 31/57 (54%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
             V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +   M    +
Sbjct: 247 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 69.3 bits (170), Expect = 4e-16
 Identities = 16/50 (32%), Positives = 29/50 (58%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            LA+V   +EKG ++  P+ C  + Y +M + W +   +RPTF++L  + 
Sbjct: 222 RLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 68.9 bits (169), Expect = 5e-16
 Identities = 14/50 (28%), Positives = 27/50 (54%)

Query: 11  PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           P +++   +EKG ++  P  C  + Y +M + W +  + RP FR+L  + 
Sbjct: 224 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.2 bits (169), Expect = 5e-16
 Identities = 17/57 (29%), Positives = 29/57 (50%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
            +  + +++G +M AP+   PE Y+ M   W  +P  RPTF +L   L   +  + Q
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 68.9 bits (169), Expect = 5e-16
 Identities = 18/54 (33%), Positives = 28/54 (51%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN 66
            DV+K V++GY++  P  CP   Y++M   W      RP F Q+ + L   + N
Sbjct: 257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 68.1 bits (167), Expect = 8e-16
 Identities = 14/55 (25%), Positives = 26/55 (47%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
            +V+K +  G+++  P  CP   Y++M Q W  +   RP F  + + L   +   
Sbjct: 257 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 65.3 bits (160), Expect = 8e-15
 Identities = 19/58 (32%), Positives = 33/58 (56%), Gaps = 1/58 (1%)

Query: 13  ADVVKHVEK-GYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ 69
           + ++  ++K G ++  PE CP + Y +M Q W+ +PE RPTF  L+  LL      ++
Sbjct: 231 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 63.1 bits (154), Expect = 5e-14
 Identities = 11/56 (19%), Positives = 23/56 (41%), Gaps = 2/56 (3%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSL 68
              ++  E  +Q+ AP+        ++      +P+ RP+FR +   L +     L
Sbjct: 225 QRKLQFYEDRHQLPAPKAAEL--ANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 59.3 bits (144), Expect = 1e-12
 Identities = 14/48 (29%), Positives = 21/48 (43%)

Query: 13  ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            D   +V        P  CPP  + +  +   L PE RP+F +L+  L
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 53.4 bits (129), Expect = 2e-10
 Identities = 12/51 (23%), Positives = 20/51 (39%)

Query: 10  EPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           + LA           +  P  CP    ++M   W+  P  RP+F  +  +L
Sbjct: 218 DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 53.1 bits (128), Expect = 2e-10
 Identities = 9/54 (16%), Positives = 23/54 (42%), Gaps = 4/54 (7%)

Query: 11  PLADVVKHVEKGYQM----EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
               +++ V +G       +    CP     +M +    + + RP+F ++ A++
Sbjct: 230 NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 48.9 bits (117), Expect = 6e-09
 Identities = 12/54 (22%), Positives = 24/54 (44%), Gaps = 1/54 (1%)

Query: 8   SDEPLADVVKHVEKGYQMEAPE-GCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             +P   ++  +  G +    + G   E  +++   W+ + E RPTF +L   L
Sbjct: 244 KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 48.1 bits (115), Expect = 1e-08
 Identities = 10/50 (20%), Positives = 23/50 (46%)

Query: 19  VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSL 68
             K  ++E P    P+   ++   W+ +P  RP+F  +   L   + +++
Sbjct: 252 GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 47.6 bits (114), Expect = 2e-08
 Identities = 11/51 (21%), Positives = 20/51 (39%)

Query: 10  EPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             +   +K   +G +   P G  P   ++M+   +  P  RP F  +   L
Sbjct: 215 SNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 46.2 bits (110), Expect = 7e-08
 Identities = 15/53 (28%), Positives = 24/53 (45%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           S   +  +    E+G +   PE CPP    ++   WS  P+ RP F  +  +L
Sbjct: 232 SYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 45.4 bits (108), Expect = 1e-07
 Identities = 11/56 (19%), Positives = 21/56 (37%)

Query: 9   DEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
             P   ++  V  G +    +  P     +M + WS  P  RP+  ++   +   M
Sbjct: 207 GGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	69
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.72
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.72
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.72
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.7
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.57
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.53
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.5
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.49
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.49
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.47
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.45
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.45
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.44
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.41
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.41
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.41
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.4
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.39
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.35
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.32
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.32
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.31
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.31
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.3
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.3
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.29
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.24
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.23
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.21
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.2
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.17
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.15
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.15
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.14
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.13
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.13
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.13
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.12
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.08
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.07
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.06
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.04
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.01
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	98.99
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	98.98
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	98.98
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	98.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	98.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	98.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	98.93
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	98.92
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	98.92
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	98.92
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	98.89
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	98.89
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	98.87
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	98.86
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	98.86
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	98.86
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	98.85
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	98.84
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	98.83
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	98.8
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	98.8
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	98.78
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	98.78
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	98.77
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	98.77
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	98.77
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	98.77
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	98.76
2dyl_A	318	Dual specificity mitogen-activated protein kinase	98.76
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	98.76
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	98.76
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	98.75
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	98.74
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	98.74
3soc_A	322	Activin receptor type-2A; structural genomics cons	98.74
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	98.74
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	98.74
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	98.73
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	98.72
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	98.72
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	98.72
3fme_A	290	Dual specificity mitogen-activated protein kinase;	98.72
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	98.71
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	98.71
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	98.71
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	98.71
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	98.71
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	98.7
3q4u_A	301	Activin receptor type-1; structural genomics conso	98.7
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	98.7
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	98.69
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	98.68
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	98.68
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	98.67
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	98.67
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	98.67
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	98.66
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	98.66
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	98.64
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	98.64
3an0_A	340	Dual specificity mitogen-activated protein kinase;	98.64
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	98.63
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	98.63
3bhy_A	283	Death-associated protein kinase 3; death associate	98.61
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	98.61
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	98.61
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	98.61
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	98.61
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	98.6
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	98.6
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	98.6
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	98.6
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	98.6
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	98.59
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	98.58
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	98.58
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	98.57
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	98.57
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	98.56
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	98.56
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	98.55
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	98.54
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	98.54
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	98.53
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	98.53
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	98.53
3aln_A	327	Dual specificity mitogen-activated protein kinase;	98.53
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	98.53
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	98.52
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	98.51
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	98.51
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	98.51
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	98.51
3ork_A	311	Serine/threonine protein kinase; structural genomi	98.5
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	98.5
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	98.5
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	98.48
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	98.46
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	98.46
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	98.46
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	98.45
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	98.45
3niz_A	311	Rhodanese family protein; structural genomics, str	98.44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	98.44
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	98.43
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	98.43
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	98.43
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	98.43
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	98.42
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	98.41
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	98.41
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	98.41
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	98.39
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	98.39
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	98.39
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	98.39
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	98.37
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	98.35
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	98.35
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	98.34
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	98.34
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	98.33
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	98.33
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	98.32
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	98.32
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	98.31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	98.29
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	98.29
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	98.29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	98.29
3uqc_A	286	Probable conserved transmembrane protein; structur	98.28
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	98.27
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	98.26
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	98.25
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	98.25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	98.24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	98.24
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	98.23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	98.22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	98.22
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	98.22
2a19_B	284	Interferon-induced, double-stranded RNA-activated	98.22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	98.22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	98.2
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	98.2
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	98.19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	98.19
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	98.18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	98.16
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	98.15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	98.15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	98.14
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	98.12
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	98.12
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	98.1
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	98.09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	98.07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	98.07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	98.05
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	98.05
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	98.01
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	98.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	97.98
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	97.93
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	97.88
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	97.86
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	97.84
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	97.82
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	97.82
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	97.81
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	97.77
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	97.77
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	97.75
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	97.7
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	97.6
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	97.38
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	97.35
3rp9_A	458	Mitogen-activated protein kinase; structural genom	97.3
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	95.77
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	95.72
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	92.83
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	83.42

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.72  E-value=1.2e-17  Score=93.33  Aligned_cols=61  Identities=23%  Similarity=0.513  Sum_probs=57.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||.+.+..+++..|.+|.+++.|..||.++++||..||..+|.+||+|.+|+..|+.+
T Consensus       244 g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          244 GLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            8899999999999999999999999999999999999999999999999999999988754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.72  E-value=2.7e-17  Score=91.61  Aligned_cols=65  Identities=22%  Similarity=0.462  Sum_probs=61.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..+++..+..|.+++.|..+|.++++||..||..+|.+||+|.+|+..|+.+...+
T Consensus       227 G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          227 GKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             TCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            89999999999999999999999999999999999999999999999999999999998887643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.72  E-value=4.5e-17  Score=91.67  Aligned_cols=64  Identities=23%  Similarity=0.561  Sum_probs=60.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..+++..|..|.+++.|..+|+++++||..||..+|.+||+|.+|+..|+.+.+.
T Consensus       257 G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          257 GKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             SCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            8999999999999999999999999999999999999999999999999999999999988654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.70  E-value=8.1e-17  Score=91.35  Aligned_cols=68  Identities=25%  Similarity=0.482  Sum_probs=60.7

Q ss_pred             CC-cCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhc
Q psy925            1 MN-RAEMSSDEPL-ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSL   68 (69)
Q Consensus         1 ~~-g~~Py~~~~~-~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~~   68 (69)
                      ++ |..||.+.+. .++...+.+|.+++.|+.++++++++|..||..+|.+||+|.+|+..|+.+++.+.
T Consensus       281 ~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          281 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             TTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            35 8999999875 45667789999999999999999999999999999999999999999999987654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.57  E-value=8.1e-15  Score=84.81  Aligned_cols=66  Identities=44%  Similarity=0.820  Sum_probs=62.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhc
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSL   68 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~~   68 (69)
                      |..||.+.+..++...+..|.+++.|..++.+++++|..||..+|.+||+|.+++..|+.+..+.+
T Consensus       383 g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l  448 (450)
T 1k9a_A          383 GRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL  448 (450)
T ss_dssp             TCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence            899999999888999999999999999999999999999999999999999999999999987765

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.53  E-value=5.3e-14  Score=79.77  Aligned_cols=64  Identities=27%  Similarity=0.505  Sum_probs=59.9

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..|.+++.|..++.+++++|..||..+|.+||+|.+|+..|..+...
T Consensus       312 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          312 GASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             SCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            8999999999999989999999999999999999999999999999999999999999988653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.50  E-value=1.4e-13  Score=82.24  Aligned_cols=64  Identities=27%  Similarity=0.529  Sum_probs=60.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..|.++..|..++.++++||..||..+|.+||+|.+|+..|+.++..
T Consensus       536 G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          536 GQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             SCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            8999999999999999999999999999999999999999999999999999999999988654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.49  E-value=3.9e-14  Score=81.99  Aligned_cols=63  Identities=33%  Similarity=0.654  Sum_probs=59.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..|.+++.|..++.+++++|..||..+|.+||+|.+|+..|+.+..
T Consensus       382 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          382 GRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             SCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            899999999999999999999999999999999999999999999999999999999987754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.49  E-value=1.4e-13  Score=77.04  Aligned_cols=64  Identities=17%  Similarity=0.204  Sum_probs=52.5

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcCCCCC----CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKGYQME----APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g~r~~----~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      +|..||.+.+.. .+...+..+.+.+    .+..+|.++.+||..||..+|.+||+|.+|+..|+.+..
T Consensus       232 tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          232 TGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             HSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             HCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            689999998765 4555667776543    356799999999999999999999999999999876653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.47  E-value=7.9e-14  Score=80.73  Aligned_cols=63  Identities=33%  Similarity=0.579  Sum_probs=59.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..|.+++.|..++.++.++|..||..+|.+||+|.+++..|+.++.
T Consensus       378 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          378 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             TCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            899999999999999999999999999999999999999999999999999999999987754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.45  E-value=1.1e-12  Score=71.91  Aligned_cols=64  Identities=28%  Similarity=0.571  Sum_probs=59.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.++..|..++.++.+++..||..+|.+||++.+++..|+.++..
T Consensus       217 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          217 GQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             TCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            8999999999898888999988888899999999999999999999999999999999998764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.45  E-value=8.4e-13  Score=79.31  Aligned_cols=65  Identities=28%  Similarity=0.558  Sum_probs=61.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...+..|.++..|..++.++++||..||..+|.+||++.+|+..|+.++...
T Consensus       569 G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          569 GQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             TCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            89999999999999999999999999999999999999999999999999999999999987653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.44  E-value=2.9e-13  Score=79.81  Aligned_cols=63  Identities=33%  Similarity=0.579  Sum_probs=59.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+....++...+..|.+++.|..++.++.+||..||..+|.+||+|.+|+..|+.++.
T Consensus       461 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          461 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             TCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            899999999999999999999999899999999999999999999999999999999887654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.41  E-value=1.4e-12  Score=71.34  Aligned_cols=64  Identities=27%  Similarity=0.529  Sum_probs=59.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.++..|..++.++.+++..||..+|.+||++.+++..|..++.+
T Consensus       210 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          210 GQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             SCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            8999999988888888899988888899999999999999999999999999999999998765

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.41  E-value=1.6e-12  Score=72.49  Aligned_cols=64  Identities=28%  Similarity=0.510  Sum_probs=60.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+++.|..++.++.+++..||..+|.+||++.+|+..|+.+...
T Consensus       251 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          251 GERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             SCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            8999999999999999999988888999999999999999999999999999999999988754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.41  E-value=1.1e-12  Score=74.35  Aligned_cols=65  Identities=31%  Similarity=0.583  Sum_probs=60.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...+..+.++..|..++.++.++|..||..+|.+||++.+++..|+.++...
T Consensus       302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          302 GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             SCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            89999999988888889999988889999999999999999999999999999999999987643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.40  E-value=2.6e-12  Score=71.78  Aligned_cols=64  Identities=22%  Similarity=0.485  Sum_probs=59.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+++.+..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       247 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          247 GERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             SCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            8999999999899988999988888889999999999999999999999999999999988653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.39  E-value=3.8e-13  Score=78.71  Aligned_cols=62  Identities=35%  Similarity=0.706  Sum_probs=58.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      |..||.+.+..++...+..+.++..|..++.++++||..||..+|.+||++.+|+..|+.++
T Consensus       416 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          416 GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             SCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            88999999998888889999999999999999999999999999999999999999988764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.39  E-value=2.9e-12  Score=69.19  Aligned_cols=65  Identities=22%  Similarity=0.448  Sum_probs=59.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|..+....
T Consensus       202 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (267)
T 3t9t_A          202 GKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG  266 (267)
T ss_dssp             SCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            88999999988888889999888888899999999999999999999999999999999988764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.39  E-value=3e-12  Score=69.41  Aligned_cols=65  Identities=22%  Similarity=0.448  Sum_probs=60.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|..+....
T Consensus       204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g  268 (269)
T 4hcu_A          204 GKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG  268 (269)
T ss_dssp             SCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence            89999999999998889989888888899999999999999999999999999999999988764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.38  E-value=2.1e-12  Score=70.28  Aligned_cols=66  Identities=44%  Similarity=0.842  Sum_probs=60.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhc
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSL   68 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~~   68 (69)
                      |..||.+.+..++...+..+.+...+..++.++.+++..||..+|.+||++.+++..|+.+..+.+
T Consensus       211 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~  276 (278)
T 1byg_A          211 GRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL  276 (278)
T ss_dssp             SCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence            889999998888888888888888888999999999999999999999999999999999887654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.37  E-value=4.3e-12  Score=69.22  Aligned_cols=66  Identities=30%  Similarity=0.628  Sum_probs=60.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      .|..||.+.+..++...+..+.+.+.+..++.++.+++..||..+|.+||++.+++..|..+....
T Consensus       213 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          213 HGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             TSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            388999999888888888888888888999999999999999999999999999999999987653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.36  E-value=2.1e-12  Score=73.36  Aligned_cols=64  Identities=28%  Similarity=0.554  Sum_probs=58.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+++.+..++.++.+++..||..+|.+||++.+|+..|+.+...
T Consensus       247 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          247 GERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             C-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            8999999999999988999988888889999999999999999999999999999999988754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.36  E-value=4.3e-12  Score=71.82  Aligned_cols=64  Identities=27%  Similarity=0.502  Sum_probs=59.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.++..+..++.++.+++..||..+|.+||++.+|+..|..+...
T Consensus       283 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          283 GYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             SCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            8899999999999999999988888899999999999999999999999999999999887653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.35  E-value=6.2e-12  Score=68.39  Aligned_cols=64  Identities=34%  Similarity=0.675  Sum_probs=59.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+...+..++.++.+++..||..+|.+||++.+++..|+.++..
T Consensus       207 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          207 GRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             TCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            8899999998888888999988888889999999999999999999999999999999988764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.35  E-value=6.5e-12  Score=70.03  Aligned_cols=64  Identities=31%  Similarity=0.584  Sum_probs=59.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+...+..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       256 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          256 GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             SCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            8999999998888888888988888889999999999999999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.34  E-value=4.3e-12  Score=70.63  Aligned_cols=63  Identities=29%  Similarity=0.478  Sum_probs=58.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..+..+..|..++.++.+++..||..+|.+||++.+++..|+.+..
T Consensus       273 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          273 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            889999999989888899998888889999999999999999999999999999999988754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.34  E-value=7.2e-12  Score=68.26  Aligned_cols=64  Identities=20%  Similarity=0.380  Sum_probs=59.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..+....+..+.+...|..++.++.+++..||..+|.+||++.+++..|..+..+
T Consensus       218 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          218 GKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            8999999999888888999988888889999999999999999999999999999999988764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.34  E-value=5.1e-12  Score=69.56  Aligned_cols=64  Identities=27%  Similarity=0.579  Sum_probs=59.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+...+..++.++.+++..||..+|.+||++.+++..|+.+...
T Consensus       249 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          249 GGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             SCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            8899999998888888888888888899999999999999999999999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.34  E-value=7.1e-12  Score=71.15  Aligned_cols=64  Identities=31%  Similarity=0.583  Sum_probs=59.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|+.+...
T Consensus       290 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          290 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             SCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            8899999999999999999988888999999999999999999999999999999999988754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.33  E-value=6.4e-12  Score=68.47  Aligned_cols=64  Identities=28%  Similarity=0.468  Sum_probs=58.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+++.|..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       211 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          211 GKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             TCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            8899998888888888888888888889999999999999999999999999999999988754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.32  E-value=4.3e-12  Score=72.12  Aligned_cols=64  Identities=27%  Similarity=0.500  Sum_probs=58.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..|.++..|..++.++.++|..||..+|.+||++.+++..|..+...
T Consensus       293 ~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          293 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             SCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            7889998887777778888988888899999999999999999999999999999999988754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.32  E-value=6.6e-12  Score=69.94  Aligned_cols=63  Identities=22%  Similarity=0.479  Sum_probs=58.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..+.+.+.|..++.++.+++..||..+|.+||++.+++..|..+..
T Consensus       216 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          216 GSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            899999999888888888898888889999999999999999999999999999999988764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.32  E-value=8.4e-12  Score=67.35  Aligned_cols=63  Identities=21%  Similarity=0.296  Sum_probs=55.4

Q ss_pred             CcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +|..||.+.+..++...+ ..+.++..|..++.++.+++..||..+|.+||++.+++..|..+.
T Consensus       206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          206 TREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             hCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            589999999888776555 567778888999999999999999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.31  E-value=1.3e-11  Score=69.09  Aligned_cols=69  Identities=26%  Similarity=0.486  Sum_probs=59.4

Q ss_pred             CC-cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhcC
Q psy925            1 MN-RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSLQ   69 (69)
Q Consensus         1 ~~-g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~~~   69 (69)
                      ++ |..||.+.... .+...+..+.+...|..++.++.+++..||..+|.+||++.+++..|..+.....|
T Consensus       289 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  359 (359)
T 3vhe_A          289 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ  359 (359)
T ss_dssp             TTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHTC
T ss_pred             HhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHhcC
Confidence            35 89999988754 55566788888888899999999999999999999999999999999999887643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.31  E-value=9.3e-12  Score=68.95  Aligned_cols=65  Identities=25%  Similarity=0.453  Sum_probs=59.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...+..+.++..+..++.++.+++..||..+|.+||++.+++..|+.++.+.
T Consensus       236 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          236 GQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            89999999988888888888888888899999999999999999999999999999999987653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.31  E-value=6.9e-12  Score=69.97  Aligned_cols=63  Identities=24%  Similarity=0.515  Sum_probs=58.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..+.+++.|..++.++.+++..||..+|.+||++.+++..|..+..
T Consensus       216 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          216 GSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            899999999888888888898888889999999999999999999999999999999998864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.30  E-value=9.8e-12  Score=68.97  Aligned_cols=65  Identities=22%  Similarity=0.332  Sum_probs=56.6

Q ss_pred             CcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLADVVKHVE-KGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~-~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+.+..++...+. .+.+...|..++.++.+++..||..+|.+||++.+++..|+.+...
T Consensus       234 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          234 TLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             hCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            5889999999888777664 5566778889999999999999999999999999999999988754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.30  E-value=2.1e-11  Score=73.51  Aligned_cols=65  Identities=31%  Similarity=0.636  Sum_probs=60.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      .|..||.+.+..++...+..+.+++.|..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       588 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          588 HGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             TSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            38899999999899888999998888999999999999999999999999999999999998754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.29  E-value=4.8e-12  Score=70.38  Aligned_cols=63  Identities=29%  Similarity=0.530  Sum_probs=58.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..+.++..|..++.++.+++..||..+|.+||++.+++..|..+..
T Consensus       214 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          214 GAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             SCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            899999998888888889998888888999999999999999999999999999999988753

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.29  E-value=1.4e-11  Score=68.40  Aligned_cols=65  Identities=28%  Similarity=0.557  Sum_probs=59.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|..+....
T Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          238 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             SCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             CCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            89999999988888888888888888899999999999999999999999999999999987653

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.29  E-value=1.4e-11  Score=68.03  Aligned_cols=64  Identities=25%  Similarity=0.432  Sum_probs=58.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.++..|..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       246 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          246 GMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             SCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            7899999988888888888888888899999999999999999999999999999999998754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.28  E-value=2.9e-11  Score=67.19  Aligned_cols=64  Identities=27%  Similarity=0.502  Sum_probs=58.4

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.++..+..++.++.+++..||..+|.+||++.+++..+..+...
T Consensus       242 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          242 GYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             SCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            8899999998888888988888888889999999999999999999999999999999877643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.28  E-value=2.1e-11  Score=66.46  Aligned_cols=64  Identities=34%  Similarity=0.680  Sum_probs=58.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|..++..
T Consensus       209 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          209 GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             SCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            8899999988888888888888888899999999999999999999999999999999988764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.27  E-value=1.2e-11  Score=66.88  Aligned_cols=63  Identities=25%  Similarity=0.342  Sum_probs=57.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|+.+..
T Consensus       202 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          202 GKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            899999999988888888898888888999999999999999999999999999999877643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.24  E-value=3.4e-11  Score=66.31  Aligned_cols=66  Identities=26%  Similarity=0.482  Sum_probs=57.3

Q ss_pred             cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhc
Q psy925            3 RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNSL   68 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~~   68 (69)
                      |..||.+.+.. .+...+..+.+...|..++.++.+++..||..+|.+||++.+++..|+.+.....
T Consensus       247 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            88999887654 5556677888888888899999999999999999999999999999999987653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.23  E-value=2.3e-11  Score=65.83  Aligned_cols=61  Identities=21%  Similarity=0.352  Sum_probs=52.0

Q ss_pred             CcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVE-KGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~-~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      +|..||.+.+.......+. .+...+.+..++.++.+++..||..+|.+||++.+++..|+.
T Consensus       209 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          209 TGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             hCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            5889999998877666654 445566788999999999999999999999999999998865

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.21  E-value=5.3e-11  Score=65.22  Aligned_cols=64  Identities=27%  Similarity=0.500  Sum_probs=57.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..+.+...|..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          229 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             SCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            6778888887777778888888888889999999999999999999999999999999998764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.21  E-value=5.7e-11  Score=64.80  Aligned_cols=64  Identities=31%  Similarity=0.546  Sum_probs=54.5

Q ss_pred             cCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEK-GYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~-g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+.. +.+.+.+..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          221 GQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             SCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            8999999998888777744 556667788999999999999999999999999999999877544

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.21  E-value=3.3e-11  Score=68.51  Aligned_cols=57  Identities=11%  Similarity=0.123  Sum_probs=53.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+++..+.++..++.+..++.++.+||.+||..+|.+||++.+++.
T Consensus       220 tG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          220 TLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            689999999999999999888888888899999999999999999999999999975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.21  E-value=5.7e-11  Score=66.26  Aligned_cols=64  Identities=22%  Similarity=0.445  Sum_probs=54.1

Q ss_pred             cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+.. .+...+..+.++..|..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            88999988765 44555677888888889999999999999999999999999999999887643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.20  E-value=1.2e-10  Score=64.70  Aligned_cols=64  Identities=30%  Similarity=0.480  Sum_probs=54.6

Q ss_pred             cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.... .+...+..+.+...|..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       263 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          263 GLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             SCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            88899987654 44455677887778888999999999999999999999999999999887654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.19  E-value=9.2e-11  Score=64.52  Aligned_cols=65  Identities=28%  Similarity=0.568  Sum_probs=55.9

Q ss_pred             cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.... .+...+..+.+...+..++.++.+++..||..+|.+||++.+++..|+.+..+.
T Consensus       244 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             TCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            88999888754 445556778777778889999999999999999999999999999999988654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.18  E-value=1.8e-10  Score=62.95  Aligned_cols=65  Identities=28%  Similarity=0.515  Sum_probs=57.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...+..+.+.+.+..++.++.+++..||..+|.+||++.+++..|+.+....
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          225 GAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             SCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            56677777777888888888888888899999999999999999999999999999999987653

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.17  E-value=2.1e-11  Score=69.03  Aligned_cols=65  Identities=14%  Similarity=0.174  Sum_probs=55.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM--EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~--~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+.+..++...|..+..+  ..|+.+++++.+++.+||..+|.+||++.++++.+...+..
T Consensus       251 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          251 NGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             HSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            689999998877777777666543  35788999999999999999999999999999998877654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.17  E-value=1.2e-10  Score=64.46  Aligned_cols=62  Identities=24%  Similarity=0.556  Sum_probs=56.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      |..||.+.+..++...+..+..+..+..++.++.+++..||..+|.+||++.+++..|....
T Consensus       237 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          237 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             SCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             CCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            78999999988888888888877888899999999999999999999999999999887653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.15  E-value=7.8e-11  Score=63.99  Aligned_cols=59  Identities=12%  Similarity=0.130  Sum_probs=53.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL   60 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l   60 (69)
                      +|..||.+.+..++...+..+.....|..++.++.+++..||..+|.+||++.+++..+
T Consensus       211 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          211 ALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            58899999988888888888888778889999999999999999999999999998643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.15  E-value=1.3e-10  Score=63.72  Aligned_cols=53  Identities=26%  Similarity=0.614  Sum_probs=46.6

Q ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925           14 DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus        14 ~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      .+...+..+.+.+.|..++.++.+++..||..+|.+||++.+++..|+.+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            44555677888888999999999999999999999999999999999988754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.14  E-value=1e-10  Score=65.12  Aligned_cols=63  Identities=19%  Similarity=0.185  Sum_probs=46.8

Q ss_pred             CCCCCCCC-----HHHHHHHH-HcCCCCCCCCC-----CCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            4 AEMSSDEP-----LADVVKHV-EKGYQMEAPEG-----CPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         4 ~~Py~~~~-----~~~i~~~v-~~g~r~~~p~~-----~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +.||.+..     ..++...+ ..+.++..|..     ++..+++||..||..+|.+||+|.+|+..|+.+.++
T Consensus       225 ~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            55776553     23455555 45667766643     345789999999999999999999999999988754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.13  E-value=7.2e-11  Score=65.16  Aligned_cols=64  Identities=20%  Similarity=0.309  Sum_probs=54.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAP-EGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p-~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      +|..||.+.+..++...+..+.++..+ ..++.++.+++..||..+|.+||++.+++..|..+..
T Consensus       238 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          238 AREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             HSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             hCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            588999999988888888888766544 4689999999999999999999999999998877654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.13  E-value=7.3e-11  Score=64.39  Aligned_cols=61  Identities=23%  Similarity=0.505  Sum_probs=50.0

Q ss_pred             CcCCCCCCCCHHHH--HHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADV--VKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus         2 ~g~~Py~~~~~~~i--~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      +|..||.+.+..++  ...+ ..+.++..+..++.++.+++..||..+|.+||++.+++..|+.
T Consensus       223 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          223 TGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             cCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            58899987765433  3333 5567777888999999999999999999999999999998864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.12  E-value=2.5e-10  Score=63.11  Aligned_cols=64  Identities=17%  Similarity=0.263  Sum_probs=53.9

Q ss_pred             CcCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPL--ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         2 ~g~~Py~~~~~--~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      +|..||.+...  ..+...+..+.+++.+..++.++.+++..||..+|.+||++.+++..|..+..
T Consensus       198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          198 TRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             HTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             HCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            58889986543  35556677788888888999999999999999999999999999999988753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.08  E-value=6.4e-11  Score=65.86  Aligned_cols=57  Identities=16%  Similarity=0.135  Sum_probs=47.3

Q ss_pred             CcCCCCCCCCH-HHHHHHHHcCCCCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPL-ADVVKHVEKGYQME-APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~-~~i~~~v~~g~r~~-~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+. .++...+..+.++. .+..+++++.+|+.+||..+|.+||++.+++.
T Consensus       224 tg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          224 TSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            68999987655 46677777776654 45678999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.07  E-value=2.9e-10  Score=63.08  Aligned_cols=52  Identities=31%  Similarity=0.688  Sum_probs=45.6

Q ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925           15 VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus        15 i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +...+..+.+.+.+..++.++.+++..||..+|.+||++.+++..|+.+...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            4455677888888899999999999999999999999999999999888654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.06  E-value=4.3e-10  Score=62.17  Aligned_cols=57  Identities=16%  Similarity=0.257  Sum_probs=50.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+.++. ...|..+++++.+|+.+|+..+|.+||++.+++.+
T Consensus       207 tg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          207 CRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             HCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            5899999998888888888775 45678899999999999999999999999999863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.04  E-value=3.4e-10  Score=61.97  Aligned_cols=63  Identities=16%  Similarity=0.273  Sum_probs=50.3

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcCCCCC----CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKGYQME----APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g~r~~----~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +|..||.+.... .+...+..+...+    .+..++.++.+++..||..+|.+||++.+++..|+.+.
T Consensus       220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          220 TGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            588999887554 5566666665433    23578999999999999999999999999999998764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.01  E-value=3.8e-10  Score=62.70  Aligned_cols=52  Identities=31%  Similarity=0.648  Sum_probs=44.7

Q ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925           14 DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus        14 ~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      ++...+..+.+++.+..++.++.+++..||..+|.+||++.+++..|+.+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            4455667788888889999999999999999999999999999999987754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=98.99  E-value=2.5e-09  Score=58.93  Aligned_cols=65  Identities=12%  Similarity=0.068  Sum_probs=49.6

Q ss_pred             CcCCCCCCCC--HHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEP--LADVVKHVEKGYQMEA-PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~--~~~i~~~v~~g~r~~~-p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+..  ..++...+..+..+.. +..++.++.+++..||..+|.+||++.+++..|+++...
T Consensus       231 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          231 ALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             HSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            5788887653  3355666666654443 367899999999999999999999999999999988654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=98.98  E-value=1.8e-09  Score=59.97  Aligned_cols=52  Identities=25%  Similarity=0.603  Sum_probs=45.4

Q ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925           15 VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus        15 i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +...+..+.+++.|..++.++.+++..||..+|.+||++.+++..|+.+...
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            4455667777888889999999999999999999999999999999988654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=98.98  E-value=8.5e-10  Score=60.62  Aligned_cols=58  Identities=16%  Similarity=0.144  Sum_probs=51.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+..+..+..+..++.++.+++..||..+|.+||++.+++..
T Consensus       214 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          214 RGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             cCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            5889999998888877787787777778899999999999999999999999999764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=98.97  E-value=8.3e-10  Score=61.78  Aligned_cols=56  Identities=14%  Similarity=0.199  Sum_probs=48.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      +|..||.+.+..++...+.++. +..|..+++++.+|+.+||..+|.+||+     +++++.
T Consensus       221 tG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          221 TGTLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             hCCCCCCCcCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            6899999999989988888775 4567889999999999999999999998     466654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=98.96  E-value=9.9e-10  Score=60.05  Aligned_cols=65  Identities=14%  Similarity=0.120  Sum_probs=48.6

Q ss_pred             CcCCCCCCCC---HHHHHHHHHcCC-CCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEP---LADVVKHVEKGY-QME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~---~~~i~~~v~~g~-r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+.+   ..+....+..+. ..+   ....++.++.+++..||..+|.+||++.+|...|..+...
T Consensus       213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          213 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            5889998853   334444443321 121   2357899999999999999999999999999999988754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=98.96  E-value=2.1e-09  Score=58.92  Aligned_cols=52  Identities=29%  Similarity=0.735  Sum_probs=46.2

Q ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925           13 ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus        13 ~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      ..+...+..+.+.+.|..++.++.+++..||..+|.+||++.+++..|+.++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            3555667788888888999999999999999999999999999999998875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=98.93  E-value=1.3e-09  Score=59.50  Aligned_cols=65  Identities=12%  Similarity=0.101  Sum_probs=47.1

Q ss_pred             CcCCCCCCCCHH---HHHHHHHcC-CCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLA---DVVKHVEKG-YQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~---~i~~~v~~g-~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+.+..   +....+..+ ...+   .+..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          210 LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            578898875331   233333222 1111   2367899999999999999999999999999999998765

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=98.92  E-value=5e-09  Score=57.47  Aligned_cols=57  Identities=16%  Similarity=0.346  Sum_probs=49.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+..+. ...|..++.++.+++..||..+|.+||++.+++..
T Consensus       208 ~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          208 TGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hCCCCCCCchHHHHHHHHhcCC-CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            5889999988888888777765 34567899999999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=98.92  E-value=2.5e-09  Score=60.78  Aligned_cols=57  Identities=14%  Similarity=0.144  Sum_probs=49.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+++..+..+..+.  .+..+++++.+|+.+||..||.+||++.+++.
T Consensus       265 ~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          265 DGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            5899999999888888887775433  34578999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=98.92  E-value=3e-09  Score=59.60  Aligned_cols=56  Identities=16%  Similarity=0.191  Sum_probs=49.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..|. ...|..++.++.+++.+||..+|.+||++.+++.
T Consensus       209 ~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          209 SGSLPFDGQNLKELRERVLRGK-YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            5899999999888888887775 3456789999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=98.89  E-value=2.1e-09  Score=58.62  Aligned_cols=65  Identities=12%  Similarity=0.101  Sum_probs=46.8

Q ss_pred             CcCCCCCCCCHH---HHHHHHHcC-CCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLA---DVVKHVEKG-YQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~---~i~~~v~~g-~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+.+..   +....+..+ ...+   ....++.++.+++..||..+|.+||++.+++..|..++..
T Consensus       210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          210 LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            578899876432   222222221 1111   2256899999999999999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=98.87  E-value=9.6e-10  Score=61.99  Aligned_cols=38  Identities=21%  Similarity=0.242  Sum_probs=35.2

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      ..+|.++.+++..||..+|.+||++.+|+..|..++..
T Consensus       293 ~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          293 ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            57899999999999999999999999999999988764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=98.86  E-value=6.7e-09  Score=56.47  Aligned_cols=57  Identities=11%  Similarity=0.183  Sum_probs=48.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..+....+..+. ...|..++.++.+++..||..+|.+||++.+++.+
T Consensus       202 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          202 VGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             HCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            5889999988887777776654 34567899999999999999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=98.86  E-value=5.8e-09  Score=60.65  Aligned_cols=57  Identities=14%  Similarity=0.148  Sum_probs=49.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM--EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~--~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+++..+..+..+  ..+..++.++.+|+.+||..||.+|+++.+++.
T Consensus       342 ~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          342 DGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            589999999988888888776543  345679999999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=98.85  E-value=7.5e-09  Score=56.07  Aligned_cols=57  Identities=16%  Similarity=0.228  Sum_probs=48.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+..+. ...|..++.++.+++..||..+|.+||++.+++.+
T Consensus       206 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          206 CGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            5889999988877777776664 34567889999999999999999999999999873

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=98.84  E-value=1e-09  Score=60.53  Aligned_cols=63  Identities=11%  Similarity=0.123  Sum_probs=46.0

Q ss_pred             CcCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPL--ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         2 ~g~~Py~~~~~--~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +|..||.+...  ..+...+......+.+..++.++.+++..||..+|.+||++.+++..|..+.
T Consensus       241 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          241 FGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            47778754211  1233344555555556788999999999999999999999999999988764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=98.83  E-value=3e-09  Score=62.48  Aligned_cols=65  Identities=12%  Similarity=0.102  Sum_probs=47.6

Q ss_pred             CcCCCCCCCCHH---HHHHHHHcC----CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLA---DVVKHVEKG----YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~---~i~~~v~~g----~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+....   +.+..+...    .....+..++.++.+++..||..+|.+||++.+|+..|..++..
T Consensus       208 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          208 RGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            588999886542   333333221    11112367899999999999999999999999999999988764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=98.80  E-value=1.8e-08  Score=55.24  Aligned_cols=57  Identities=11%  Similarity=0.098  Sum_probs=46.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGY-QMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~-r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+...+...+..+. ..+....++.++.+++..||..+|.+||++.+++.
T Consensus       235 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          235 FGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            5889999988777777665553 33334578999999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=98.80  E-value=1e-08  Score=56.96  Aligned_cols=64  Identities=17%  Similarity=0.148  Sum_probs=47.2

Q ss_pred             CCCCCCCC-----HHHHHHHHHc-CCCCCCCC-----CCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            4 AEMSSDEP-----LADVVKHVEK-GYQMEAPE-----GCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         4 ~~Py~~~~-----~~~i~~~v~~-g~r~~~p~-----~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      ..||.+..     ..++...+.. +.++..|.     .++..+.+++..||..+|.+||++.+++..|..+..+.
T Consensus       264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            77887652     3345555533 44554443     34568999999999999999999999999999987653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=98.78  E-value=1.1e-08  Score=57.72  Aligned_cols=58  Identities=12%  Similarity=0.048  Sum_probs=46.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME-APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~-~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..+....+..+..+. .+..++..+.+++..||..+|.+||++.+++..
T Consensus       248 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          248 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            5889999988776666665554433 456789999999999999999999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=98.78  E-value=1.1e-08  Score=56.45  Aligned_cols=57  Identities=12%  Similarity=0.166  Sum_probs=45.7

Q ss_pred             CcCCCCCCCCHHHHHHHHH-cCC-CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVE-KGY-QMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~-~g~-r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+. .+. ....|..++..+.+++.+||..+|.+||++.+++.
T Consensus       211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          211 EGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            5889999988776555553 332 34456789999999999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=98.77  E-value=1.5e-08  Score=55.47  Aligned_cols=57  Identities=19%  Similarity=0.192  Sum_probs=46.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+..+.  .+..++.++.+++..||..+|.+||++.+++.
T Consensus       217 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          217 QIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            5889999988877766665554432  35678999999999999999999999999865

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=98.77  E-value=2.3e-08  Score=54.63  Aligned_cols=57  Identities=21%  Similarity=0.250  Sum_probs=47.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC-CC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME-AP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~-~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+.... .+  ..++.++.+++..||..+|.+||++.+++.
T Consensus       217 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          217 SGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            5889999998888888887765332 22  578999999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=98.77  E-value=2.3e-08  Score=55.21  Aligned_cols=58  Identities=10%  Similarity=0.092  Sum_probs=44.6

Q ss_pred             CcCCCCCCCCHH-HHHH-HHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVK-HVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~-~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.... .... .+..+.+...|..++.++.+++..||..+|.+||++.+++..
T Consensus       234 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          234 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            578899876443 2233 334445566778889999999999999999999999999863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=98.77  E-value=1.5e-08  Score=56.18  Aligned_cols=63  Identities=21%  Similarity=0.228  Sum_probs=45.7

Q ss_pred             CCCCCCCCH-----HHHHHHH-HcCCCCCCCC-----CCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            4 AEMSSDEPL-----ADVVKHV-EKGYQMEAPE-----GCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         4 ~~Py~~~~~-----~~i~~~v-~~g~r~~~p~-----~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      ..||.+...     ..+...+ ..+.++..|.     .++.++.+++..||..+|.+||++.+++..|..+..+
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            677766522     2333333 2334444443     5677899999999999999999999999999998765

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=98.76  E-value=2.2e-08  Score=54.40  Aligned_cols=58  Identities=16%  Similarity=0.110  Sum_probs=47.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC-CCC--CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ-MEA--PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r-~~~--p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+..+.. .+.  ...++.++.+++..||..+|.+||++.+++..
T Consensus       202 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          202 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            58899999988888877766643 222  25789999999999999999999999999763

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=98.76  E-value=2.5e-08  Score=54.91  Aligned_cols=57  Identities=12%  Similarity=0.105  Sum_probs=44.8

Q ss_pred             CcCCCCCCC-CHHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDE-PLADVVKHVEKGYQMEAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~-~~~~i~~~v~~g~r~~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+. ...++...+..+..+..|  ..++.++.+++..||..+|.+||++.+++.
T Consensus       224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          224 TGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             hCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            578899875 344666666666554444  468999999999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=98.76  E-value=2.8e-08  Score=55.33  Aligned_cols=57  Identities=14%  Similarity=0.028  Sum_probs=46.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGY-QMEAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~-r~~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+. ....+  ..++.++.+++..||..+|.+||++.+++.
T Consensus       271 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          271 MGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            5889999998887776665543 33333  348999999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=98.76  E-value=7.3e-09  Score=57.25  Aligned_cols=64  Identities=16%  Similarity=0.152  Sum_probs=49.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM--EAPEGCPPEEYEMMRQAWSLQPELRP-TFRQLKAKLLTFML   65 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~--~~p~~~~~~~~~l~~~cw~~~p~~Rp-~~~~i~~~l~~~~~   65 (69)
                      +|..||.+.+...+...+......  ..+..++.++.+++..||..+|.+|| ++.++...|..++.
T Consensus       230 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          230 TGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             HSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             HCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            588999987766555555544322  24567899999999999999999999 99999998877643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=98.75  E-value=2e-08  Score=56.33  Aligned_cols=65  Identities=11%  Similarity=0.050  Sum_probs=46.4

Q ss_pred             CcCCCCCCCC--HHHHHHHHH--cCCCCCCC------CCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEP--LADVVKHVE--KGYQMEAP------EGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~--~~~i~~~v~--~g~r~~~p------~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+..  ...+.....  .......+      ..++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          263 YGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             HSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            5788998764  233333222  11111111      24689999999999999999999999999999988754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=98.74  E-value=9.7e-09  Score=55.96  Aligned_cols=62  Identities=16%  Similarity=0.230  Sum_probs=46.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||................  ..|...+.++.+++..||..+|.+||++.+++..|..++..
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          215 GDKPLSALDSQRKLQFYEDRH--QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTC--CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             CCCCccccchHHHHHHhhccC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            566777777665554444433  33456688999999999999999999999999999877543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=98.74  E-value=1.3e-08  Score=55.23  Aligned_cols=57  Identities=16%  Similarity=0.098  Sum_probs=47.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAP---EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p---~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+......   ..++.++.+++..||..+|.+||++.+++.
T Consensus       202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          202 CGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            588999999888888888777543322   368999999999999999999999999975

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=98.74  E-value=1.5e-08  Score=56.35  Aligned_cols=36  Identities=11%  Similarity=0.128  Sum_probs=31.9

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      ++.++.+++..||..+|.+||++.+++..|..+...
T Consensus       284 ~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          284 GMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            345699999999999999999999999999988653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=98.74  E-value=2.2e-08  Score=54.66  Aligned_cols=57  Identities=14%  Similarity=0.081  Sum_probs=43.6

Q ss_pred             CcCCCCCCCCHH-HHH-HHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVV-KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~-~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.... ... ........+..|..++.++.+++..||..+|.+||++.+++.
T Consensus       220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          220 TGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            588899765443 222 222445556678889999999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=98.74  E-value=4.2e-09  Score=59.04  Aligned_cols=34  Identities=24%  Similarity=0.217  Sum_probs=31.4

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      .++.++.+++..||..+|.+||++.+|+..|+..
T Consensus       293 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          293 SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            7899999999999999999999999999988653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=98.73  E-value=3.2e-08  Score=55.43  Aligned_cols=58  Identities=10%  Similarity=0.087  Sum_probs=45.0

Q ss_pred             CcCCCCCCCCHH-HHH-HHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVV-KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~-~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.... ... ..+........|...+.++.+++..||..+|.+||++.+++.+
T Consensus       215 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          215 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            588999886543 223 3334455566778889999999999999999999999999764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=98.72  E-value=5.4e-08  Score=53.52  Aligned_cols=57  Identities=11%  Similarity=0.076  Sum_probs=47.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+....   .+..++.++.+++..||..+|.+||++.+++.
T Consensus       202 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          202 CGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            5889999988888888887775322   23678999999999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=98.72  E-value=1.2e-08  Score=56.46  Aligned_cols=62  Identities=15%  Similarity=0.150  Sum_probs=42.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+....++   +......+.+..++..+.+++..||..+|.+||++.+++..|..+...
T Consensus       248 ~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          248 FRQHPFEDGAKLRI---VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             HSSCCC---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hCCCCCcchhHHHh---hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            47788876544332   223344445567888999999999999999999999999999988654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=98.72  E-value=9.6e-09  Score=57.71  Aligned_cols=55  Identities=11%  Similarity=0.073  Sum_probs=48.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK   57 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~   57 (69)
                      +|..||.+.+..++...|.++. +..|..+++++.+|+.+|+..+|.+|++..++.
T Consensus       229 ~G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          229 AGLPPFRAGNEGLIFAKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTC-CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             hCCCCCCCCCHHHHHHHHHcCC-CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            6899999999889988888775 456788999999999999999999999998863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=98.72  E-value=1.6e-08  Score=55.06  Aligned_cols=57  Identities=14%  Similarity=0.039  Sum_probs=42.9

Q ss_pred             CcCCCCCCCCH-H-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPL-A-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~-~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+... . .+...+..+.....+..++.++.+++..||..+|.+||++.+++.
T Consensus       208 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          208 ILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            58899986433 3 333334444444445678999999999999999999999999976

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=98.71  E-value=4e-08  Score=53.53  Aligned_cols=56  Identities=5%  Similarity=0.059  Sum_probs=47.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+. ...|..++.++.+++..||..+|.+||++.+++.
T Consensus       207 ~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          207 VGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            5889999888777776666554 4556789999999999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=98.71  E-value=4.5e-08  Score=57.48  Aligned_cols=56  Identities=14%  Similarity=0.304  Sum_probs=48.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..|. ...|..++.++.+++..||..+|.+||++.+++.
T Consensus       211 tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          211 CGTLPFDDDHVPTLFKKICDGI-FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HSSCSSCCSSSHHHHHHHHTTC-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHhcCC-cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            5889999988878888887775 3456789999999999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=98.71  E-value=6.7e-08  Score=56.26  Aligned_cols=57  Identities=16%  Similarity=0.188  Sum_probs=48.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC-CC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME-AP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~-~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..|.... .+  ..++.++.+++..||..+|.+||++.+++.
T Consensus       208 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          208 VGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            5889999998888888887775322 22  478999999999999999999999999976

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=98.71  E-value=6.6e-08  Score=52.83  Aligned_cols=57  Identities=16%  Similarity=0.179  Sum_probs=45.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+....  .....++++.+++..||..+|.+||++.+++.
T Consensus       220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          220 TGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             hCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            5889999998888777665543322  22457899999999999999999999999875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=98.71  E-value=4.7e-08  Score=54.43  Aligned_cols=57  Identities=11%  Similarity=0.135  Sum_probs=46.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+..+.  .+..++.++.+++..||..+|.+||++.+++.
T Consensus       236 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          236 DGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            5889999988877777776665433  23468999999999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=98.70  E-value=4.7e-08  Score=54.10  Aligned_cols=57  Identities=11%  Similarity=0.002  Sum_probs=45.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM-EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~-~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+..+ ..+..++.++.+++..||..+|.+||++.+++.
T Consensus       229 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          229 EGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            588999998877666656544333 345678999999999999999999999999976

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=98.70  E-value=3.2e-08  Score=54.13  Aligned_cols=60  Identities=20%  Similarity=0.206  Sum_probs=42.4

Q ss_pred             CCCCCCCCH-----HHHHHHH-HcCCCCCCCC-----CCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            4 AEMSSDEPL-----ADVVKHV-EKGYQMEAPE-----GCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         4 ~~Py~~~~~-----~~i~~~v-~~g~r~~~p~-----~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      ..||.+...     ..+...+ ..+.++..|.     .++.++.+++..||..+|.+||++.+++..|+.+
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            788865422     2333333 2344444442     2567899999999999999999999999998865

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=98.70  E-value=4.4e-08  Score=55.96  Aligned_cols=58  Identities=10%  Similarity=0.076  Sum_probs=44.9

Q ss_pred             CcCCCCCCCCHH-HHHHHHHc-CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEK-GYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~-g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.... ..+..+.. ......|...+.++.+++..||..+|.+||++.+++..
T Consensus       262 ~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          262 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            588999876443 33444433 45556677889999999999999999999999999753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=98.69  E-value=1.2e-08  Score=56.71  Aligned_cols=64  Identities=11%  Similarity=0.070  Sum_probs=46.2

Q ss_pred             CcCCCCCCCCHH---HHHHHHHcCCCCCC----CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLA---DVVKHVEKGYQMEA----PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~---~i~~~v~~g~r~~~----p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+.+..   +.+..+..+.....    ...+| ++.+++..||..+|.+||++.+|...|..+...
T Consensus       212 ~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          212 RGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            588999886443   34444433322211    13355 999999999999999999999999999887654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=98.68  E-value=1.4e-08  Score=55.57  Aligned_cols=57  Identities=16%  Similarity=0.225  Sum_probs=47.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+....+....+..+. ...|..++.++.+++..||..+|.+||++.+++..
T Consensus       210 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          210 VGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            5889999988877766666554 44567899999999999999999999999998863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=98.68  E-value=2.4e-08  Score=54.57  Aligned_cols=57  Identities=16%  Similarity=0.135  Sum_probs=45.2

Q ss_pred             CcCCCCCCCCH-HHHHHHHHcCCCCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPL-ADVVKHVEKGYQME-APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~-~~i~~~v~~g~r~~-~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+... .++...+..+..+. .+...++++.+++..||..+|.+||++.+++.
T Consensus       224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          224 TSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            58899988654 45566666665443 45678899999999999999999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=98.67  E-value=5.7e-08  Score=53.87  Aligned_cols=57  Identities=7%  Similarity=-0.039  Sum_probs=47.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+.....   +..++..+.+++..||..+|.+||++.+++.
T Consensus       213 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          213 SGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            58899999888887777776643322   2578999999999999999999999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=98.67  E-value=3.2e-08  Score=55.18  Aligned_cols=58  Identities=7%  Similarity=-0.024  Sum_probs=48.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+..+.....   ...++.++.+++..||..+|.+||++.+++.+
T Consensus       198 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          198 SGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            58899999998888888877654332   25789999999999999999999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=98.66  E-value=1.6e-08  Score=56.46  Aligned_cols=56  Identities=16%  Similarity=0.226  Sum_probs=47.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+....+....+..+. ...|..++.++.+++..||..+|.+||++.+++.
T Consensus       236 ~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          236 VGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            5889999988777776666554 3456789999999999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=98.66  E-value=5.2e-08  Score=53.67  Aligned_cols=57  Identities=18%  Similarity=0.103  Sum_probs=45.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM--EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~--~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.......+..+...  ..+..++.++.+++..||..+|.+||++.+++.
T Consensus       220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          220 EGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             hCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            588999988877665555544332  235678999999999999999999999999975

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=98.64  E-value=3.6e-09  Score=58.17  Aligned_cols=36  Identities=14%  Similarity=0.230  Sum_probs=31.8

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      ..++..+.+++..||..+|.+||++.+++..|+.+.
T Consensus       270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            345678999999999999999999999999998764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=98.64  E-value=1.2e-07  Score=55.46  Aligned_cols=57  Identities=14%  Similarity=0.194  Sum_probs=48.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC-CC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME-AP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~-~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+.... .+  ..++.++.+++..||..+|.+||++.+++.
T Consensus       232 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          232 AGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            5899999999989888887775433 22  468999999999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=98.63  E-value=4.6e-08  Score=54.56  Aligned_cols=56  Identities=13%  Similarity=0.054  Sum_probs=44.9

Q ss_pred             CcCCCCCCCCH-HHHHHHHHcCCCCCCC-------------------CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPL-ADVVKHVEKGYQMEAP-------------------EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~-~~i~~~v~~g~r~~~p-------------------~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+. .++...+..+.. ..|                   ..++.++.+++..||..+|.+||++.+++.
T Consensus       247 ~g~~pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          247 YNVVPFSLKISLVELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HSSCSSCCSSCSHHHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCCCCcHHHHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            58899988776 677777766642 223                   568999999999999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=98.63  E-value=5.4e-08  Score=53.19  Aligned_cols=57  Identities=18%  Similarity=0.084  Sum_probs=42.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC---------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME---------APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~---------~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+.......+....         ....++.++.+++..||..+|.+||++.+++.
T Consensus       222 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          222 TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            5888998887765554443332211         23567899999999999999999999999975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=98.61  E-value=6.9e-08  Score=52.44  Aligned_cols=57  Identities=12%  Similarity=0.016  Sum_probs=46.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+.....   +..++..+.+++..||..+|.+||++.+++.
T Consensus       206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          206 SGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            58899999888777777766543222   2578999999999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=98.61  E-value=1.4e-07  Score=53.29  Aligned_cols=56  Identities=9%  Similarity=0.112  Sum_probs=48.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      +|..||.+.+..++...+..+. +..|..++.++.+++.+||..+|.+||+     +.+|+.
T Consensus       233 ~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          233 AGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            5899999998888888887775 4567889999999999999999999998     787764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=98.61  E-value=5e-08  Score=53.66  Aligned_cols=30  Identities=17%  Similarity=0.206  Sum_probs=27.4

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+++..||..+|.+||++.+++.
T Consensus       255 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          255 PNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            357889999999999999999999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=98.61  E-value=8.4e-08  Score=53.49  Aligned_cols=57  Identities=11%  Similarity=0.023  Sum_probs=46.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+.....   +..++.++.+++..||..+|.+||++.+++.
T Consensus       212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          212 SGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            58899999888877777765543221   2578999999999999999999999999976

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=98.61  E-value=1.3e-07  Score=55.20  Aligned_cols=58  Identities=21%  Similarity=0.249  Sum_probs=48.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC-CC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME-AP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~-~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+..+.... .|  ..++.++.+++..||..+|.+||++.+++.+
T Consensus       217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          217 SGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            5899999999888888887775332 22  4689999999999999999999999999863

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=98.60  E-value=1.1e-07  Score=55.08  Aligned_cols=56  Identities=9%  Similarity=0.080  Sum_probs=47.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+. ...|..++.++.+++..||..+|.+||     ++.+++.
T Consensus       344 ~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          344 CGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            5899999998888877776554 345678999999999999999999999     9999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=98.60  E-value=1.1e-07  Score=53.45  Aligned_cols=56  Identities=9%  Similarity=0.080  Sum_probs=47.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+. ...|..++.++.+++.+||..+|.+|+     ++.+|+.
T Consensus       200 ~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          200 CGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             cCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            5899999988888887776654 445778999999999999999999999     8888865

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=98.60  E-value=1.3e-07  Score=55.49  Aligned_cols=57  Identities=18%  Similarity=0.081  Sum_probs=48.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+++..+..+.....   ...++.++.+++..||..+|.+||++.+++.
T Consensus       242 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          242 CGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            58999999999899888887754322   2578999999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=98.60  E-value=1.5e-07  Score=53.28  Aligned_cols=57  Identities=12%  Similarity=0.109  Sum_probs=46.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC-CC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME-AP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~-~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+.... .|  ..++.++.+++..||..+|.+||++.+++.
T Consensus       300 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          300 AGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            5889999888777777776664332 22  578999999999999999999999999876

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=98.60  E-value=2e-07  Score=50.46  Aligned_cols=43  Identities=21%  Similarity=0.258  Sum_probs=37.6

Q ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           16 VKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        16 ~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ...+..+..+..|..++.++.+++..||..+|.+||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            4456677777778899999999999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=98.59  E-value=7.6e-08  Score=52.61  Aligned_cols=57  Identities=12%  Similarity=0.108  Sum_probs=46.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC-CCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM-EAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~-~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+... ..+  ..++.++.+++..||..+|.+||++.+++.
T Consensus       224 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          224 AGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            588999988887777777665432 222  468999999999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=98.58  E-value=1.7e-07  Score=53.23  Aligned_cols=57  Identities=7%  Similarity=-0.039  Sum_probs=47.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+.....   +..++.++.+++..||..+|.+||++.+++.
T Consensus       213 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          213 SGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            58899999988888888877653322   2578999999999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=98.58  E-value=5.6e-08  Score=56.60  Aligned_cols=57  Identities=21%  Similarity=0.296  Sum_probs=48.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC-CCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM-EAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~-~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+... ..|  ..++.++.+++..||..+|.+||++.+++.
T Consensus       222 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          222 SGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            589999999988888888777532 222  468999999999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=98.57  E-value=1.2e-07  Score=52.75  Aligned_cols=57  Identities=12%  Similarity=0.067  Sum_probs=45.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ---MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r---~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+.....   ...+..++..+.+++..||..+|.+||++.+++.
T Consensus       228 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          228 THTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            58899999888777666654432   2234678999999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=98.57  E-value=6.4e-08  Score=53.20  Aligned_cols=64  Identities=11%  Similarity=0.048  Sum_probs=49.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC----CCCCCCHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME----APEGCPPEEYEMMRQAWSLQPELRP-TFRQLKAKLLTFML   65 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~----~p~~~~~~~~~l~~~cw~~~p~~Rp-~~~~i~~~l~~~~~   65 (69)
                      +|..||.+.+..+.......+..+.    .+..+|..+.+++.+||..+|.+|| ++.++...|..+..
T Consensus       207 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          207 VGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             hCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            5889999988776554444443332    2467899999999999999999998 88888888776543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=98.56  E-value=9.3e-08  Score=57.25  Aligned_cols=57  Identities=16%  Similarity=0.145  Sum_probs=48.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM-E--APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~-~--~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+++..|..+... +  .+..++.+..+||.+||..+|.+||++.+++.
T Consensus       351 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          351 SGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            589999999998888888776432 2  23578999999999999999999999999876

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=98.56  E-value=9.3e-08  Score=54.15  Aligned_cols=58  Identities=17%  Similarity=0.154  Sum_probs=47.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC-CC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME-AP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~-~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+..|.... .+  ..++.++.+++..||..+|.+||++.+++.+
T Consensus       225 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          225 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            5889999998888888887775322 22  4689999999999999999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=98.55  E-value=1.7e-07  Score=52.32  Aligned_cols=56  Identities=13%  Similarity=0.131  Sum_probs=46.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+. ...|..++.++.+++.+||..+|.+||     ++.+++.
T Consensus       216 ~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          216 TGAPPFTGENRKKTIDKILKCK-LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            5899999998888777776654 445678999999999999999999999     6777764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=98.54  E-value=3.1e-07  Score=50.58  Aligned_cols=58  Identities=12%  Similarity=0.131  Sum_probs=43.5

Q ss_pred             CCcCCCCCCCCHHHHHHHHHc--CCCCC------------------------CCCCCCHHHHHHHHHhccCCCCCCCCHH
Q psy925            1 MNRAEMSSDEPLADVVKHVEK--GYQME------------------------APEGCPPEEYEMMRQAWSLQPELRPTFR   54 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~~--g~r~~------------------------~p~~~~~~~~~l~~~cw~~~p~~Rp~~~   54 (69)
                      ++|..||.+.+..+....+..  |..+.                        ..+.++.++.+++.+||..+|.+||++.
T Consensus       213 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  292 (308)
T 3g33_A          213 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF  292 (308)
T ss_dssp             TTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH
Confidence            468999999888766655532  11110                        0135788999999999999999999999


Q ss_pred             HHHH
Q psy925           55 QLKA   58 (69)
Q Consensus        55 ~i~~   58 (69)
                      +++.
T Consensus       293 e~l~  296 (308)
T 3g33_A          293 RALQ  296 (308)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=98.54  E-value=1e-08  Score=56.77  Aligned_cols=37  Identities=16%  Similarity=0.044  Sum_probs=32.7

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      .++.++.+++..||..+|.+||++.+++..|+.+...
T Consensus       280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            3556889999999999999999999999999988653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=98.53  E-value=1.4e-07  Score=54.06  Aligned_cols=57  Identities=14%  Similarity=0.155  Sum_probs=47.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM---EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~---~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+...   .....++.++.+++..||..+|.+||++.+++.
T Consensus       245 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          245 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            588999998888877777665422   223578999999999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=98.53  E-value=2.6e-07  Score=52.03  Aligned_cols=57  Identities=7%  Similarity=0.064  Sum_probs=45.6

Q ss_pred             CcCCCCCCC---CHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDE---PLADVVKHVEKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~---~~~~i~~~v~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.   +..++...+..|.....   +..++.++.+++..||..+|.+||++.+++.
T Consensus       215 ~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          215 TGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            588999863   45677778877754332   3578999999999999999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=98.53  E-value=3.7e-07  Score=50.31  Aligned_cols=57  Identities=5%  Similarity=-0.073  Sum_probs=42.5

Q ss_pred             CcCCCCCCCCH---------------HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPL---------------ADVVKHVEKGYQMEAP---EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~---------------~~i~~~v~~g~r~~~p---~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.               ..+...+..+......   ..++.++.+++.+||..+|.+||++.+++.
T Consensus       221 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          221 SGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            57888877542               3455566666432211   468999999999999999999999999976

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=98.53  E-value=2.1e-08  Score=55.64  Aligned_cols=57  Identities=14%  Similarity=0.141  Sum_probs=38.5

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcCCCCCCC----CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKGYQMEAP----EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g~r~~~p----~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.. +....+..+..+..+    ..++.++.+++..||..+|.+||++.+++.
T Consensus       224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          224 TGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             HSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            578888876432 222223334333322    468999999999999999999999999975

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=98.53  E-value=9.9e-08  Score=52.58  Aligned_cols=39  Identities=33%  Similarity=0.681  Sum_probs=35.0

Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925           28 PEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus        28 p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..++.++.+++..||..+|.+||++.+++..|+.+...
T Consensus       245 ~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            567889999999999999999999999999998887643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=98.52  E-value=2.6e-08  Score=54.03  Aligned_cols=56  Identities=13%  Similarity=0.102  Sum_probs=39.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+.... ...|..++.++.+++..||..+|.+||++.+++.
T Consensus       207 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          207 IGRPPFDTDTVKNTLNKVVLAD-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HSSCSSCCCSCC-----CCSSC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hCCCCCCChhHHHHHHHHhhcc-cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            4777887765544443332221 3346778999999999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=98.51  E-value=1.2e-07  Score=51.33  Aligned_cols=57  Identities=7%  Similarity=0.004  Sum_probs=41.5

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcC-CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKG-YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g-~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.. .....+..+ ........++.++.+++..||..+|.+||++.+++.
T Consensus       203 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          203 AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            588899876543 233333333 223333578999999999999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=98.51  E-value=3.2e-07  Score=51.67  Aligned_cols=56  Identities=14%  Similarity=0.103  Sum_probs=43.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAP---EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p---~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+. ..++...+..+.....+   ..++.++.+++.+||..+|.+||++.+++.
T Consensus       228 ~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          228 SGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            588999885 45566666666433322   578999999999999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=98.51  E-value=2.3e-07  Score=52.75  Aligned_cols=57  Identities=7%  Similarity=-0.072  Sum_probs=46.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+.+..+..+....   ....++.++.+++..||..+|.+||++.+++.
T Consensus       283 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          283 SGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            5889999998877777775553222   12568999999999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=98.51  E-value=6.3e-08  Score=54.97  Aligned_cols=31  Identities=19%  Similarity=0.291  Sum_probs=26.4

Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           28 PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        28 p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +..++.++.+|+.+||..+|.+||++.+++.
T Consensus       303 ~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          303 HRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            4567889999999999999999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=98.50  E-value=1.8e-07  Score=51.62  Aligned_cols=57  Identities=12%  Similarity=0.044  Sum_probs=43.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+...+   .+..++.++.+++.+||..+|.+||+..+++.
T Consensus       214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          214 TGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             hCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            5889999998877665554443322   23568999999999999999999997776654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=98.50  E-value=3.1e-07  Score=51.94  Aligned_cols=58  Identities=14%  Similarity=0.199  Sum_probs=40.8

Q ss_pred             CcCCCCCCCCH----HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPL----ADVVKHVEKG-YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~----~~i~~~v~~g-~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+.    ..+...+... ...+....++.++.+|+.+||..+|.+||++.+++.+
T Consensus       213 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          213 VGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            58899987643    2444444333 3333344689999999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=98.50  E-value=4.7e-07  Score=50.28  Aligned_cols=46  Identities=17%  Similarity=0.290  Sum_probs=37.1

Q ss_pred             cCCCCCCCCC------CCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925           21 KGYQMEAPEG------CPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus        21 ~g~r~~~p~~------~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      .+.++..|..      ++.++.+++..||..+|.+||++.+++..|..++..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            3445555544      344899999999999999999999999999988753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=98.48  E-value=1.5e-07  Score=53.24  Aligned_cols=56  Identities=9%  Similarity=0.052  Sum_probs=48.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF------RQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~------~~i~~   58 (69)
                      +|..||.+.+..++...+..+. ...|..++.++.+++..|+..+|.+|++.      .+|+.
T Consensus       219 ~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          219 CGHAPFEAENEDDLFEAILNDE-VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            5899999999888888887775 34567899999999999999999999998      66654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=98.46  E-value=3.9e-07  Score=50.36  Aligned_cols=57  Identities=7%  Similarity=0.046  Sum_probs=42.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC--------------------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM--------------------------EAPEGCPPEEYEMMRQAWSLQPELRPTFRQ   55 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~--------------------------~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~   55 (69)
                      +|..||.+.+..+....+......                          ..+..++.++.+++.+||..+|.+||++.+
T Consensus       214 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  293 (326)
T 1blx_A          214 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  293 (326)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHH
Confidence            588999988876655554321100                          012468899999999999999999999999


Q ss_pred             HHH
Q psy925           56 LKA   58 (69)
Q Consensus        56 i~~   58 (69)
                      ++.
T Consensus       294 ~l~  296 (326)
T 1blx_A          294 ALS  296 (326)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=98.46  E-value=2.1e-07  Score=51.88  Aligned_cols=57  Identities=9%  Similarity=0.015  Sum_probs=41.9

Q ss_pred             CcCCCCCCCCHH-HHHHHHH-cCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVE-KGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~-~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.. ....... ..........++.++.+|+.+||..+|.+||++.+++.
T Consensus       203 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          203 AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             HSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            588999876653 2233333 33333334678999999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=98.46  E-value=3.4e-07  Score=50.01  Aligned_cols=30  Identities=20%  Similarity=0.316  Sum_probs=27.4

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+++.+||..+|.+||++.+++.
T Consensus       251 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          251 KGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            357899999999999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=98.45  E-value=5.7e-07  Score=50.95  Aligned_cols=56  Identities=13%  Similarity=0.146  Sum_probs=46.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      +|..||.+.+..++...+..+. +..|..++.++.+++..||..+|.+||+     ..+|+.
T Consensus       216 ~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          216 AGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             cCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            5899999998888888887664 4567789999999999999999999996     466653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=98.45  E-value=7.6e-09  Score=58.25  Aligned_cols=57  Identities=18%  Similarity=0.223  Sum_probs=41.2

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+....++...+..+. ...|..++.++.+++..||..+|.+||++.+++..
T Consensus       203 ~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          203 VGRLPFDDEFIPNLFKKVNSCV-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             HSSCSSBCSSSTTCBCCCCSSC-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             hCCCCCCCccHHHHHHHHHcCC-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            4667776654443333333332 34567899999999999999999999999999753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=98.44  E-value=2e-07  Score=51.62  Aligned_cols=29  Identities=17%  Similarity=0.293  Sum_probs=26.7

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+|+.+||..+|.+||++.+++.
T Consensus       272 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          272 GFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            46789999999999999999999999876

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=98.44  E-value=9.1e-07  Score=49.67  Aligned_cols=30  Identities=17%  Similarity=0.173  Sum_probs=27.7

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+++..||..+|.+||++.+++.
T Consensus       295 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          295 GVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            457999999999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=98.43  E-value=1.7e-07  Score=51.51  Aligned_cols=57  Identities=11%  Similarity=0.099  Sum_probs=42.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCC------------------------CC-----CCCCCCHHHHHHHHHhccCCCCCCCC
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQ------------------------ME-----APEGCPPEEYEMMRQAWSLQPELRPT   52 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r------------------------~~-----~p~~~~~~~~~l~~~cw~~~p~~Rp~   52 (69)
                      +|..||.+.+..+....+..+..                        +.     .+..++.++.+++..||..+|.+||+
T Consensus       220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  299 (320)
T 2i6l_A          220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT  299 (320)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence            58899998887655554432211                        11     12468999999999999999999999


Q ss_pred             HHHHHH
Q psy925           53 FRQLKA   58 (69)
Q Consensus        53 ~~~i~~   58 (69)
                      +.+++.
T Consensus       300 ~~ell~  305 (320)
T 2i6l_A          300 AEEALS  305 (320)
T ss_dssp             HHHHHT
T ss_pred             HHHHhC
Confidence            999976

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=98.43  E-value=1.3e-07  Score=51.99  Aligned_cols=58  Identities=14%  Similarity=0.068  Sum_probs=37.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcC---CCCCCC----CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKG---YQMEAP----EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g---~r~~~p----~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+...   .....|    ..++.++.+++..||..+|.+||++.+++.+
T Consensus       193 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          193 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             HSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            578888776554432222111   111222    5689999999999999999999999999863

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=98.43  E-value=2.8e-07  Score=51.08  Aligned_cols=57  Identities=9%  Similarity=0.059  Sum_probs=43.2

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.... .+...+..+.....   +..++.++.+++..||..+|.+||++.+++.
T Consensus       214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          214 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            578898776443 44555666654333   2568999999999999999999999999874

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=98.43  E-value=4.3e-07  Score=51.15  Aligned_cols=57  Identities=16%  Similarity=0.005  Sum_probs=43.7

Q ss_pred             CcCCCCCCCCHHH-HHHHHHcCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLAD-VVKHVEKGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~-i~~~v~~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+....+ +...+..+....   ....++.++.+++..||..+|.+||++.+++.
T Consensus       245 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          245 CGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            5889998776553 555565553322   22578999999999999999999999999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=98.42  E-value=1.9e-07  Score=51.91  Aligned_cols=57  Identities=2%  Similarity=0.018  Sum_probs=42.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHhccCCCCCCCC
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME-----------------------------APEGCPPEEYEMMRQAWSLQPELRPT   52 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~-----------------------------~p~~~~~~~~~l~~~cw~~~p~~Rp~   52 (69)
                      +|..||.+.+..+....+.+....+                             .+..++.++.+|+..||..+|.+||+
T Consensus       196 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  275 (324)
T 3mtl_A          196 TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS  275 (324)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC
Confidence            5889999988876665553311111                             01346889999999999999999999


Q ss_pred             HHHHHH
Q psy925           53 FRQLKA   58 (69)
Q Consensus        53 ~~~i~~   58 (69)
                      +.+++.
T Consensus       276 ~~e~l~  281 (324)
T 3mtl_A          276 AEDAMK  281 (324)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=98.41  E-value=9.5e-07  Score=49.30  Aligned_cols=56  Identities=7%  Similarity=-0.004  Sum_probs=47.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+. ...|..++.++.+++.+|+..+|.+|+     ++.+++.
T Consensus       198 ~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          198 AGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            5889999988888777776664 455778999999999999999999999     7888764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=98.41  E-value=7.1e-08  Score=54.47  Aligned_cols=55  Identities=11%  Similarity=0.121  Sum_probs=47.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR-QLK   57 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~-~i~   57 (69)
                      +|..||.+.+..++...+..+. +..|..++.++.+++.+||..+|.+||++. +|+
T Consensus       213 ~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          213 IGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             cCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            5899999998888888887765 455778999999999999999999999987 554

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=98.41  E-value=2.8e-07  Score=51.35  Aligned_cols=28  Identities=11%  Similarity=0.184  Sum_probs=26.2

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++.++.+|+.+||..+|.+||++.+++.
T Consensus       291 ~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          291 LDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            6789999999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=98.39  E-value=3.9e-07  Score=51.74  Aligned_cols=31  Identities=29%  Similarity=0.495  Sum_probs=28.3

Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           28 PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        28 p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      |..++.++.+|+.+||..+|.+||++.+++.
T Consensus       291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            4568999999999999999999999999974

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=98.39  E-value=7.5e-07  Score=48.69  Aligned_cols=29  Identities=14%  Similarity=0.148  Sum_probs=26.8

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++..||..+|.+||++.+++.
T Consensus       255 ~~~~~~~~li~~~L~~dP~~Rpt~~~~l~  283 (299)
T 2r3i_A          255 PLDEDGRSLLSQMLHYDPNKRISAKAALA  283 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            47899999999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=98.39  E-value=5.3e-07  Score=50.55  Aligned_cols=57  Identities=12%  Similarity=0.111  Sum_probs=41.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHc--CCCC--------------------CC-----CCCCCHHHHHHHHHhccCCCCCCCCHH
Q psy925            2 NRAEMSSDEPLADVVKHVEK--GYQM--------------------EA-----PEGCPPEEYEMMRQAWSLQPELRPTFR   54 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~--g~r~--------------------~~-----p~~~~~~~~~l~~~cw~~~p~~Rp~~~   54 (69)
                      +|..||.+.+..+.+..+..  |...                    ..     ...++.++.+++..||..+|.+||++.
T Consensus       208 ~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  287 (346)
T 1ua2_A          208 LRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT  287 (346)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred             HCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHH
Confidence            47888988887665555432  2110                    00     145678999999999999999999999


Q ss_pred             HHHH
Q psy925           55 QLKA   58 (69)
Q Consensus        55 ~i~~   58 (69)
                      +++.
T Consensus       288 ell~  291 (346)
T 1ua2_A          288 QALK  291 (346)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=98.39  E-value=4.9e-08  Score=55.33  Aligned_cols=52  Identities=8%  Similarity=-0.071  Sum_probs=34.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..     .+..++.++.+++..||..+|.+||++.+++.
T Consensus       308 tg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          308 CADLPITKDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HSSCCC------CCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HCCCCCcccccccchhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            46677766544332222211     23578999999999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=98.37  E-value=9.5e-07  Score=53.75  Aligned_cols=56  Identities=13%  Similarity=0.164  Sum_probs=48.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF-----RQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~-----~~i~~   58 (69)
                      +|..||.+.+..++...+..+. +..|..++.++.+|+..||..+|.+|+++     .+|+.
T Consensus       537 tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          537 AGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             cCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            5899999999888888887765 45678899999999999999999999997     66653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=98.35  E-value=6.3e-07  Score=51.61  Aligned_cols=57  Identities=11%  Similarity=0.132  Sum_probs=43.7

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcCCCCCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKGYQMEAP---EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g~r~~~p---~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.... .+...+..+.....|   ..++.++.+++..||..+|.+||++.+++.
T Consensus       339 tg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          339 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            578899876543 445556666543333   568999999999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=98.35  E-value=3.7e-07  Score=50.65  Aligned_cols=29  Identities=14%  Similarity=0.211  Sum_probs=26.9

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++..||..+|.+||++.+++.
T Consensus       265 ~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          265 PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            57889999999999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=98.34  E-value=5.5e-07  Score=50.38  Aligned_cols=58  Identities=10%  Similarity=0.038  Sum_probs=34.7

Q ss_pred             CcCCCCCCCCHHHHHH----HHHcCC---CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVK----HVEKGY---QMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~----~v~~g~---r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.....+..    .+..+.   ..+....++.++.+++..||..+|.+||++.+++..
T Consensus       224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          224 CGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             HSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            5888998776544322    222221   112225789999999999999999999999999863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=98.34  E-value=1.4e-07  Score=53.62  Aligned_cols=30  Identities=13%  Similarity=0.336  Sum_probs=27.6

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      .++.++.+|+.+||..+|.+||++.+++.+
T Consensus       300 ~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          300 DCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             CCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             cCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence            678999999999999999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=98.33  E-value=5.3e-07  Score=51.69  Aligned_cols=58  Identities=12%  Similarity=0.099  Sum_probs=42.5

Q ss_pred             CcCCCCCCCCHH----HHHHHHHcCCC-CCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLA----DVVKHVEKGYQ-MEAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~----~i~~~v~~g~r-~~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..    .+...+..|.. .+.+  ..++.++.+||..||..+|.+||++.+++.+
T Consensus       258 ~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          258 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            588899766432    23445555532 2222  5689999999999999999999999999864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=98.33  E-value=3.8e-07  Score=52.66  Aligned_cols=57  Identities=9%  Similarity=0.144  Sum_probs=43.1

Q ss_pred             CcCCCCCCCCHHHHHHHHHc--CCCC-----------------------CC-----CCCCCHHHHHHHHHhccCCCCCCC
Q psy925            2 NRAEMSSDEPLADVVKHVEK--GYQM-----------------------EA-----PEGCPPEEYEMMRQAWSLQPELRP   51 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~--g~r~-----------------------~~-----p~~~~~~~~~l~~~cw~~~p~~Rp   51 (69)
                      +|..||.+.+..+.+..|..  |...                       +.     .+.++.+..+|+.+|+..||.+|+
T Consensus       258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~  337 (398)
T 4b99_A          258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI  337 (398)
T ss_dssp             HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred             HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence            58999999988776666633  2111                       00     134688999999999999999999


Q ss_pred             CHHHHHH
Q psy925           52 TFRQLKA   58 (69)
Q Consensus        52 ~~~~i~~   58 (69)
                      +..+++.
T Consensus       338 ta~e~L~  344 (398)
T 4b99_A          338 SAAAALR  344 (398)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=98.32  E-value=8.8e-08  Score=53.31  Aligned_cols=29  Identities=14%  Similarity=0.287  Sum_probs=27.0

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++..||..+|.+||++.+++.
T Consensus       278 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          278 KLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             chhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            57899999999999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=98.32  E-value=4.7e-07  Score=52.33  Aligned_cols=28  Identities=21%  Similarity=0.215  Sum_probs=25.9

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++++.+|+.+||..+|.+||++.+++.
T Consensus       381 ~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          381 DDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence            4788999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=98.31  E-value=5.9e-07  Score=50.64  Aligned_cols=30  Identities=13%  Similarity=0.266  Sum_probs=27.5

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+|+..||..+|.+||++.+++.
T Consensus       284 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          284 PNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            457899999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=98.29  E-value=4.7e-07  Score=51.67  Aligned_cols=36  Identities=11%  Similarity=-0.045  Sum_probs=31.9

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      ++..+.+++..||..+|.+||++.+++..+..++..
T Consensus       275 ~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          275 LQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            445788999999999999999999999999888764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=98.29  E-value=3.2e-06  Score=47.42  Aligned_cols=30  Identities=17%  Similarity=0.237  Sum_probs=27.7

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+++.+||..+|.+||++.+++.
T Consensus       276 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          276 PRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            467899999999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=98.29  E-value=9.1e-07  Score=50.09  Aligned_cols=30  Identities=17%  Similarity=0.237  Sum_probs=27.5

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+|+..||..+|.+||++.+++.
T Consensus       294 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          294 PRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            457899999999999999999999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=98.29  E-value=9.2e-08  Score=54.04  Aligned_cols=31  Identities=6%  Similarity=-0.097  Sum_probs=28.4

Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           28 PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        28 p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +..++.++.+++..||..+|.+||++.+++.
T Consensus       322 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            3578999999999999999999999999964

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=98.28  E-value=9.5e-08  Score=52.57  Aligned_cols=63  Identities=8%  Similarity=-0.026  Sum_probs=43.6

Q ss_pred             CcCCCCCCCCHHHHHH---HHHcCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVK---HVEKGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~---~v~~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      +|..||.+.+..+.+.   ....+....   .+..++.++.+++.+||..+|.+| ++.+++..|..+..
T Consensus       197 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          197 VNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             HSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             HCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            4777887765432111   011121111   235789999999999999999999 99999999988654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=98.27  E-value=9.3e-07  Score=49.48  Aligned_cols=27  Identities=15%  Similarity=0.220  Sum_probs=25.2

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++++.+|+.+||..+|.+||++.+++.
T Consensus       285 ~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          285 DPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            678999999999999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=98.26  E-value=1e-06  Score=49.21  Aligned_cols=30  Identities=13%  Similarity=0.286  Sum_probs=27.7

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+++.+||..+|.+||++.+++.
T Consensus       276 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          276 PRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            468899999999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=98.25  E-value=4.4e-07  Score=50.13  Aligned_cols=28  Identities=14%  Similarity=0.283  Sum_probs=25.3

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+.++.+++..||..+|.+||++.+++.
T Consensus       301 ~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          301 EHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            4578899999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=98.25  E-value=4.5e-07  Score=51.35  Aligned_cols=28  Identities=4%  Similarity=0.146  Sum_probs=25.3

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +.++.+|+.+||..+|.+||++.+++.+
T Consensus       292 ~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          292 ASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            4678999999999999999999999863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=98.24  E-value=2.9e-06  Score=46.37  Aligned_cols=29  Identities=7%  Similarity=0.071  Sum_probs=27.0

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.++.+++..|+..+|.+||++.+++.
T Consensus       254 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          254 KLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            57889999999999999999999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=98.24  E-value=6.6e-07  Score=49.92  Aligned_cols=57  Identities=12%  Similarity=0.194  Sum_probs=41.4

Q ss_pred             CcCCCCCCCC-------HHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEP-------LADVVKHVEKGYQMEAP---EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~-------~~~i~~~v~~g~r~~~p---~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+       ..++...+..|.....+   ..++.++.+|+..||..+|.+||++.+++.
T Consensus       204 ~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             hCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            5888997643       24566667666543322   358999999999999999999999988763

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=98.23  E-value=1e-06  Score=50.22  Aligned_cols=52  Identities=4%  Similarity=-0.049  Sum_probs=44.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR   54 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~   54 (69)
                      +|..||.+.+..++...+..+. ...|..++.++.+++.+||..+|.+|++..
T Consensus       234 ~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          234 YGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             HSSCTTCCSBHHHHHHHHHHSC-CCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             cCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence            5899999988888888876664 345678999999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=98.22  E-value=1.3e-06  Score=48.92  Aligned_cols=34  Identities=21%  Similarity=0.228  Sum_probs=30.2

Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           26 EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        26 ~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ..|..++.++.+++..||..+|.+||++.+++..
T Consensus       242 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          242 HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            3456789999999999999999999999999863

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=98.22  E-value=2.1e-06  Score=47.31  Aligned_cols=34  Identities=18%  Similarity=0.481  Sum_probs=30.5

Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           25 MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        25 ~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ...+..++.++.+++..||..+|.+||++.+++.
T Consensus       250 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            3456789999999999999999999999999976

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=98.22  E-value=2.7e-07  Score=52.40  Aligned_cols=26  Identities=8%  Similarity=-0.010  Sum_probs=23.8

Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           33 PEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        33 ~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++.+|+.+||..+|.+||++.+++.
T Consensus       347 ~~~~dli~~mL~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          347 LKFKDLILRMLDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHHhcCCChhhCCCHHHHhc
Confidence            37889999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=98.22  E-value=2.2e-06  Score=46.38  Aligned_cols=39  Identities=18%  Similarity=0.249  Sum_probs=34.6

Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925           27 APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus        27 ~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      .+..++.++.+++..||..+|.+||++.+++..+..+..
T Consensus       236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            356789999999999999999999999999999887653

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=98.22  E-value=1.3e-06  Score=48.56  Aligned_cols=33  Identities=24%  Similarity=0.396  Sum_probs=29.8

Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           26 EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        26 ~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+..++.++.+++..||..+|.+||++.+++.
T Consensus       261 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            345788999999999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=98.20  E-value=2e-06  Score=49.20  Aligned_cols=30  Identities=17%  Similarity=0.318  Sum_probs=27.5

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+|+.+||..+|.+||++.+++.
T Consensus       292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          292 PRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             TTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            458899999999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=98.20  E-value=4.4e-06  Score=47.09  Aligned_cols=57  Identities=12%  Similarity=0.193  Sum_probs=42.5

Q ss_pred             CcCCCCCCC----CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q psy925            2 NRAEMSSDE----PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~----~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~~   59 (69)
                      +|..||...    ...++...+..+ .++.|..++..+.+++.+||..+|.+||     ++.+++..
T Consensus       257 ~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          257 TGASPFTVDGEKNSQAEISRRILKS-EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HSSCTTSCTTSCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HCCCCCccCCccchHHHHHHHHhcc-CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            578898643    223444444444 3456778999999999999999999999     88888753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=98.19  E-value=1e-06  Score=49.28  Aligned_cols=28  Identities=18%  Similarity=0.199  Sum_probs=25.9

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+.++.+|+..||..+|.+||++.+++.
T Consensus       287 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          287 DAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             THHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            5788999999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=98.19  E-value=1.8e-06  Score=48.41  Aligned_cols=30  Identities=13%  Similarity=0.246  Sum_probs=27.3

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ...++.+.+++..||..+|.+||++.+++.
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          287 PTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            456889999999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=98.18  E-value=1e-06  Score=49.44  Aligned_cols=27  Identities=19%  Similarity=0.288  Sum_probs=24.3

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +..+.+|+..||..+|.+||++.+++.
T Consensus       329 ~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          329 HELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            367889999999999999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=98.16  E-value=9.4e-06  Score=45.75  Aligned_cols=51  Identities=6%  Similarity=-0.001  Sum_probs=38.3

Q ss_pred             CcCCCCCCC---------CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            2 NRAEMSSDE---------PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         2 ~g~~Py~~~---------~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      +|..||...         ....+...+..+. ...|..++.++.+++.+||..+|.+||+.
T Consensus       205 ~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          205 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HSSCTTTTTTC-------CHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             hCCCCcCCcccccccccccHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            588899652         2234445555443 45678899999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=98.15  E-value=1.1e-06  Score=48.82  Aligned_cols=27  Identities=19%  Similarity=0.347  Sum_probs=24.4

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.++.+|+..||..+|.+||++.+++.
T Consensus       307 ~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          307 HVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            457889999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=98.15  E-value=3.8e-06  Score=47.64  Aligned_cols=30  Identities=20%  Similarity=0.235  Sum_probs=27.6

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+++++.+|+.+|+..+|.+||++.+++.
T Consensus       278 ~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          278 TNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             TTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            467899999999999999999999999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=98.14  E-value=6.6e-06  Score=47.21  Aligned_cols=56  Identities=11%  Similarity=0.186  Sum_probs=41.3

Q ss_pred             CcCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHHH
Q psy925            2 NRAEMSSDEP---LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-FRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~---~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-~~~i~~   58 (69)
                      +|..||.+.+   ..++...+..+. ...|..++.++.+|+..||..+|.+||+ +.++..
T Consensus       212 tG~~Pf~~~~~~~~~~~~~~~~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          212 RGRRPYHIRSSTSSKEIVHTFETTV-VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HSSCSSCCCTTSCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             hCCCCCCCCCCccHHHHHHHHhhcc-cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            5888997543   334444444443 4567889999999999999999999998 666653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=98.12  E-value=9.7e-07  Score=50.76  Aligned_cols=52  Identities=10%  Similarity=-0.031  Sum_probs=36.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+     ...+|.++.+||..||..+|.+||++.+++.
T Consensus       312 tg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HCCCCCCCcchhhhHHHHHhh-----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            467777666544333222211     2367899999999999999999999777643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=98.12  E-value=4.5e-07  Score=50.54  Aligned_cols=53  Identities=19%  Similarity=0.059  Sum_probs=36.8

Q ss_pred             CCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            6 MSSDEPL-ADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         6 Py~~~~~-~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ||.+... ...+..+.++..++.+...+++..+|+..||..+|.+||++.+++.
T Consensus       226 Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          226 PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            6654322 1334445555544444456677889999999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=98.10  E-value=3.8e-06  Score=48.42  Aligned_cols=30  Identities=23%  Similarity=0.256  Sum_probs=27.4

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+|+.+||..+|.+||++.+++.
T Consensus       307 ~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          307 PRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            457899999999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=98.09  E-value=9.5e-07  Score=48.88  Aligned_cols=33  Identities=12%  Similarity=-0.061  Sum_probs=28.4

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      ++..+.+++..||..+|.+||++.+++.....-
T Consensus       275 ~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          275 LQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            445788999999999999999999999876643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=98.07  E-value=6.9e-07  Score=52.19  Aligned_cols=27  Identities=7%  Similarity=0.222  Sum_probs=24.6

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.++.+|+.+|+..+|.+||++.+++.
T Consensus       329 s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          329 ASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            457899999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=98.07  E-value=1.7e-05  Score=45.67  Aligned_cols=51  Identities=8%  Similarity=0.017  Sum_probs=37.8

Q ss_pred             CcCCCCCCCC---------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            2 NRAEMSSDEP---------LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         2 ~g~~Py~~~~---------~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      +|..||.+..         ...+...+..+ .+..|..++.++.+|+..||..+|.+|++.
T Consensus       248 ~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          248 AGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HSSCSSTTTTC------CCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             hCCCCCcccccccccchhhHHHHHHHHhcc-ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            5889996431         22344445444 355678899999999999999999999984

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=98.05  E-value=6.2e-06  Score=47.68  Aligned_cols=58  Identities=7%  Similarity=0.024  Sum_probs=46.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKG---YQMEAPEGCPPEEYEMMRQAWSLQPEL--RPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g---~r~~~p~~~~~~~~~l~~~cw~~~p~~--Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+..+   ...+....++.++.+|+..|+..+|.+  |+++.+|+.+
T Consensus       268 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          268 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             hCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            589999999888888777554   223333578999999999999988888  9999998753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=98.05  E-value=4.2e-06  Score=47.51  Aligned_cols=29  Identities=24%  Similarity=0.313  Sum_probs=26.8

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+++++.+|+.+||..+|.+||++.+++.
T Consensus       283 ~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          283 GANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            56889999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=98.01  E-value=2.4e-06  Score=47.33  Aligned_cols=31  Identities=13%  Similarity=0.072  Sum_probs=28.2

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKAKLLT   62 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~   62 (69)
                      +.++.+++..||..+|.+||++.+++..|+.
T Consensus       278 ~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          278 VEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            4689999999999999999999999998864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=98.00  E-value=1.3e-06  Score=48.98  Aligned_cols=30  Identities=17%  Similarity=0.180  Sum_probs=26.5

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++.++.+|+..||..+|.+||++.+++.
T Consensus       304 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          304 KDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             cchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            345678899999999999999999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=97.98  E-value=6.5e-06  Score=45.53  Aligned_cols=31  Identities=26%  Similarity=0.287  Sum_probs=28.6

Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           28 PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        28 p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +..++.++.+++..||..+|.+||++.+++.
T Consensus       274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          274 TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            4678999999999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=97.93  E-value=1.7e-05  Score=47.44  Aligned_cols=51  Identities=14%  Similarity=0.158  Sum_probs=40.4

Q ss_pred             CcCCCCCCC----CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            2 NRAEMSSDE----PLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         2 ~g~~Py~~~----~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      +|..||.+.    ...++...+..+. ...|..++.++.+++.+||..+|.+||++
T Consensus       384 tG~~PF~~~~~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          384 AARGPFRARGEKVENKELKQRVLEQA-VTYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HSSCSSCCTTCCCCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             hCCCCCCCCccchhHHHHHHHHhhcc-cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence            588999875    3356666665553 44567899999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=97.88  E-value=4.9e-05  Score=43.98  Aligned_cols=54  Identities=15%  Similarity=0.228  Sum_probs=37.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcC-CCCCCC-----CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKG-YQMEAP-----EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g-~r~~~p-----~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      |..||.+....+  ..+..+ ...+..     ..++.++.+++..||..+|.+||++.+++.
T Consensus       236 g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          236 GKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             SCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            788997765443  223233 222211     124578999999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=97.86  E-value=7.5e-06  Score=47.48  Aligned_cols=56  Identities=7%  Similarity=0.059  Sum_probs=36.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQ--MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r--~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      |..||.+....+....+.....  ...+...+..+.+|+..||..+|.+||++.+++.
T Consensus       226 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          226 GSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             SCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            7788866554433222222111  1112234556889999999999999999999974

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=97.84  E-value=4.4e-06  Score=46.24  Aligned_cols=28  Identities=18%  Similarity=0.283  Sum_probs=26.7

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ++.++.+++.+||..+|.+||++.+++.
T Consensus       292 ~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          292 VSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            7999999999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=97.82  E-value=3e-05  Score=42.15  Aligned_cols=32  Identities=22%  Similarity=0.224  Sum_probs=28.4

Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           27 APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        27 ~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+...+..+.+++..||..+|.+||++.+++.
T Consensus       252 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            34567888999999999999999999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=97.82  E-value=2.2e-05  Score=45.45  Aligned_cols=56  Identities=14%  Similarity=0.153  Sum_probs=41.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcC----CCCCCCCCCCHHHHHHHHHhccCCCCCC---CCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKG----YQMEAPEGCPPEEYEMMRQAWSLQPELR---PTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g----~r~~~p~~~~~~~~~l~~~cw~~~p~~R---p~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+    ..+..+..++.++.++|.+||. +|.+|   |++.+|+.
T Consensus       265 tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          265 YGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            589999999888777776442    1222346799999999999998 89887   68888764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=97.81  E-value=2.2e-05  Score=47.38  Aligned_cols=56  Identities=18%  Similarity=0.154  Sum_probs=42.9

Q ss_pred             CcCCCCCCCC----HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            2 NRAEMSSDEP----LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~----~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      +|..||.+.+    ..++...+..+. ...|..++.++.+|+..||..+|.+|+     ++.+++.
T Consensus       380 tG~~PF~~~~~~~~~~~i~~~i~~~~-~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          380 AGQSPFQQRKKKIKREEVERLVKEVP-EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HSSCSSSCSSSCCCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             hCCCCCcccccchhHHHHHHHhhccc-ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            5889998763    345555555443 445678999999999999999999999     6787764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=97.77  E-value=7.7e-06  Score=45.09  Aligned_cols=40  Identities=20%  Similarity=0.086  Sum_probs=30.5

Q ss_pred             HHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           19 VEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        19 v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +..+..+..+...++++.+++..||..+|.+||++.+++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          286 VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             hhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            3344333333456788899999999999999999999886

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=97.77  E-value=3e-05  Score=47.73  Aligned_cols=56  Identities=11%  Similarity=0.087  Sum_probs=42.7

Q ss_pred             CcCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            2 NRAEMSSDEP---LADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~---~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      +|..||.+.+   ..++...+..+. +..|..+++++.+|+..|+..+|.+|++     +.+|+.
T Consensus       386 tG~~PF~~~~~~~~~~i~~~i~~~~-~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          386 RGHSPFRQHKTKDKHEIDRMTLTMA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HSSCTTCGGGCCCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             hCCCCCCCCChHHHHHHHHhhcCCC-CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            5899997643   335555555544 4567889999999999999999999998     577653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=97.75  E-value=1.5e-05  Score=45.53  Aligned_cols=27  Identities=15%  Similarity=0.288  Sum_probs=25.0

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.++.+|+.+||..+|.+||++.+++.
T Consensus       307 ~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          307 DSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             TSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            678899999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=97.70  E-value=8.3e-05  Score=42.43  Aligned_cols=30  Identities=23%  Similarity=0.408  Sum_probs=27.2

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++++..+|+.+|+..||.+|++.++++.
T Consensus       323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          323 NEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             TTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            457889999999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=97.60  E-value=2.2e-05  Score=45.72  Aligned_cols=57  Identities=9%  Similarity=0.124  Sum_probs=43.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcC-CCCCCC---CCCCHHHHHHHHHhccCCCCC--CCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKG-YQMEAP---EGCPPEEYEMMRQAWSLQPEL--RPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g-~r~~~p---~~~~~~~~~l~~~cw~~~p~~--Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+ .+...|   ..++.++.+|+.+|+..++..  |+++.+++.
T Consensus       276 tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          276 YGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            589999999888887777442 223333   458999999999998777776  999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=97.38  E-value=2.4e-05  Score=44.10  Aligned_cols=28  Identities=18%  Similarity=0.095  Sum_probs=25.1

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .+.++.+|+.+||..+|.+||++.+++.
T Consensus       364 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          364 EAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             hHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            4567889999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=97.35  E-value=0.00029  Score=40.75  Aligned_cols=30  Identities=13%  Similarity=0.213  Sum_probs=27.7

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.+++++.+|+.+||..+|.+||++.+++.
T Consensus       332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          332 PSISDDGINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            458999999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=97.30  E-value=0.00029  Score=40.89  Aligned_cols=30  Identities=13%  Similarity=0.292  Sum_probs=27.5

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +.++.++.+|+.+||..+|.+||++.+++.
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            456899999999999999999999999886

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=95.77  E-value=0.0026  Score=39.30  Aligned_cols=26  Identities=12%  Similarity=-0.120  Sum_probs=20.6

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQL   56 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i   56 (69)
                      ++.++.+++..||..+|.+||++.++
T Consensus       270 ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          270 LAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             GHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            56789999999999999999999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=95.72  E-value=0.016  Score=35.42  Aligned_cols=33  Identities=21%  Similarity=0.229  Sum_probs=25.8

Q ss_pred             CHHHHHHHHHhccCCCCCCCC-HHHHHHHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPT-FRQLKAKLLTFM   64 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~-~~~i~~~l~~~~   64 (69)
                      +..+.+++.+||..+|.+||+ ..++...+..+.
T Consensus       294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            568999999999999999995 555555555543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=92.83  E-value=0.26  Score=27.64  Aligned_cols=37  Identities=14%  Similarity=0.115  Sum_probs=30.2

Q ss_pred             CCHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHHHhh
Q psy925           31 CPPEEYEMMRQAWSLQPELR-PTFRQLKAKLLTFMLNS   67 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~R-p~~~~i~~~l~~~~~~~   67 (69)
                      .+..+.+++..|+..+|.+| |++.++...|..++...
T Consensus       304 ~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          304 HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            35678899999999999988 67888888888877654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=83.42  E-value=0.63  Score=25.77  Aligned_cols=23  Identities=13%  Similarity=0.079  Sum_probs=19.2

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLK   57 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~   57 (69)
                      .+++++.+|+.+||..+     +..+++
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHH
Confidence            47789999999999976     777776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	69
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-11
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-10
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-10
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-10
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-09
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-09
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-09
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-09
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-09
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-09
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-09
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-09
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-08
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-08
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-08
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-08
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-08
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-08
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-08
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-08
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-07
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-06
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-06
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-06
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-05
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-05
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-04
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-04
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-04
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	0.002
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	0.003
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	0.004

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.9 bits (129), Expect = 3e-11
 Identities = 28/53 (52%), Positives = 37/53 (69%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
              PL DVV  VEKGY+M+AP+GCPP  YE+M+  W L   +RP+F QL+ +L
Sbjct: 202 PRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.8 bits (121), Expect = 4e-10
 Identities = 21/53 (39%), Positives = 34/53 (64%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
                 +V++++E+GY+M  P+ CP E Y++MR  W  +PE RPTF  L++ L
Sbjct: 212 PGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.9 bits (121), Expect = 5e-10
 Identities = 17/53 (32%), Positives = 28/53 (52%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
                 +V+  +E+G +ME P  CPPE Y +M   W  + E RP F  ++ ++
Sbjct: 214 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.2 bits (119), Expect = 9e-10
 Identities = 16/53 (30%), Positives = 31/53 (58%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            D    D+  ++ +G ++  PE CP   YE+M + W  + E+RP+F +L +++
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.7 bits (118), Expect = 1e-09
 Identities = 18/53 (33%), Positives = 28/53 (52%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
                ++V   +EKG +M  P GCP E Y++M   W+   E RP F  ++ +L
Sbjct: 212 RGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 49.3 bits (117), Expect = 2e-09
 Identities = 23/62 (37%), Positives = 32/62 (51%)

Query: 6   MSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML 65
                 L+ V + +EK Y+ME PEGCP + YE+MR  W   P  RP+F ++     T   
Sbjct: 216 PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

Query: 66  NS 67
            S
Sbjct: 276 ES 277

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (116), Expect = 2e-09
 Identities = 12/54 (22%), Positives = 26/54 (48%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
                ++  +H+ +G ++  P     + Y +M   W  + + RPTF+ L + +L
Sbjct: 203 ERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.6 bits (115), Expect = 4e-09
 Identities = 21/53 (39%), Positives = 30/53 (56%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
                 +V+  VE+GY+M  P  CP   +++M Q W  +PE RPTF  L+A L
Sbjct: 216 PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (114), Expect = 4e-09
 Identities = 14/53 (26%), Positives = 27/53 (50%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
              P +++   +EKG ++  P  C  + Y +M + W +  + RP FR+L  + 
Sbjct: 215 DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.9 bits (113), Expect = 6e-09
 Identities = 20/53 (37%), Positives = 30/53 (56%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
              P+ ++ K +++G++M+ P  C  E Y MMR  W   P  RPTF+QL   L
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.9 bits (113), Expect = 7e-09
 Identities = 14/54 (25%), Positives = 25/54 (46%)

Query: 7   SSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
                 A+  K ++ G++M+ P     E Y +M+  W+     RP+F  L + L
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.5 bits (112), Expect = 9e-09
 Identities = 18/52 (34%), Positives = 30/52 (57%)

Query: 9   DEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
               A++ + + +GY++E P  C  E Y++MRQ W  +P  RP+F Q+   L
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.1 bits (111), Expect = 1e-08
 Identities = 20/56 (35%), Positives = 30/56 (53%)

Query: 9   DEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM 64
                DV+  +E G ++  P  CPP  Y +M + W+  P  RP F +LKA+L T +
Sbjct: 212 GVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 46.7 bits (110), Expect = 2e-08
 Identities = 15/53 (28%), Positives = 24/53 (45%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            D    DV+  +E+ Y++  P  CP   +++M   W      RP F Q+   L
Sbjct: 235 WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.4 bits (109), Expect = 2e-08
 Identities = 16/60 (26%), Positives = 29/60 (48%)

Query: 1   MNRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +  +     +   +  + +++G +M AP+   PE Y+ M   W  +P  RPTF +L   L
Sbjct: 232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (109), Expect = 2e-08
 Identities = 19/45 (42%), Positives = 28/45 (62%)

Query: 17  KHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL 61
           K  ++G ++  PE CP + Y +M Q W+ +PE RPTF  L+  LL
Sbjct: 226 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.0 bits (108), Expect = 3e-08
 Identities = 18/53 (33%), Positives = 25/53 (47%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
                 +V+ +V  G  +  PE CP E Y +MR  WS  P  RP+F  +   L
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.6 bits (107), Expect = 3e-08
 Identities = 16/58 (27%), Positives = 30/58 (51%)

Query: 3   RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            +        +   K +++G++M +PE  P E Y++M+  W   P  RPTF+Q+   +
Sbjct: 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (107), Expect = 3e-08
 Identities = 14/53 (26%), Positives = 27/53 (50%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
            +   ++VV+ +  G+++  P       Y++M   W  +PE RP F +L  +L
Sbjct: 204 ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.6 bits (107), Expect = 4e-08
 Identities = 14/52 (26%), Positives = 26/52 (50%)

Query: 9   DEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           +    +V+K +  G+++  P  CP   Y++M Q W  +   RP F  + + L
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 2e-07
 Identities = 14/52 (26%), Positives = 29/52 (55%)

Query: 9   DEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
                 V++ V +G  ++ P+ CP   +E+MR  W   P++RP+F ++ + +
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (95), Expect = 2e-06
 Identities = 12/58 (20%), Positives = 23/58 (39%), Gaps = 4/58 (6%)

Query: 7   SSDEPLADVVKHVEKGYQM----EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
           S+      ++  V +GY      +    CP     +M +    + + RP F Q+ A +
Sbjct: 210 SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (93), Expect = 3e-06
 Identities = 7/50 (14%), Positives = 20/50 (40%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK 57
           +     ++   + +G     P     E  E++ +  +L+   RP+  ++ 
Sbjct: 215 TAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.0 bits (90), Expect = 7e-06
 Identities = 10/56 (17%), Positives = 21/56 (37%)

Query: 5   EMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKL 60
             ++ +    + +  +     E   G P E Y+ M  A +L  +  P +  L+   
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.9 bits (87), Expect = 2e-05
 Identities = 7/42 (16%), Positives = 14/42 (33%)

Query: 26  EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS 67
              +G P E    +    SL+ + +P +  L+          
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (85), Expect = 4e-05
 Identities = 6/50 (12%), Positives = 17/50 (34%), Gaps = 1/50 (2%)

Query: 8   SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK 57
                 +  K + +  +   P+       +++ +     P  RP  R++ 
Sbjct: 205 EANTYQETYKRISRV-EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 35.0 bits (80), Expect = 2e-04
 Identities = 5/55 (9%), Positives = 14/55 (25%)

Query: 3   RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLK 57
           +  + +   ++ +    +                  +       P+ RPT   L 
Sbjct: 211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 34.6 bits (79), Expect = 3e-04
 Identities = 7/53 (13%), Positives = 16/53 (30%), Gaps = 2/53 (3%)

Query: 8   SDEPLADVVKHVEKG--YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA 58
            +     V+  + K     +  P        + +++      + R T  QL  
Sbjct: 216 HELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 34.6 bits (79), Expect = 3e-04
 Identities = 9/52 (17%), Positives = 20/52 (38%), Gaps = 1/52 (1%)

Query: 7   SSDEPLADVVKHVEKGYQMEA-PEGCPPEEYEMMRQAWSLQPELRPTFRQLK 57
           S  +  A + + V  G +  +  +   PE  E++        + R + + L 
Sbjct: 213 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 32.0 bits (72), Expect = 0.002
 Identities = 11/55 (20%), Positives = 26/55 (47%), Gaps = 1/55 (1%)

Query: 4   AEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA 58
            +M   +   +  + + +G Q+   +    E   ++R   +L+P  RPTF +++ 
Sbjct: 201 YDMVCGDIPFEHDEEIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 32.0 bits (72), Expect = 0.003
 Identities = 9/52 (17%), Positives = 16/52 (30%)

Query: 7   SSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA 58
             D      VK  +  +  +A     PE  + ++     +P  R T      
Sbjct: 231 EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 31.5 bits (71), Expect = 0.004
 Identities = 9/52 (17%), Positives = 16/52 (30%)

Query: 7   SSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA 58
            +D  L + +   E  +     +       + +R      PE R T  Q   
Sbjct: 212 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	69
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.71
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.69
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.68
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.64
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.63
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.62
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.62
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.6
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.6
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.59
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.59
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.59
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.59
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.58
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.55
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.53
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.5
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.5
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.49
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.48
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.45
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.45
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.33
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.15
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.1
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.06
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.05
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	98.98
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	98.98
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	98.96
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	98.95
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	98.95
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	98.91
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	98.89
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	98.86
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	98.84
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	98.8
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	98.76
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	98.71
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	98.71
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	98.7
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	98.69
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	98.69
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	98.65
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	98.57
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	98.57
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	98.54
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	98.52
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	98.49
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	98.48
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	98.45
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	98.44
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	98.34
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	98.31
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	98.29
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	98.25
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	98.12
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	98.11
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	98.08
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	98.02
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	97.37
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	97.14
d1jhda2	223	ATP sulfurylase catalytic domain {Sulfur-oxidizing	82.26
d1kxpd3	69	Vitamin D binding protein {Human (Homo sapiens) [T	81.25

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=2.2e-17  Score=90.04  Aligned_cols=64  Identities=27%  Similarity=0.529  Sum_probs=59.9

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...|.+|.+++.|+.+|.++++||..||..+|.+||+|.+|.+.|+..+.+
T Consensus       209 G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         209 GQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             SCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            8999999998899999999999999999999999999999999999999999999998877653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=1.3e-16  Score=86.54  Aligned_cols=64  Identities=28%  Similarity=0.571  Sum_probs=59.8

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+.+|.+++.|..+|.++++||..||..+|.+||+|.+|...|+.++..
T Consensus       207 g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         207 GQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             TCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            8999999999999999999999999999999999999999999999999999999888877643

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.68  E-value=2e-16  Score=86.58  Aligned_cols=64  Identities=25%  Similarity=0.470  Sum_probs=60.6

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..|.+++.|..++.++.+||..||..+|.+||++.+|+..|++++.+
T Consensus       230 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         230 GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             SCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            8999999999999999999999999999999999999999999999999999999999988754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=2.1e-16  Score=85.05  Aligned_cols=59  Identities=20%  Similarity=0.405  Sum_probs=56.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+.+..++...+.+|.+++.|..+++++.+||.+||..+|.+||+|.+|+..|.
T Consensus       198 g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         198 GKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             SCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence            78999999999999999999999999999999999999999999999999999998874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.63  E-value=7.3e-16  Score=83.26  Aligned_cols=64  Identities=31%  Similarity=0.640  Sum_probs=60.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+.+|.+++.|+.+|.++.+||..||..+|.+||++.+|+..|..+++.
T Consensus       206 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         206 GVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            8999999999999999999999999999999999999999999999999999999999988764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=8.3e-16  Score=82.91  Aligned_cols=65  Identities=43%  Similarity=0.835  Sum_probs=61.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...|.+|.+++.|..+++++++|+..||..+|.+||+|.++++.|+++..+.
T Consensus       197 ~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~  261 (262)
T d1byga_         197 GRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  261 (262)
T ss_dssp             SCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence            78899999988999999999999999999999999999999999999999999999999987664

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=1.9e-15  Score=81.36  Aligned_cols=64  Identities=22%  Similarity=0.454  Sum_probs=59.5

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..|.++..|..++++++++|..||..+|.+||++++|++.|+++.++
T Consensus       199 ~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         199 GKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             SCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            6788888888899999999999999999999999999999999999999999999999998764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.60  E-value=1.5e-15  Score=82.97  Aligned_cols=63  Identities=29%  Similarity=0.493  Sum_probs=57.9

Q ss_pred             Cc-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            2 NR-AEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         2 ~g-~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +| ..||.+.+..++...|.+|.+++.|..+++++++|+..||..+|.+||+|.+|++.|+++.
T Consensus       237 ~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         237 SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            44 5789999999999999999999999999999999999999999999999999999988764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=2.6e-15  Score=82.30  Aligned_cols=64  Identities=28%  Similarity=0.566  Sum_probs=59.3

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...|.+|.+++.|..+++++.+||.+||..+|++||++.+|+..|+++.+.
T Consensus       223 ~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         223 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             SCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            4568999999999999999999999999999999999999999999999999999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=4.9e-15  Score=80.06  Aligned_cols=65  Identities=34%  Similarity=0.673  Sum_probs=59.2

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..++...+..|.++..|..++.++.+|+..||..+|.+||++.+|+..|+.++.++
T Consensus       207 ~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst  271 (272)
T d1qpca_         207 GRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (272)
T ss_dssp             TCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence            56677888888999999999999999999999999999999999999999999999999988653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=7.7e-15  Score=79.62  Aligned_cols=64  Identities=22%  Similarity=0.485  Sum_probs=58.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+..|.+++.|..++.++.+||..||..+|.+||+|.+|+..|+.+...
T Consensus       210 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         210 GERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             SCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            5667777888899999999999999999999999999999999999999999999999888653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=4.9e-15  Score=80.91  Aligned_cols=64  Identities=31%  Similarity=0.583  Sum_probs=60.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      |..||.+.+..++...+.+|.+++.|..+++++.+||..||..+|.+|||+.+|++.|+++...
T Consensus       234 g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         234 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             SCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            7899999999999999999999999999999999999999999999999999999999998653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=2.8e-15  Score=82.40  Aligned_cols=63  Identities=22%  Similarity=0.479  Sum_probs=59.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..|.+++.|..++.++++|+..||..+|.+||+|.+|+..|..+..
T Consensus       210 g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         210 GSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             SCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            899999999999999999999999999999999999999999999999999999999887754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=5.6e-15  Score=79.95  Aligned_cols=61  Identities=31%  Similarity=0.569  Sum_probs=54.9

Q ss_pred             cCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHV-EKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTF   63 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v-~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~   63 (69)
                      |..||.+.+..++...+ ..+.+++.|..+|.++.+|+..||..+|.+||+|.+|.+.|.+.
T Consensus       211 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         211 GQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             SCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            89999999999888777 56788888999999999999999999999999999998877653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=3.7e-15  Score=81.72  Aligned_cols=62  Identities=24%  Similarity=0.556  Sum_probs=57.1

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFM   64 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~   64 (69)
                      +..||.+.+..++...+.+|.+++.|+.++..++++|..||..+|.+||++.+|+..|.+..
T Consensus       232 ~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         232 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             SCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            36899999999999999999999999999999999999999999999999999999886643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=1.7e-14  Score=79.54  Aligned_cols=59  Identities=24%  Similarity=0.478  Sum_probs=52.5

Q ss_pred             cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy925            3 RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLL   61 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~   61 (69)
                      |..||.+.+.. .+...+..+.+++.|..+++++.+||..||..+|.+||+|++|+..|.
T Consensus       263 g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         263 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            89999998765 445566888999999999999999999999999999999999998875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=4.9e-14  Score=76.71  Aligned_cols=65  Identities=26%  Similarity=0.496  Sum_probs=56.8

Q ss_pred             cCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLA-DVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~-~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      +..||.+.+.. .+...+..|.++..|..+++++.++|..||..+|.+||++.+|+..|+++++..
T Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            35689887654 566677899999999999999999999999999999999999999999987653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=4.2e-14  Score=77.65  Aligned_cols=65  Identities=26%  Similarity=0.528  Sum_probs=52.3

Q ss_pred             CcCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMS-SDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py-~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..|| .+.+..++...+.+|.++..|+.++.++++||..||..+|.+||++.+|+..|+.+...
T Consensus       229 t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         229 TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             TTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            545555 45555677888899999999999999999999999999999999999999999998754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.49  E-value=4.6e-14  Score=76.77  Aligned_cols=63  Identities=35%  Similarity=0.686  Sum_probs=56.0

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..++...+..+.+++.|..++.++.+|+..||..+|.+||++.+|+..|+.+++
T Consensus       213 ~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         213 GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             SCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            455677888888888889999999999999999999999999999999999999998887654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=5.5e-14  Score=76.13  Aligned_cols=66  Identities=20%  Similarity=0.280  Sum_probs=54.4

Q ss_pred             CCcCCCCCCCCHH-HHHHHHHcCCCCC----CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            1 MNRAEMSSDEPLA-DVVKHVEKGYQME----APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         1 ~~g~~Py~~~~~~-~i~~~v~~g~r~~----~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      ++|..||.+.+.. .+...+..+...+    .+..+|+++.+||.+||..+|.+||+|.+|+..|+.+..+
T Consensus       203 ~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         203 MTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             HHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            3689999998765 5556667776544    3567999999999999999999999999999999887654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=1.8e-13  Score=75.01  Aligned_cols=65  Identities=28%  Similarity=0.568  Sum_probs=55.6

Q ss_pred             cCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q psy925            3 RAEMSSDEPLAD-VVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLNS   67 (69)
Q Consensus         3 g~~Py~~~~~~~-i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~~   67 (69)
                      |..||.+.+..+ +...+..|.++..|..++.++.+||..||..+|.+||+|.+|+..|++++.++
T Consensus       244 g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             TCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence            667777776654 45567889999999999999999999999999999999999999999877654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=1e-13  Score=75.40  Aligned_cols=63  Identities=33%  Similarity=0.579  Sum_probs=55.9

Q ss_pred             cCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q psy925            3 RAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFML   65 (69)
Q Consensus         3 g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~   65 (69)
                      |..||.+.+..+++..+..+.+++.|..+++++.++|..||..+|++||++.+|+..|+.++.
T Consensus       211 ~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         211 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             TCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            456677778788999999999999999999999999999999999999999999988877654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=1.2e-12  Score=70.65  Aligned_cols=57  Identities=12%  Similarity=0.144  Sum_probs=52.7

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+.++.....|..+++++.+|+.+||..+|.+||++.++++
T Consensus       209 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         209 ALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            589999999999999999999877888899999999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=3.6e-11  Score=64.59  Aligned_cols=57  Identities=11%  Similarity=0.183  Sum_probs=50.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      +|..||.+.+..++...+.++. +..|+.+++++.+|+..||..+|.+||++.+++.+
T Consensus       199 ~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         199 VGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             cCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            5899999999888888887765 45678899999999999999999999999999863

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=3.6e-11  Score=65.31  Aligned_cols=57  Identities=12%  Similarity=0.067  Sum_probs=49.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQM--EAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~--~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+++..+..+..+  ..|..+++++.+|+.+||..+|.+||++.+++.
T Consensus       210 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         210 EIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            589999999988888888777543  345789999999999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.06  E-value=3.7e-11  Score=64.74  Aligned_cols=57  Identities=16%  Similarity=0.135  Sum_probs=47.1

Q ss_pred             CcCCCCCCCCH-HHHHHHHHcCCCCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPL-ADVVKHVEKGYQME-APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~-~~i~~~v~~g~r~~-~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+... .++...+..|.++. .+..+++++.+++.+||..+|.+||++.+++.
T Consensus       207 ~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         207 TSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            58999987754 46677777776544 45678999999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.05  E-value=1.2e-10  Score=63.77  Aligned_cols=57  Identities=12%  Similarity=0.046  Sum_probs=48.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME-APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~-~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+++..+..+..+. .+..+++++.+|+..||..+|.+||++.+++.
T Consensus       209 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         209 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            5899999998888777776665544 45678999999999999999999999999865

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.98  E-value=2.1e-10  Score=62.11  Aligned_cols=65  Identities=15%  Similarity=0.100  Sum_probs=44.9

Q ss_pred             CcCCCCCCCCHHHHHHHHH----cCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLADVVKHVE----KGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~----~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+.+.......+.    .....+   .+..+|+++.++|..||..+|.+||++.+|.+.|..++..
T Consensus       208 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         208 LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            5899998876654333221    111111   2467999999999999999999999999999888877543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=98.98  E-value=1.3e-09  Score=58.54  Aligned_cols=63  Identities=16%  Similarity=0.119  Sum_probs=50.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcC-CCCC--CCCCCCHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKG-YQME--APEGCPPEEYEMMRQAWSLQPELRP-TFRQLKAKLLTFM   64 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g-~r~~--~p~~~~~~~~~l~~~cw~~~p~~Rp-~~~~i~~~l~~~~   64 (69)
                      +|..||.+.+..++...+..+ ..++  ....+|+++.+++.+||..+|.+|| +++++...|.++.
T Consensus       209 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         209 TGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             hCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            689999999888777665444 3332  3467999999999999999999999 8999988887764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.96  E-value=9.9e-10  Score=60.01  Aligned_cols=57  Identities=18%  Similarity=0.031  Sum_probs=48.5

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+.++....   .+..+++++.+|+.+||..+|.+||++.+++.
T Consensus       204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         204 CGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            5899999999888888887764322   23678999999999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.95  E-value=7e-10  Score=60.34  Aligned_cols=57  Identities=11%  Similarity=0.116  Sum_probs=46.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGY--QMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~--r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+....+..+.  ....|..++.++.+++.+||..+|.+||++.+++.
T Consensus       211 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         211 EGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            6899999988877666654433  23456789999999999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.95  E-value=5.5e-10  Score=60.49  Aligned_cols=57  Identities=11%  Similarity=0.010  Sum_probs=48.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+....   .+..++.++.+|+.+||..+|.+||++++++.
T Consensus       211 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         211 SGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            5899999999988888887775432   23678999999999999999999999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=98.91  E-value=8.4e-10  Score=59.56  Aligned_cols=57  Identities=12%  Similarity=0.075  Sum_probs=47.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGY-QMEA--PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~-r~~~--p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+.++. .++.  ...+++++.+|+.+||..+|.+||++.+++.
T Consensus       210 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         210 AGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            5899999999888888887764 3332  3479999999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=4.2e-10  Score=61.09  Aligned_cols=56  Identities=11%  Similarity=0.070  Sum_probs=49.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+. +..|..+++++.+||.+||..+|.+|||++++..
T Consensus       205 ~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         205 AGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             hCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            5899999998888888887775 4567889999999999999999999999998643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=98.86  E-value=2.1e-09  Score=59.65  Aligned_cols=57  Identities=14%  Similarity=0.117  Sum_probs=48.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+++..+.++....   .+..+++++.+||..||..+|.+||++.+++.
T Consensus       223 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         223 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            5899999999988888887765322   23578999999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=98.84  E-value=3e-09  Score=59.04  Aligned_cols=57  Identities=16%  Similarity=0.117  Sum_probs=47.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..+++..+..+....   ....++.++.+|+.+||..+|.+||++++++.
T Consensus       220 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         220 SGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            5899999999888888887664322   22468999999999999999999999999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.80  E-value=2.5e-09  Score=58.64  Aligned_cols=55  Identities=11%  Similarity=0.121  Sum_probs=48.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFR-QLK   57 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~-~i~   57 (69)
                      +|..||.+.+..++...+..+. +..|..+++++.+|+.+||..+|.+||++. +++
T Consensus       198 tG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         198 IGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             hCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            5899999999989888887775 566788999999999999999999999985 564

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.76  E-value=5.3e-09  Score=57.34  Aligned_cols=57  Identities=7%  Similarity=-0.028  Sum_probs=48.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEA---PEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~---p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+..++...+.++.....   ...++.++.+|+..|+..+|.+||++.+++.
T Consensus       198 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         198 SGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            58999999999898888877754321   2478999999999999999999999999976

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.71  E-value=1.3e-08  Score=56.37  Aligned_cols=56  Identities=9%  Similarity=0.112  Sum_probs=48.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+. +..|..+++++.+++..||..+|.+|+     ++++++.
T Consensus       233 tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         233 AGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             hCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            6899999998888888887775 455778999999999999999999994     8888875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.71  E-value=1e-08  Score=55.73  Aligned_cols=54  Identities=20%  Similarity=0.260  Sum_probs=40.3

Q ss_pred             HHHHHHH-HcCCCCCCCCC-----CCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925           13 ADVVKHV-EKGYQMEAPEG-----CPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus        13 ~~i~~~v-~~g~r~~~p~~-----~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      ..+...+ ..+.++..|..     ++.++.+|+..||..+|.+||+|.+|+..|+.+...
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            3444444 34566665533     334689999999999999999999999999988654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.70  E-value=1.5e-08  Score=55.44  Aligned_cols=56  Identities=7%  Similarity=-0.004  Sum_probs=48.8

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRP-----TFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp-----~~~~i~~   58 (69)
                      +|..||.+.+..++...+..+. ...|..+++++.+++.+||..+|.+|+     +.++++.
T Consensus       196 tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         196 AGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             hCCCCCCCcCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            6899999999989888888775 355778999999999999999999996     8888865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.69  E-value=2e-08  Score=55.41  Aligned_cols=56  Identities=9%  Similarity=0.074  Sum_probs=48.6

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      +|..||.+.+..++...+..+. +..|..+++++.+||..||..+|.+|++     +.+++.
T Consensus       200 ~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         200 CGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            5899999999888888887775 5668899999999999999999999995     777765

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.69  E-value=8e-09  Score=55.55  Aligned_cols=57  Identities=7%  Similarity=0.004  Sum_probs=42.0

Q ss_pred             CcCCCCCCCCHH-HHHHHHHcC-CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLA-DVVKHVEKG-YQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~-~i~~~v~~g-~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.+.. .....+... ........+++++.+|+.+||..+|.+||++++++.
T Consensus       201 ~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         201 AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            589999876543 223333333 333334678999999999999999999999999875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.65  E-value=1.2e-08  Score=55.14  Aligned_cols=65  Identities=15%  Similarity=0.144  Sum_probs=47.2

Q ss_pred             CcCCCCCCCCHH---HHHHHHHcCC-CCC---CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q psy925            2 NRAEMSSDEPLA---DVVKHVEKGY-QME---APEGCPPEEYEMMRQAWSLQPELRPTFRQLKAKLLTFMLN   66 (69)
Q Consensus         2 ~g~~Py~~~~~~---~i~~~v~~g~-r~~---~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~l~~~~~~   66 (69)
                      +|..||.+.+..   +....+.... ..+   .+..+|+++.+++..||..+|++||++..+...|..++..
T Consensus       208 tg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         208 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             HSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence            589999876432   3333332221 111   2467899999999999999999999999999988887653

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.57  E-value=3.9e-08  Score=53.07  Aligned_cols=57  Identities=9%  Similarity=0.085  Sum_probs=43.0

Q ss_pred             CcCCCCCCCCHHHHHHHHHc--CCC------------------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEK--GYQ------------------------MEAPEGCPPEEYEMMRQAWSLQPELRPTFRQ   55 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~--g~r------------------------~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~   55 (69)
                      +|..||.+.+..+.+..+..  |..                        ...+..+++++.+|+.+||..+|.+|||+.+
T Consensus       210 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e  289 (305)
T d1blxa_         210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  289 (305)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence            58999999988766655422  110                        0123467889999999999999999999999


Q ss_pred             HHH
Q psy925           56 LKA   58 (69)
Q Consensus        56 i~~   58 (69)
                      ++.
T Consensus       290 ~L~  292 (305)
T d1blxa_         290 ALS  292 (305)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=98.57  E-value=4.2e-08  Score=52.63  Aligned_cols=57  Identities=18%  Similarity=0.201  Sum_probs=42.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHc--CCC--------------------------CCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            2 NRAEMSSDEPLADVVKHVEK--GYQ--------------------------MEAPEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~--g~r--------------------------~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      +|..||.+.+..+....+..  |..                          ...+..+++++.+++..|+..||.+|||+
T Consensus       196 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~  275 (286)
T d1ob3a_         196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA  275 (286)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence            58999999887766554421  110                          01134578899999999999999999999


Q ss_pred             HHHHH
Q psy925           54 RQLKA   58 (69)
Q Consensus        54 ~~i~~   58 (69)
                      .+++.
T Consensus       276 ~ell~  280 (286)
T d1ob3a_         276 KQALE  280 (286)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.54  E-value=6.2e-08  Score=51.85  Aligned_cols=50  Identities=18%  Similarity=0.293  Sum_probs=39.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      +|..||.+.  .+    +.++. ...+..+|+++.+++..||..+|.+|||+++++.
T Consensus       205 ~g~~Pf~~~--~~----i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         205 CGDIPFEHD--EE----IIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HSSCSCCSH--HH----HHHCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCCc--hH----Hhhcc-cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            588888763  22    33343 3456789999999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.52  E-value=3.7e-08  Score=54.81  Aligned_cols=57  Identities=12%  Similarity=0.081  Sum_probs=42.1

Q ss_pred             CcCCCCCCCCHHHHHHHHH--cCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVE--KGYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~--~g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      +|..||.+.+..+......  .......|..+++++.+||.+||..+|.+||+     +++++.
T Consensus       201 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         201 RGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            5899998765443322222  23345567889999999999999999999999     577764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.49  E-value=7.4e-08  Score=51.97  Aligned_cols=57  Identities=11%  Similarity=0.056  Sum_probs=42.4

Q ss_pred             CcCCCCCCCCHHHHHHHHHcC--CC--------------------CCC-----CCCCCHHHHHHHHHhccCCCCCCCCHH
Q psy925            2 NRAEMSSDEPLADVVKHVEKG--YQ--------------------MEA-----PEGCPPEEYEMMRQAWSLQPELRPTFR   54 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~g--~r--------------------~~~-----p~~~~~~~~~l~~~cw~~~p~~Rp~~~   54 (69)
                      +|..||.+.+..+.+..+.+.  ..                    +..     .+..++++.+|+.+|+..+|.+|||++
T Consensus       196 ~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~  275 (299)
T d1ua2a_         196 LRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT  275 (299)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred             hCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            588999998887666555321  10                    000     135688999999999999999999999


Q ss_pred             HHHH
Q psy925           55 QLKA   58 (69)
Q Consensus        55 ~i~~   58 (69)
                      +++.
T Consensus       276 e~L~  279 (299)
T d1ua2a_         276 QALK  279 (299)
T ss_dssp             HHHT
T ss_pred             HHhC
Confidence            9875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.48  E-value=8.1e-08  Score=52.86  Aligned_cols=59  Identities=12%  Similarity=0.104  Sum_probs=39.7

Q ss_pred             CCcCCCCCCCCHHHHHHHHH----cCCC-CCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925            1 MNRAEMSSDEPLADVVKHVE----KGYQ-MEAP--EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus         1 ~~g~~Py~~~~~~~i~~~v~----~g~r-~~~p--~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++|..||.+.+..++...+.    .+.. .+.+  ..+++++.+|+..|+..+|.+||++.+++.+
T Consensus       207 ltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         207 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             TTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            47999998876554444332    2221 1111  3588999999999999999999999999763

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.45  E-value=4.1e-08  Score=53.77  Aligned_cols=57  Identities=9%  Similarity=0.094  Sum_probs=42.3

Q ss_pred             CcCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q psy925            2 NRAEMSSDEPLADVVKHVEK---GYQMEAPEGCPPEEYEMMRQAWSLQPELRPT-----FRQLKA   58 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~---g~r~~~p~~~~~~~~~l~~~cw~~~p~~Rp~-----~~~i~~   58 (69)
                      +|..||.+.+..+....+.+   ...++.|..++.++.+++.+||..+|.+|++     .++++.
T Consensus       227 tG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         227 TGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            58999987755433333322   2345667889999999999999999999995     677764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.44  E-value=1.3e-07  Score=51.04  Aligned_cols=58  Identities=12%  Similarity=0.116  Sum_probs=41.9

Q ss_pred             CcCCCCCCCCHHHHHHHHHc--CCC---------------CCC-----------CCCCCHHHHHHHHHhccCCCCCCCCH
Q psy925            2 NRAEMSSDEPLADVVKHVEK--GYQ---------------MEA-----------PEGCPPEEYEMMRQAWSLQPELRPTF   53 (69)
Q Consensus         2 ~g~~Py~~~~~~~i~~~v~~--g~r---------------~~~-----------p~~~~~~~~~l~~~cw~~~p~~Rp~~   53 (69)
                      +|..||.+.+..+....+..  |..               ...           ...++.++.+|+.+|+..+|.+||++
T Consensus       198 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~  277 (298)
T d1gz8a_         198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA  277 (298)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH
Confidence            58999999887765554421  110               000           12467899999999999999999999


Q ss_pred             HHHHHH
Q psy925           54 RQLKAK   59 (69)
Q Consensus        54 ~~i~~~   59 (69)
                      .+++.+
T Consensus       278 ~ell~H  283 (298)
T d1gz8a_         278 KAALAH  283 (298)
T ss_dssp             HHHHTS
T ss_pred             HHHhCC
Confidence            999763

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.34  E-value=4.4e-07  Score=49.15  Aligned_cols=28  Identities=14%  Similarity=0.220  Sum_probs=25.1

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++++.+|+.+|+..+|.+|+|+.+++.+
T Consensus       278 ~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         278 DPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            6677899999999999999999998863

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=9.1e-07  Score=48.25  Aligned_cols=29  Identities=17%  Similarity=0.188  Sum_probs=26.9

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+.++.+++.+||..+|.+|||+++++.
T Consensus       269 ~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         269 VFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             TBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            46889999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.29  E-value=4.4e-07  Score=49.76  Aligned_cols=31  Identities=19%  Similarity=0.234  Sum_probs=28.1

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ..+++++.+|+..|+..+|.+|||+.+++.+
T Consensus       271 ~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         271 TNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            4678899999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.25  E-value=2.8e-07  Score=50.48  Aligned_cols=30  Identities=23%  Similarity=0.273  Sum_probs=27.4

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..++++..+|+.+|+..+|.+|||+++++.
T Consensus       271 ~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         271 IGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            357889999999999999999999999976

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.12  E-value=1.8e-06  Score=47.49  Aligned_cols=30  Identities=23%  Similarity=0.256  Sum_probs=27.4

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ..+++++.+|+.+|+..||.+|||+.+++.
T Consensus       273 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         273 PRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            357889999999999999999999999875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.11  E-value=4.2e-06  Score=44.57  Aligned_cols=30  Identities=7%  Similarity=0.063  Sum_probs=27.1

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      ...+++..+|+..|+..+|.+|||+++++.
T Consensus       253 ~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         253 PKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            456889999999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.08  E-value=3.2e-07  Score=50.60  Aligned_cols=28  Identities=7%  Similarity=0.221  Sum_probs=25.0

Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           32 PPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        32 ~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ++++.+|+..|+..+|.+|||+++++.+
T Consensus       284 s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         284 ASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            5578899999999999999999999753

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.02  E-value=6.2e-06  Score=45.20  Aligned_cols=31  Identities=13%  Similarity=0.264  Sum_probs=27.6

Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHHHH
Q psy925           29 EGCPPEEYEMMRQAWSLQPELRPTFRQLKAK   59 (69)
Q Consensus        29 ~~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~~   59 (69)
                      ..++.++.+|+..|+..||.+||++.+++.+
T Consensus       265 ~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         265 PNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            3567899999999999999999999999853

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=97.37  E-value=4.1e-05  Score=41.46  Aligned_cols=29  Identities=17%  Similarity=0.223  Sum_probs=26.8

Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           30 GCPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        30 ~~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++++..+||.+|+..+|.+|||+++++.
T Consensus       290 ~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         290 LVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            47889999999999999999999999875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.14  E-value=0.0001  Score=40.18  Aligned_cols=28  Identities=18%  Similarity=0.177  Sum_probs=25.3

Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy925           31 CPPEEYEMMRQAWSLQPELRPTFRQLKA   58 (69)
Q Consensus        31 ~~~~~~~l~~~cw~~~p~~Rp~~~~i~~   58 (69)
                      .++++.+|+.+|+..||.+|||+++++.
T Consensus       300 ~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         300 EAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             cCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            4568899999999999999999999875

>d1jhda2 c.26.1.5 (A:174-396) ATP sulfurylase catalytic domain {Sulfur-oxidizing endosymbiont of Riftia pachyptila [TaxId: 35843]}

class: Alpha and beta proteins (a/b)
fold: Adenine nucleotide alpha hydrolase-like
superfamily: Nucleotidylyl transferase
family: ATP sulfurylase catalytic domain
domain: ATP sulfurylase catalytic domain
species: Sulfur-oxidizing endosymbiont of Riftia pachyptila [TaxId: 35843]

Probab=82.26  E-value=1.2  Score=22.26  Aligned_cols=38  Identities=16%  Similarity=0.092  Sum_probs=28.0

Q ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcc
Q psy925            6 MSSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMRQAWS   44 (69)
Q Consensus         6 Py~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~~cw~   44 (69)
                      |+-+.+.++|...+.+|...+ ....++++.+.|.++|+
T Consensus       182 ~~i~ISST~IR~~l~~G~~ip-~~l~~p~V~~yI~~~y~  219 (223)
T d1jhda2         182 DFVLLSGTKVREMLGQGIAPP-PEFSRPEVAKILMDYYQ  219 (223)
T ss_dssp             GEECCCHHHHHHHHHTTCCCC-TTTCCHHHHHHHHHHHH
T ss_pred             CcceeCHHHHHHHHHCcCCCC-cccCCHHHHHHHHHHHH
Confidence            444678889999999986432 23567889999988774

>d1kxpd3 a.126.1.1 (D:405-473) Vitamin D binding protein {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: Serum albumin-like
superfamily: Serum albumin-like
family: Serum albumin-like
domain: Vitamin D binding protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.25  E-value=0.25  Score=20.71  Aligned_cols=34  Identities=15%  Similarity=0.344  Sum_probs=24.8

Q ss_pred             CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q psy925            7 SSDEPLADVVKHVEKGYQMEAPEGCPPEEYEMMR   40 (69)
Q Consensus         7 y~~~~~~~i~~~v~~g~r~~~p~~~~~~~~~l~~   40 (69)
                      |..++..+....+.+..|-..|+..+.++.+++.
T Consensus         6 Yse~tFte~kkkL~e~lr~k~P~as~~~l~~mVe   39 (69)
T d1kxpd3           6 YSENTFTEYKKKLAERLKAKLPDATPKELAKLVN   39 (69)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHCTTSCHHHHHHHHH
T ss_pred             hhhccHHHHHHHHHHHHHhhCCCCCHHHHHHHHH
Confidence            6677777877777777666677777888777663